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Abstract
The main aim of this dissertation work was to develop an intelligent system to monitor,
quantify and differentiate variances in human gait with high reliability and efficiency using the
fusion of multiple sensor data and the methods of fuzzy inferential logic.
Gait disorders are heterogeneous and produce disabilities that vary substantially from
individual to individual. The recognition, quantification and analysis of gait dysfunction is
complex and, requires the integration of large amounts of data across multiple domains (kinetic,
kinematic and electromyographic). Current systems for gait analysis generally require space and
complex imaging equipment, as well as prolonged processing time, rendering them unsuitable
for real-time applications. Quantitative gait analysis has been used to elucidate characteristic
features of neurological gait disturbances. Although a number of studies have compared single
patient groups with controls, there are only a few studies comparing gait parameters between
patients with different neurological disorders.
This dissertation work is based on the hypothesis that functional rehabilitation can be
most effectively achieved through the reduction of variances from normal patterns through
training and other compensatory strategies, hence, efficient and reliable detection, quantification
and differentiation of these variances is a critical link between diagnosis and optimal recovery.
Current clinical methods of gait analysis are time and labor intensive and involve extensive posthoc data analysis. These limitations reduce access to gait analysis and exclude direct application
of the patient’s gait data to rehabilitative interventions in real-time.
The goal of the dissertation work was to develop a novel intelligent system to monitor,
quantify and differentiate variances in human gait with high reliability and efficiency using the
fusion of multiple sensor data and the methods of fuzzy inferential logic.
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Applications of this innovative technology will include improved recognition of complex
patterns related to variable and combined pathophysiologic factors, and reliable quantitative
monitoring of gait-related disability with recovery or therapeutic intervention over time.
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Chapter 1: Introduction

Locomotion disabilities are most commonly caused by neurological disorders to the
central nervous system (CNS). Hemiplegic stroke, paraparesis from spinal cord injuries, and
other upper motor neuron syndromes such as multiple sclerosis and cerebral palsy, cause serious
neurological impairments and mobility-related disabilities. Each year, approximately 700,000
suffer stroke [203], 12,000 spinal cord injuries [180] and over 250,000 are disabled by multiple
sclerosis [176] in the United States. Cerebral palsy is one of the most common chronic childhood
disorders, occurring in approximately 1 in 500 children [44]. The mobility impairments can
affect patients physically, mentally, emotionally, or a combination of the three. Moreover, the
reduction in inpatient rehabilitation length of stay and the decline in outpatient care times
covered by insurers, efficacious and cost-effective interventions for the recovery of walking have
become critical. The associated reduction in the quality of life for the patient and the burden
placed on the health care system and therapists have led to efforts to improve the rehabilitation
strategies employed in a clinical setting (for example, partial weight bearing treadmill training,
PWBTT, and functional electrical stimulation), according to [76-87, 200, 212, 243, 244, 245,
249, 263].
Neurological disorders are an important cause of mortality and constitute 12% of total
deaths globally [177]. Within these, cerebrovascular diseases are responsible for 85% of the
deaths due to neurological disorders [177]. Neurological disorders constitute 16.8% of the
deaths in lower middle income countries compared with 13.2% of the total deaths in high income
countries [177, 178]. Among the neurological disorders, Alzheimer and other dementias are
estimated to constitute 2.84% of the total deaths in high income countries in 2005.
Cerebrovascular disease constitutes 15.8%, 9.6%, 9.5% and 6.4% of the total deaths in lower
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middle, upper middle, high and low income countries respectively [177, 178]. Thus neurological
disorders constitute 6.3% of the global burden of disease [178].
The disabling consequences of neurological disease present a great challenge. Many
neurological diseases are age-related and populations in the developed world are aging. In the
USA today some 65 to 80 million citizens are disabled or elderly and the population is growing
older, with people living longer and the numbers of younger people falling. The proportion of
people with disability and/or frailty due to age in the population will continue to climb across the
community. Both the incidence of disability and the capital cost of care rise steeply with
advancing age. Today, it is estimated that nearly 70% of persons with disabilities are aged 60 or
over. The number of people over 60 is projected to rise to one in four of the population by the
year 2020. The cost of health care will rise even more steeply. The burden of caring will fall,
both physically and financially on an ever smaller proportion of the population. Ways of
reducing the burden of care and improving the quality of life for the elderly and disabled people
through independent living are urgently needed.
Most recent studies depict that stroke is the second most common cause of mortality
world-wide and the third most common disease in more developed countries [178]. According to
the World Health Organization (WHO), stroke causes about 5.54 million deaths worldwide each
year, with two thirds of these deaths occurring in less developed countries. Stroke is a major
cause of long-term disability. About half of the patients surviving for three months after stroke
will be alive for five years later, and one third will survive for 10 years. Approximately 60% of
survivors are expected to recover independence with self-care, and 75% are expected to walk
independently. It is estimated that 20% will require institutional care. The remainder will need
assistance either by family, a close friend, or paid attendant. It is noteworthy that psychosocial
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disabilities (such as difficulties in socialization and vocational functions) are more common than
physical disabilities (such as problems with mobility or activities of daily living). According to
WHO in 2006 [178], further increase in stroke is expected, with the majority of deaths from
stroke to occur in less developed countries. By 2015, over 50 million healthy life years will be
lost from stroke, with 90% of this burden in low and middle income countries. While some
progress has been made in preventing conditions such as stroke and in attenuating symptoms in
progressive conditions such as Parkinson’s disease (PD), it has been slow and so major focus has
been on neurorehabilitation.
Our society is, therefore, faced with the challenge to improve the quality of life for our
citizens who experience disabilities and handicaps by virtue of impairment or ageing. This
challenge may involve the facilitation of independent living of these citizens through promotion
of greater community/societal integration, and also through the enhancement of opportunities for
education

and

training,

communication,

employment,

transportation

and

leisure.

Neurorehabilitation seeks to lessen the disabling impact of neurological diseases when there is
limited potential for reversing the underlying pathological process. There is evidence of its
effectiveness in many conditions but the degree of disability carried by many patients remains
high. Though a simplification, it is useful to divide neurorehabilitation into measures primarily
aimed at assisting adaptation to impairment and those primarily aimed at reducing impairments.
The latter addresses underlying neurological deficits more directly but are relatively poorly
developed.
Rehabilitation technology not only provides means for independent living but can help
reduce the cost of care. Rehabilitation technology is applied technology provided to elderly and
disabled people to enable them to live independently and participate in the everyday social and

3

economic activities of the community. The use of technology to enable people with disabilities to
gain access to education and to contribute through working is both cost-effective and socially
desirable.
This research project is prompted by the belief that recent advances in neuroscience
should benefit individuals with neurological disability by reducing impairment and that such
advances are not being exploited clinically as fast as they might. One reason for this may be a
lack of efficient transfer of knowledge between basic neuroscience and clinical
neurorehabilitation, a lack this research is designed to address.
An area where rehabilitation strategies could be improved may involve the application of
automated diagnostic and therapeutic algorithms. Currently, clinical interpretation of
neurological data is solely performed manually and requires long-term experience of highly
specialized clinical experts [84]. Current concepts employed for gait analysis using human
experts have failed to acquire data and properly use these data as a tool for diagnosis with respect
to the variability of each patient’s gait pattern. The variability between the diagnoses by experts
and even between diagnoses by the same expert at different times provides a motivation for
designing intelligent systems that are capable of emulating the human reasoning process in a
consistent and repeatable manner.
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1.1

Background and Significance

Chronic diseases, such as arrhythmias, stroke, multiple sclerosis, congestive heart failure,
cancer, arthritis, chronic respiratory diseases and diabetes, are leading causes of morbidity and
mortality in the world, representing 60% of all deaths. Stroke survivors, for example, show
marked decreases in their ability to ambulate 6 months post-insult, with 20% of them unable to
walk without physical assistance and half of them walking at less than 50% of normal casual
speed. These changes in mobility translate into a significant reduction in the patients’ quality of
life, and increase the burden of therapists and the health care system in treating these patients.
Following a stroke, patients often suffer from impairments of motor and sensory functions of the
body contralateral to the site of lesion. Other common symptoms include speech disturbances,
perception disorders and cognitive disturbances. Efforts to improve walking ability and
efficiency have been undertaken using rehabilitative strategies such as partial weight bearing
treadmill training (PWBTT) to establish or re-initiate normal gait patterns in human subjects
following injury [40, 76-77, 158, 198, 212, 226, 249, 254, 255].
Recovery of locomotor activity following spinal cord injury has been extensively studied
in animal models. Rats and cats that have undergone complete low-thoracic spinal cord
transection can be trained to walk on a treadmill, and have been shown to accomplish full
weight-bearing stepping at normal speeds [12, 42, 110, 116, 143]. Other data suggest, however,
that this type of training induces a motor task-specific kind of learning. For example, Hodgson
et al. showed that spinalized cats trained to step were less able to stand and bear weight without
the motion of walking, whereas animals trained to stand were deficient in their ability to walk on
a moving treadmill [84, 144]. The re-establishment of ambulation following treadmill training
may be due to the activation of central pattern generator (CPG) neurons in the spinal cord, in
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which locomotor-associated motor neuron pools are activated in response to sensory input
coming from the limbs [142, 165, 174, 191, 235-236]. An important aspect of this behavior is
that it occurs in the absence of supraspinal input. Crucial to the success of this training, therefore,
is the coordination of sensory input to the spinal cord. The ability to step in both human and
animal subjects is highly influenced by the pattern of loading placed on the legs and by the
kinematics of the gait cycle [40, 42].
Animal studies have led to the development of measures to assist human patients
following spinal cord injury (SCI). Wernig et al. [254, 255] demonstrated a significant increase
in the ability to ambulate independently or semi-independently following intensive PWBTT in
people with incomplete spinal cord transections.

Moreover, the positive effects of this

intervention persisted for more than 6 years following training. In patients with complete SCI,
Dietz et al. [36] showed improved gait patterns as a result of treadmill training, possibly due to
the normalization of muscle activation patterns. In support of this idea, Harkema et al. recorded
electromyographic (EMG) data in lower limb muscles during stepping in complete SCI patients
and showed that their ambulatory patterns were, in fact, regulated by sensory input to the
lumbosacral spinal cord [67]. Results from both human and animal experiments, therefore,
provide evidence that spinal cord CPGs can control locomotion, and that their activity is largely
a function of proprioceptive and other sensory inputs from the limbs [116, 117, 139]. Steprelated cues can thus alter CPG activity somewhat independently of higher central nervous
system activation.
In addition to SCI, patients with brain injury or disease also have been shown to respond
positively to PWBTT. One problematic variable in patients learning to walk after a neurological
insult is that of maintaining balance during locomotion. The trunk stability provided by PWBTT
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allows for gait training, through the performance of repetitive and complicated motor activities,
without the interference of vestibular reflexes. For example, adult hemiplegic stroke patients
who failed to respond to traditional physical therapy interventions showed a 123% improvement
in swing symmetry, with a 24% improvement in stance symmetry, after PWBTT [76]. These
results were obtained in 25 training sessions carried out over 5 weeks, with the amount of body
weight support provided decreasing from 31% to 0% (full weight-bearing) in 7 out of 9 patients.
Further comparisons between subjects walking under different levels of body weight support
versus normal overground ambulation showed that partial weight support provided the most
efficacious circumstance for reducing spasticity, limiting co-contraction of antagonistic muscle
groups, and producing appropriate gait patterns [78, 226]. In another controlled study of partial
compared to no body weight support in 100 patients, increased performance, as evidenced by
positive outcomes in balance, speed, endurance and recovery was seen in the partially supported
group following a 6-week treadmill training intervention [249].

Other investigations have

resulted in rehabilitative success following PWBTT in stroke [31] and Parkinson’s [169] patients.
Several studies have suggested that plastic processes taking place in brain areas
contralateral to the injury might be of importance for functional recovery [15, 19-20, 102-104,
179]. Stimulation of axonal outgrowth from the intact hemisphere and re-innervation of
denervated regions in the midbrain and spinal cord correlated with functional improvement after
stroke [23]. Synchronous neuronal depolarization activity in the perilesional area appears to
constitute a signal for axonal sprouting from the non-lesional hemisphere [20]. Other studies
have, however, indicated that contralesional activation is accompanied by worsened outcome and
shown that re-organization of ipsilateral regions might be involved in functional recovery after
stroke, findings that are in agreement with current clinical data [37, 50, 192].
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The concept of neural plasticity includes not only synaptogenesis and dendritic branching,
but also neurogenesis, a relatively novel aspect of structural regeneration [142]. Neurogenesis
occurs in the adult mammalian central nervous system (CNS) following the migration and
differentiation of neural stem/progenitor cells (NSPCs). The majority of these cells reside in one
of two germinal zones; the subventricular zone in the wall of the lateral ventricles (SVZ) and the
subgranular zone of the hippocampus (SGZ) [236].
Evidence of neuronal self-repair following insults to the adult brain has been scarce until
very recently [19, 107, 183]. Ischemic insults have now been shown to trigger neurogenesis from
neural stem cells or progenitor cells located in the dentate subgranular zone, the subventricular
zone lining the lateral ventricle, and the posterior periventricle adjacent to the hippocampus.
New neurons migrate to the granule cell layer or to the damaged CA1 region and striatum, where
they express morphological markers characteristic of those neurons that have died. Some
evidence indicates that these neurons can re-establish connections and contribute to functional
recovery [96, 120,142]. Neural stem cells undergo symmetric or asymmetric cell divisions. In a
symmetric division, both progeny will be stem cells. In contrast, an asymmetric division
produces one new stem cell that is identical to the mother cell and one cell that is more
determined for a certain lineage of differentiation. These daughter cells have less stem cell
properties and are term progenitor cells.
It has been unambiguously demonstrated that persistent neurogenesis occurs in two
regions of the brain, i.e. in the subventricular zone (SVZ) lining the lateral ventricles, and in the
subgranular zone (SGZ) of the dentate gyrus [215]. In these areas, populations of neural stem
cells have been identified in rodents [100], monkeys [119] and humans [13]. Proliferating SVZ
cells normally migrate along the rostral migratory stream into the olfactory bulb and are finally
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incorporated as olfactory interneurons, whereas newborn neurons in the SGZ migrate into the
granular cell layer and establish synaptic contacts with the hippocampal CA3 region [153].
Although the physiological function of persistent neurogenesis is poorly understood, it has been
shown that hippocampal neurogenesis is important for spatial learning and memory [218]. In
addition, recent studies have demonstrated that focal cerebral ischemia induces SVZ and SGZ
cell proliferation, and that these cells differentiate into mature region-specific neurons, and
replace damaged neurons [8, 188]. These findings suggest the possibility of a restorative method
that aids stroke recovery.
Physical therapy has been widely used to promote stroke recovery, and its favorable
effects have been repeatedly confirmed by many clinical stroke trials [24]. Moreover, although
the biochemical mechanism is not fully understood, neural reorganization and plasticity are
likely to be important aspects of the recovery mechanism [202]. Furthermore, it has been
reported that voluntary exercise increases SGZ cell proliferation and neurogenesis [148]. These
data importantly suggest an association between physical exercise and neurogenesis. However,
clinically applied physical therapy for stroke patients is an enforced, scheduled, non-voluntary
form of exercise that is fundamentally different from the proposed experimental voluntary
exercise protocols. Thus, it is necessary to investigate the effects of clinically relevant exercise
with respect to its association with neurogenesis after stroke. Because previous studies have been
restricted to SGZ neurogenesis, SVZ and SGZ neurogenesis should be compared after physical
activity. In the study, the authors sought to evaluate effects of enforced physical training (EPT)
on neurogenesis in the SVZ and SGZ regions after stroke. To find evidence of cell proliferation
and neurogenesis, the authors [235] used some specific markers such as 5-bromo-2’deoxyuridine (BrdU), double cortin (Dcx), neuronal nuclei (NeuN), and glial fibrillary acidic
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protein (GFAP), because despite some limitations, these antibodies are currently the most widely
used techniques for studying adult neurogenesis in situ despite some limitations.
The restoration of healthy locomotion (gait) after stroke, traumatic brain injury, and
spinal cord injury, is a major task in neurological rehabilitation. Motor-learning and control
research clearly favors task-specific repetitive training [39]. The complexity of the interactions
of the various components of human gait has been researched and documented extensively, and
to date it is the experienced clinician who continues to perform functional gait assessment and
training in the absence of virtually any technological assistance.
There have been many attempts to elucidate the mechanisms underlying the intelligent
adaptive behavior in the complex human locomotor system. These attempts involve directly
capturing the activities of the neuronal system in human locomotion [93, 97-99]. They do not,
however, clarify how the nervous system adaptively functions as a dynamic system and how it
effectively coordinates adaptive interactions with the musculo-skeletal system during locomotion
[93, 99]. Other studies have tried to artificially emulate locomotion by using mathematical
models and robots based on control theory. Here again, the successful locomotor control of a
simulation model or robot does not lead to an understanding of biological locomotor mechanisms,
as the control laws are artificially constructed solely based on an engineering perspective
independent of actual biological mechanisms. Innovations in the quantitative analysis of gait
physiology and biomechanics are essential to truly understand the principles of adaptive behavior
in human locomotion and locomotion rehabilitation. Quantitative gait analysis has been used to
elucidate characteristic features of neurological gait disturbances. Although a number of studies
compared single patient groups with controls, there are only a few studies comparing gait
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parameters between patients with different neurological disorders affecting gait [12, 93, 99, 158,
254].
Robotic assistive devices have become the focus of clinical research due to the physical
demands therapists face when manually assisting the trunk and legs of subjects at treadmill
speeds greater than 0.8 mph. There are constraints on therapists’ ability to optimize sensory
inputs associated with the step cycle such as kinematics, temporal symmetries during the stance
and swing cycles due to the tasks therapists must perform and monitor simultaneously as they sit
by the subject’s legs. Current commercial robotic assistive devices automatically drive a
subject’s legs passively through the gait cycle and do not take into account the torques that a
subject can generate or incorporate the subject’s potential ability to step. Despite some evidence
of the benefit of partial weight bearing treadmill training after stroke [226] passive step training
would not seem to be an optimal method for retraining a complex motor skill such as walking.
Step training would more likely drive basic mechanisms of motor learning and representational
plasticity for the lower extremities [249] if it included the following: incorporate the subject’s
intentions and abilities, is based on subject-specific locomotor feedback, and proceeds at walking
speeds typical of overground ambulation.
There are other significant limitations in the current systems. The absence of objective
measures of essential gait parameters is a major shortcoming of commercially available robotic
assistive devices. No reported study has outlined a training method that can be reproduced by
others. Additionally, application of single sensors in the analysis of biomechanical/physiologic
states may offer only marginal results [12, 158, 198, 212, 254, 255]. These single-sensor singlealgorithm systems work well in situations where the environment is structured and the objects
are well known, but are severely limited in their ability to resolve ambiguities in complex
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systems like the human locomotor system involving multi-body dynamics, biomechanics,
physiology and other factors that obscure the interactions between the vestibular, somatosensory
and visual inputs for postural control [89, 143, 144, 174]. Murad et al in [102] have applied the
wearable sensors for human gait analysis using fuzzy inferential reasoning. However, this
method only recognized gait-related mobility but failed to characterize and differentiate the
subtle variances inherent in making decisions about outcome measures. Accelerometers and
gyroscopes are fixed to the body as sensing devices to measure motion of body segments, and
the orientation of the body segments, respectively, of human movement in free-living subjects.
They are used in several applications including the monitoring of activities of daily living [ 36,
42, 67], assessment of internal mechanical working load in ergonomics studies [ 15, 20, 31, 169],
measurement of neurological disorders [102, 104, 179] and mixed and augmented reality [23, 37,
50]. These inertial sensors were used as single sensors to monitor gait-related mobility.
Relatively small offset errors due to temperature effects on the gyroscope signals and noise do
introduce large integration errors. Sensor validation and fusion schemes enable high sensitivity
and resolution in measured data especially for therapy and rehabilitation of human.
This dissertation work has developed a novel technology to link the physiological and
biomechanical responses underlying human gait, to quantify and to differentiate the functional
components of normal and impaired locomotion. The dissertation work has developed an array
of wearable sensors that are unobtrusively attached to the body for real-time quantitative analysis
of human locomotion under any circumstances. This system allows the recording and
manipulation of locomotor-related parameters during different styles of training in order to
determine which features are most important for an individual patient. One of the expected
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outcomes is a reproducible methodology for helping therapists make reliable and differentiable
diagnosis and follow-ups on patients’ functional recovery.
This system derives intelligence through the fusion of data from the multiple sensors, and
the fuzzy inferential logic is correlated with each subject’s physiological states, including gender,
age, health conditions, and underlying mechanisms of disability, if any. The fuzzy inferential
logic allows perturbations during the step cycle to be incorporated into a control scheme that can
test postural adjustments and evaluate mechanisms of motor control.
Ultimately it is expected that the integration of multiple sensor data coupled with analysis
technologies based on fuzzy inferential logic will lead to a new gait rehabilitation paradigm
based on a thorough and rapidly-derived understanding of individual kinematic variations from
normal. More specifically, the overarching goal of this research is the development of an
intelligent system for rehabilitative therapies and/or compensatory interventions that are driven
by subject-specific locomotor data in real-time.
The World Health Organization (WHO) defines rehabilitation as an active process by
which those affected by injury or disease achieve a full recovery or, if a full recovery is not
possible, realize their optimal physical, mental and social potential and are integrated into their
most appropriate environment. Rehabilitation involves a coordinated and iterative problemsolving process along the continuum of care from the acute hospital to the home and community.
It is based on four key approaches integrating a wide spectrum of interventions: 1) biomedical
and engineering-based compensatory strategies; 2) strengthening of the individual’s personal
resources and residual capabilities; 3) adaptive modification of the affected individual’s
environment; and 4) coordination of care across services, sectors and payers.
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This dissertation work introduces technological innovations that will enable clinicians
and investigators to flexibly and efficiently quantify and differentiate the effects of disease,
aging, therapy and compensatory interventions on human gait, essential contributions to
rehabilitative and performance enhancements and a direct challenge to established systems for
clinical gait analysis. Existing systems are generally fixed, complex, expensive, and they require
prolonged data processing, characteristics that render them unsuitable for real-time applications.
There are other inertial-based sensing of activities of the human daily living. Single-sensor single
algorithms have been applied in these instances, and therefore are severely limited in their ability
to resolve ambiguities in a complex system like the human locomotor system [12, 102, 103, 158,
212, 254, 255]. Innovations in the quantitative analysis of gait physiology and biomechanics are
essential to truly understand the principles of adaptive behavior in human locomotion and
locomotion rehabilitation. New directions for research efforts are needed to improve the
effectiveness of rehabilitation treatments for sensorimotor disabilities, especially for ambulation,
balance, and maintenance of physical fitness across neurologic diagnoses. In recent years, there
has been a growing interest in the use of miniature inertial sensors and systems [23, 37, 42, 50,
96, 102-104, 120, 179, 192, 251].
This research project directly challenges current research and clinical practice by
providing a platform for relatively low cost, portable and rapid gait analysis that can function in
almost any rehabilitative setting and performance-enhancing technology based on subjectspecific locomotor feedback in real-time.
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1.2

Motivation

In recognition of the demographic time bomb facing the developed world, this research
work seeks to contribute to, and respond to the needs of aging populations with research into
aging and disabling diseases, coupled with technologies for maintaining independence and
reasonable quality of life. This calls for the utilization of technologies to compensate for the
growing inadequacies in traditional medical intervention.
There are very hard problems to be tackled in this area which demand much more basic
science and technology: these include supporting frail people and people with dementia, aphasia
following a stroke, memory loss within the community, and transportation and care for those
with failing senses and slowing reaction times. The unfilled needs and wants of elderly and
disabled people will lead directly to the need for new basic and strategic science and technology:
this will include new materials, new sensors, a greater understanding of degenerating cognitive,
and physical processes and methodologies for modeling and supporting these processes using
technology.
Through the use of engineering, mathematical and computational techniques in an
interdisciplinary field, this research work tries to apply optimally and newly developed
technologies to further our understanding of neuro-(patho-) physiology and improve the quality
of diagnosis, prognosis and follow-up for individual patients suffering from neurological and
other mobility-related disorders.
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1.3

Specific Aims

Gait disorders are heterogeneous and produce disabilities that vary substantially from
individual to individual. The quantification, differentiation and analysis of gait dysfunction are
complex and, more specifically, require the integration of large amounts of data across multiple
domains (kinetic, kinematic and electromyographic). Quantitative gait analysis has been used to
elucidate characteristic features of neurological gait disturbances. Although a number of studies
compared single patient groups with controls, there are only a few studies comparing gait
parameters between patients with different neurological disorders. Current systems for gait
analysis generally require space and complex imaging equipment. Additionally, these systems
generally require prolonged processing time, rendering them unsuitable for real-time applications
affecting gait. The overarching goal of this dissertation work is to develop an intelligent system
for rehabilitative therapies and/or compensatory interventions that are driven by subject-specific
locomotor data in real-time. The goal of the research is to develop an intelligent system to
monitor, quantify and differentiate variances in human gait with high reliability and efficiency
using the fusion of multiple sensor data, and the methods of fuzzy inferential logic. Sensor fusion
will be used to solve the problem of integrating information from different sensory sources. The
effort includes organizing the distributed sensing systems, integrating the sensors’ diverse
observations, coordinating and guiding the decisions based on each sensor’s observation, and
controlling devices with the goal of improving sensor system performance. The fusion of
multiple sensor data will use a fuzzy rule-based algorithm.
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The hypothesis of this dissertation is that since functional rehabilitation can be most
effectively achieved through the reduction of variances from normal patterns through training
and other compensatory strategies, efficient and reliable differentiation and quantification of
these variances is a critical link between diagnosis and optimal recovery. Therefore, the main
goals or specific aims of this research project are:
1) To investigate stride-to-stride fluctuations in gait to increase our understanding of the neural
control of locomotion.
2) To

gain

knowledge

of gait

dynamics

to

increase our understanding of the

neurophysiology/biomechanics of gait, and augment objective measurements of mobility and
functional status.
The knowledge acquired through this research work will enable the development of novel
ways to link physiological and biomechanical responses and quantify the functional attributes of
impairment. Therefore, the expected outcome of this research project will be the development of
a low-cost, real-time, compact and portable intelligent system for the assessment and evaluation
of functional impairments.
The expected outcomes of the dissertation work are the integration of multiple sensor
data and analysis technologies based on fuzzy inferential logic that will lead to a new gait
rehabilitation paradigm and an understanding of individual kinematic variations. In particular,
the work will improve our understanding of the neurophysiology and biomechanics of gait
through innovative technologies that provide more rapid and accurate measurements and analysis
of gait dynamics and functional mobility.
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1.4

Overview of this Dissertation
Chapter 2 presents the neurological disorders such as stroke, multiple sclerosis, spinal

cord injury, and cerebral palsy. In this chapter, WHO has realized that the burden on disability
adjusted life years (DALYs) for these common disorders, estimated according to prevalence,
duration and mortality rates, is higher than other global burdens of diseases.
Chapter 3 reviews the background of the neurological rehabilitation. This chapter
introduces the traditional gait training such as parallel bar training and PWBTT (partial body
weight support treadmill training), and a number of the modern robotic devices for gait training.
Chapter 4 reviews the basic concepts of human locomotion. It defines the gait parameters,
the joint kinematics, the kinetics and EMG activity.
Chapters 5 and 6 introduce the state-of-the-art in human locomotion, and the most recent
technologies including optical motion capture systems, inertial sensors, surface EMG, and
ground reaction force (GRF), to monitor the human locomotor for objective and quantitative
measurement and/or assessment of the recovery. In chapter 7, the limitations of the recent
technologies (as introduced in chapter 6) are discussed in detail.
The experimental design, data acquisition and data processing are presented in chapters 8,
9, and 10, respectively. Sensor fusion was used to augment the data acquisition, and the fuzzy
inferential logic (FIL) serves as the engine to make decisions. Subjects, both able-bodied and
neurological impaired were recruited. The ground reaction forces (GRF), electrical activities of
the muscle (EMG), and the segmental accelerations data were carefully processed.
Case studies are presented, explained and discussed in detail in chapters 11, 12, and
appendix. Chapter 13 highlights the contributions that have been made in this research. Finally,
the limitations and suggestions for future enhancement of this research are given in chapter 14.
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Chapter 2: Global Burden of Neurological Disorders

2.1

The Global Burden Awareness for Neurological Disorders

Neurological disorders are a significant and increasing public health problem. The Global
Burden of Disease (GBD) study found that the burden of neurological disorders was seriously
underestimated by traditional epidemiological and health statistical methods that take into
account only mortality rates but not disability (physically and mentally) rates [178]. A large body
of evidence shows that policy-makers and health-care providers may be unprepared to cope with
the predicted rise in the prevalence of neurological and other chronic disorders and the disability
resulting from the extension of life expectancy and ageing of populations globally [65, 209].
Most of the neurological disorders result in long-term disability, and pain is a significant
symptom in several neurological disorders and adds significantly to emotional suffering and
disability. Furthermore, even the burden estimates combining mortality and disability do not take
into account the suffering from social and economic losses affecting patients, their families and
the community. The World Health Organization (WHO) has brought a clear message that unless
immediate action is taken globally, the neurological burden is expected to become an even more
serious and unmanageable threat to public health.
This chapter addresses a number of important neurological disorders including stroke,
multiple sclerosis (MS), spinal cord injury (SCI), and cerebral palsy (CP). These neurological
disorders are studied significantly in this research and will be discussed with case studies in later
chapters.
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2.2

Stroke

A stroke is a cardiovascular disease that affects the supply of blood to the brain. It occurs
when an artery supplying blood to the brain either becomes blocked or bursts. The brain cells
lose their supply of oxygen and nutrients, which in a matter of a few minutes the cells can die.
Cell death results in areas of localized cerebral infarct, and the parts of the body that they control
are unable to function. The overwhelming effects caused by stroke can often be permanent if the
person is not properly treated or rehabilitated after he/she has had a stroke.
There are two types of stoke: ischemic (occlusion of the cerebral blood vessel) and
hemorrhagic (rupture of a blood vessel). Ischemic stroke is more prevalent, and account for more
than 80% of all stroke insults. Ischemic stroke can be divided into two types: cerebral thrombosis
and cerebral embolism. Cerebral thrombosis is a blockage in an artery of the brain caused by a
blood clot or thrombus that forms within the blood vessel system; while cerebral embolism is a
blockage caused by a detached fragment of thrombus or other material that has formed
somewhere else (usually in the heart and large arteries of the upper chest and neck) and is carried
by the bloodstream to the brain. Hemorrhagic stroke can also be divided into two types:
subarachnoid and intracerebral. Subarachnoid hemorrhage occurs when a blood vessel on the
surface of the brain ruptures and bleeds into the cavity between the brain and the skull, but not
inside the brain itself. An intracerebral hemorrhage transpires when an artery in the brain bursts,
flooding the surrounding brain tissue with blood.
There are a number of risk factors for stroke including hypertension, high cholesterol,
cardiovascular disease, brain tumors, obesity, diabetes, smoking, and other miscellaneous
conditions.
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2.2.1

Effects of Stroke

The effects of stroke vary from person to person based on the type, severity, and location
of the stroke. The brain is divided into three regions: cerebrum (including left and right
hemispheres), cerebellum, and brain stem. Since each hemisphere of the brain controls the
activity of the opposite side of the body, any damage of one side of hemisphere will lead to a
disability to the opposite side of the body. The following body functions may be impaired by
someone who has had a stroke:
•

Loss of normal motor control: muscle weakness (hemiparesis) or paralysis (hemiplegia
due to abnormal muscle tone e.g. spasticity) on one side of the body.

•

Sensory and proprioceptive loss: causing problems with speech, hearing, touch, sight,
smell and balance.

•

Problems with understanding of spatial concepts: affected depth perception and directions
such as up/down and front/back.

•

Learning, memory, and concentration may be affected.

•

Psychological and emotional problems: behavioral changes, e.g. depression which may
also lead to the social consequences.

2.2.2

Burden of Stroke

According to the most recent estimates, stroke is the second most common cause of
mortality worldwide [177, 208]. In report of the World Health Organization [2004], stroke
causes about 5.54 million deaths worldwide each year, with two thirds of these deaths occurring
in less developed countries. Without urgent action, deaths from stroke will increase over the next
decade by 12% globally and 20% in developing countries.
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Stroke is a major cause of long-term disability. About half of the patients surviving for
three months after their stroke will be alive five years later, and one third will survive for ten
years. Approximately 60% of survivors are expected to live independence with self-care, and
75% of these survivors are expected to walk independently. About 20% of the survivors will
require institutional care, and the remainder will need assistance either by family or other
communities. The long-term disability with dependent activities of daily living consequently
causes psychosocial disabilities such as difficulties in socialization and vocational functions.
Furthermore, the long-term disability has potentially enormous emotional and socioeconomic
impact on patients, families, and public health services (world health report, 2004).

2.2.3

Treatment and Rehabilitation of Stroke Survivors

Treatment of acute stroke may vary with respect to the type and subtype, severity and the
location of the disease. In the past decade, treatment of acute stroke improved dramatically in
the majority of developed countries. The development of specialized stroke services (e.g. stroke
units) plays a key role in the provision of effective therapies and in improving the overall
outcome after stroke. Evidence shows that treatment in stroke units is very effective, especially
when compared with treatment in general medical wards, geriatric wards or any other of hospital
department in which no specialized staff and equipments are exclusively dedicated to stroke care
[106].
Stroke rehabilitation is the restoration of patients to their previous physical, mental and
social capability. Rehabilitation starts as soon as possible after stroke onset (often within 24 to 48
hours after the stroke) in the stroke units. It is followed by short-term rehabilitation in the
rehabilitation centers or outpatient settings. It is of extreme importance to reacquire the ability to
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carry out the basic activities of daily living such as bathing, dressing, using a toilet in the first
stage for a stroke survivor’s return to functional independence. The scientific basis for
rehabilitation and neural repair has increased considerably, and reorganization of activation
patterns in the brain after injury may be monitored by functional imaging studies (fMRI and
PET).

2.3

Multiple Sclerosis

Nerve cells communicate by sending action potentials along the axons, which are
wrapped in an insulating protective substance called myelin sheaths, shown in figure 2-1. Myelin
sheath provides insulation for nerves, and improves the conduction of impulses along the nerves
and also is important for maintaining the normal function of the nerves. Multiple sclerosis (MS)
is generally considered to be autoimmune inflammatory condition in which the myelin sheaths
around the axons of the brain and spinal cord are damaged, leading to demyelination.
Demyelination causes scarring and sclerosis of the nerve tissue in the brain, spinal cord, and
optic nerves. In regions of inflammation, breakdown of the blood brain barrier occurs and
destruction of myelin ensures, with axonal damage, gliosis and the formation of sclerotic plaques.
Consequently, the electrical impulses that travel along the nerves decelerate or can no longer
effectively be conducted, which results in weakness, numbness, pain, and vision loss. Plaques
may form in the central nervous system (CNS) white matter in any location; thus clinical
presentations may vary from people to people, and from time to time.
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Figure 2-1: Structure of Axon with Myelin Sheath wrapping

To date no clear risk factor for the MS has been unequivocally identified. In the last two
decades, researchers have focused on disorders of the immune system and genetics for
explanations. It is now generally accepted that the etiology of MS involves some interplay of
genetic and environmental factors. Researchers also suspect that a foreign agent such as a virus
alters the immune system so that the immune system perceives myelin as an intruder and attacks
it.

2.3.1

Effects of Multiple Sclerosis

Because different nerves are affected at different times, MS symptoms may be single or
multiple, and may range from mild to severe in intensity and short to long in duration.
•

Early symptoms of the disorder may include vision changes (e.g. blurred vision, blind
spots, and color desaturation), numbness, and dizziness.

•

Heat sensitivity.

•

Muscle weakness, coordination and balance problems.
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•

Spasticity of the muscle, speech impediment, tremors.

•

Mental changes such as decreased concentration, attention deficits, loss of memory,
depression or paranoia.

2.3.2

Types of Multiple Sclerosis

MS is a complex condition, and often no two people experience the same thing. In order
to develop a common language for evaluating and researching MS, an international survey was
conducted among scientists who specialize in MS research and patient care. Analysis of
responses resulted in defining the four typical categories of MS, which were introduced in 1996
[145]:
•

Relapsing Remitting MS (RRMS) – most common type, around 80-85% of MS patients

A relapse is defined as an appearance of new symptoms or existing symptoms become more
severe. The relapse can last for varying periods (days or months) and there is partial or total
recovery (remission). In RRMS relapses occur with full or partial recovery and there is
disease/symptom stability between attacks.
•

Primary Progressive MS (PPMS) – affects around 10-15% of all MS patients

PPMS are characterized by a lack of distinct attacks, but with slow onset and then steadily
worsening symptoms. There is no relapses or remissions period. However, there are variations in
rates of progression over time, occasional plateaus and temporary minor improvements.
•

Secondary Progressive MS (SPMS) – most of RRMS convert to SPMS

Patients with SPMS experience an initial period of RRMS, followed by a steadily worsening
disease course with or without occasional flare-ups, minor recoveries (remissions), or plateaus.
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Approximately 50% of patients with RRMS will develop SPMS within 10 years, and 80% will
have developed SPMS within 20 years of disease onset.
•

Progressive Relapsing MS (PRMS) – approximately 5% of MS patients

Patients with PRMS experience a steadily worsening disease from the onset but subsequently
also have clear acute relapses, with or without recovery. In contrast to RRMS, the periods
between relapses are characterized by continuing disease progression.

2.3.3

Burden of Multiple Sclerosis

MS affects around 2.5 million people worldwide each year. It is one of the most common
neurological disorders and cause of disability of young adults (between 18 to 38 years old),
especially in Europe and North America. The frequency of MS varies by geographical region
throughout the world, apparently increasing with distance from the equator in both hemispheres.
MS is more common among women than men, is less common among non-white individuals
than whites.
Several studies have evaluated that maintaining mobility is ranked as one of the highest
priorities among patients with MS, regardless of disease duration or disability level [227]. The
loss of mobility contributes to a substantial patient burden. The statistical techniques of path
analysis has shown how difficult walking significantly affects physical activity in patients with
MS. Impaired mobility is associated with reductions in quality of life and activities of daily
living.
MS has a profound impact on patient’s social roles and the well-being of their families.
MS is frequently diagnosed during a person’s most productive years (the onset is usually at about
30 years of age), and because life expectancy for patients with MS approaches that of the general
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population, MS is associated with a considerable economic burden from medical costs and lost
productivity. Physical disability complicated by depression and possibly cognitive impairment
contributes to a high rate of unemployment. Together with their family members, they may bear
a financial burden related to home and transport modifications and the need for additional
personal services.

2.3.4

Treatment and Neurorehabilitation of Multiple Sclerosis

There are no curative treatments available for MS. Drugs that are common to MS
symptoms such as urinary dysfunction, spasticity and neuropathic pain, are relatively well
established and widely used. To date, studies on MS prevention and curative treatments focus on
neuro-protection and neuro-repair.
Even though drug treatment options are relatively limited, significant improvements in
the quality of life of people with MS can be supported by improved rehabilitation approaches.
Neurorehabilitation has been defined by WHO as “an active process by which those disabled by
injury or disease achieve a full recovery or, if a full recovery is not possible, realize their optimal
physical, mental and social potential and are integrated into their most appropriate environment”.
The essential components of successful neurorehabilitation include expert multidisciplinary
assessment, goal-oriented programs and evaluation of impact on patient and goal achievement
through the use of clinically appropriate, scientifically sound outcome measures incorporating
the patient’s perspective [197].
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2.4

Spinal Cord Injury

The spinal cord is an extension of the brain and together with the brain forms the central
nervous system (CNS). The spinal cord is the main pathway for information connecting the brain
and peripheral nervous system (PNS). The human spinal cord extends from the medulla
oblongata and continues through the conus medullaris near the first or second lumbar vertebra
(L1 or L2), terminating in the cauda equina. It consists of 31 pairs of spinal nerves containing
both sensory and motor fibers, which transmit electrical information to and from the limbs, trunk,
and other parts of the body, back to and from the brain. The spinal nerves are grouped together in
different bundles called ascending and descending tracts, forming white matter neuron pathways,
shown in Figure 2-2. Ascending tracts (bundles of afferent/sensory neurons) within the spinal
cord carry impulses, such as touch, temperature, pain and joint position, from the body upwards
to the brain. Descending tracts (bundles of efferent/motor neurons) carry impulses from the brain
downwards to the effectors to initiate movement and control body functions.
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1 Fasciculus gracilis
1a Fasciculus cuneatus
2 Dorsolateral fasciculus
3 Posterior spinocerebellar tract
4 anterior spinocerebellar tract
5 Spinothalamic, Spinoreticular,
Spinomesencephalic and
Spinohypothalamic tracts
6 Spinoolivary tracts
7 Fasciculi proprii
8 Medial longitudinal fasciculi
9 Septomarginal fasciculus
10 Interfascicular fasciculus
11 Lateral corticospinal
12 Rubrospinal tract
13 Lateral reticulospinal tract
14 Medial reticulospinal tract
15 Vestibulospinal tract
16 Anterior corticospinal tract
17 Tectospinal tract
Ascending
tracts

Descending
tracts

Bidirectional
tracts

Figure 2-2: Spinal Cord Cross-section

The major ascending and descending spinal cord pathways
(http://emedicine.medscape.com/article/1148570-overview)

The diagram of the cross-section of the spinal cord of Figure 2-2, the center of the cord
consists of gray matter shaped like H or a butterfly. The anterior or motor horns contain nerve
cells that carry signals from the CNS through the motor root to muscles; the posterior or sensory
horns contains nerve cells that receive sensory information through the sensory root from
peripheral nerve cells outside the spinal cord.
A spinal cord injury (SCI) is damage of spinal nerves (nerve roots) or myelinated fiber
tracts that carry signals to and from the brain [114, 140]. Spinal cord injury can occur from many
causes, including trauma from falls or accidents, tumor, developmental disorders, ischemia of
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spinal blood vessels, meningitis and myelitis, inflammation, multiple sclerosis and vascular
malformations. Spinal cord injury results in loss of communication between the brain and other
parts of the body and cause paralysis, loss of sensation, or weakness in the parts of the body
below the injured region.

2.4.1

Location and Effects of the Injury

There are 31 pairs of spinal nerves which branch off from the spinal cord. There are four
main groups of spinal nerves which exit different levels of the spinal cord. Figure 2-3 illustrates
the four groups in descending order down the vertebral column: cervical, thoracic, lumbar, and
sacral. Each group is referred to by the letters C, T, L, or S respectively. Cervical (neck) nerves
supply movement and sense to the arms, neck and upper trunk; thoracic (chest) nerves supply the
chest and abdomen; lumbar (lower back) and sacral (Pelvis) nerves supply the legs, bladder,
bowel and sexual organs.
The symptoms after a spinal cord injury differ by location of the injury. In general, the
higher location in the spinal column the injury occurs, the more severe symptoms a person will
experience. For example, injury between C1 and C2 can result in a loss of many involuntary
functions that are controlled by sympathetic and parasympathetic nervous systems, including the
ventilation control mechanisms for breathing, and the mechanisms to maintain blood pressure
and to control body temperature.
Since each spinal nerve runs from a specific vertebra in the spinal cord to a specific area
of the body, the skin’s surface has been divided into areas called dermatomes. A dermatome is an
area of skin whose sensory nerves all come from a single spinal nerve root. Loss of sensation in a
particular dermatome enables doctors to locate where the spinal cord is injured.
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Cervical Injuries
Between C1 and C5: paralysis of the muscle used for
breathing (more likely causing fetal), and all arms
and legs (quadriplegia).
Between C5 and T1: paralysis of the legs, trunk,
hands and wrist. Weakness of the muscles that move
the shoulder, elbow, hands and fingers.

Thoracic Injuries
Between T1 and T8: instability of the trunk above the
waist due to poor abdominal muscle control.
Between T8 and L1: loss of trunk and abdominal
muscle control, loss of sensation between the rib cage
and hips and legs.

Lumbar and Sacral Injuries
Between L1and S5: muscle weakness of the hips,
legs and foots, decreasing control of the flexors and
extensors of the lower extremity, decreased control of
urinary system and anus.

Figure 2-3: Location of the spinal cord injury and consequent effects
(http://www.spinalinjury.net/)

2.4.2

Classification of Spinal Cord Injury

SCI can be divided into two major types of injury: complete and incomplete. A complete
injury means that there is no function below the level of the injury, no sensation and no voluntary
movement. Both sides of the body are equally affected. An incomplete injury means that there is
some functioning below the primary level of the injury. However, the clinicians found this
traditional classification was difficult to apply. The American Spinal Injury Association (ASIA)
considered the difficulty and formulated the classification system for spinal cord injury in 1992.
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ASIA impairment scale classified [5, 38] the SCI into five categories from the most server to
normal:
•

A = Complete, no motor or sensory function is preserved in the sacral segments S4-S5;

•

B = Incomplete, sensory but not motor function is preserved below the neurological level
and includes the sacral segments S4-S5;

•

C = Incomplete, motor function is preserved below the neurological level, and more than
half of key muscles below the neurological level have a muscle grade less than 3, which
indicates active movement with full range of motion against gravity;

•

D = incomplete, motor function is preserved below the neurological level, and at least
half of key muscles below the neurological level have a muscle grade of 3 or more;

•

2.4.3

E = Normal, motor and sensory function are normal.

Incidence, Prevalence, and Consequence of SCI

The latest statistical report from the National Spinal Cord Injury Statistical Center
(NSCISC), Birmingham, Alabama, shows that the number of people in the United States who are
alive in 2008 who have SCI has been estimated to be within a range of 229,000 to 306,000
persons, and there are about 12,000 new injuries occurring each year. More than 80% of the
victims are male (partially due to males being more likely to engage in risk taking behavior), and
average age at time of injury is 40.2 years. The majority of all new injuries reported are the result
of auto accidents (42%), falls (27%), violence (15%), sports injuries (8%) and other or unknown
(8%). The most common cause of death is respiratory ailment such as pneumonia and pulmonary
embolism. Mortality rates are significantly higher during the first year after injury than during
subsequent years [180].
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Persons with quadriplegia have sustained injuries to one of the eight cervical segments of
the spinal cord; those with paraplegia have lesions in the thoracic, lumbar, or sacral regions of
the spinal cord. The most frequent neurologic category at discharge of persons reported to the
database is incomplete quadriplegia (30.1%), followed by complete paraplegia (25.6%),
complete quadriplegia (20.4%), and incomplete paraplegia (18.5%). Less than 1% of persons
experienced complete neurologic recovery by hospital discharge. Over the last 15 years, the
percentage of persons with incomplete quadriplegia has increased slightly while complete
paraplegia has decreased slightly [180].
Overall, median day hospitalization in the acute care unit following injury have declined
from 24 days in 1979 to 12 days in 2008. Similar downward trends are noted for days in the
rehab unit from 98 to 37 days. Median day hospitalization were greater for patients with
neurologically complete injuries [180].
The psychological impact of spinal cord injuries presents patients with the difficult task
of grieving for their lost mobility, adjusting a new dependency on others, and learning to create
different goals for their lives. Their family members must also learn to adjust to the patient’s
injury and changes in relationship dynamics.
Treatment at hospitals and rehabilitation centers can be expensive, and when combined
with costs of purchasing equipment (such as a motorized wheelchair), modifying housing and
transportation for accessibility, continuing medical visits, and personal assistance services, the
result is a large financial burden for spinal cord injury patients. This burden is made worse by
the lost earnings that spinal cord injury patients experience during treatment and beyond.
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2.4.4

Treatment and Rehabilitation of Spinal Cord Injury

In the acute stage of spinal cord injury, doctors focus on rescuing victim’s life:
maintaining the ability to breathe, preventing shock, immobilizing the neck and back to prevent
further damage, and avoiding complications, such as respiratory or cardiovascular conditions.
After the disease stabilizes, doctors turn their attention to preventing secondary damage, such as
restricted blood flow, excitotoxicity, inflammation, free radical release, and apoptosis.
•

Restriction of blood flow
Immediately after the injury, there is a major reduction in blood flow to the site, which

can last for as long as 24 hours and becomes progressively worse if untreated. The combination
of leaking, swelling, and sluggish blood flow prevents the normal delivery of oxygen and
nutrients to neurons, causing further damage. Reduction of the blood flow also causes the drop in
blood pressure and heart rate.
•

Excessive release of neurotransmitters and excitotoxicity
The crushing and tearing of axons is just the beginning of the devastation that occurs in

the injured spinal cord and continues for days. The initial physical injury sets off a cascade of
biochemical and cellular events that kills neurons and their myelin insulation, and triggers an
inflammatory immune system response. For example, after the injury, an excessive release of
neurotransmitters (Glutamate) flood the area of the injury for reasons that are not yet well
understood. These excessive glutamate triggers a process called excitotoxicity, which disrupts
normal processes and kills neurons and other cells such as oligodendrocytes that surround and
protect axons.
•

Autoimmune system cells creates inflammation
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Under normal conditions, the blood brain barrier keeps immune system cells from
entering the brain or spinal cord. When the blood brain barrier is broken by blood vessels
bursting and leaking into spinal cord tissue, immune system cells such as neutrophils, T-cells,
macrophages and monocytes, can invade the surrounding tissue and trigger an inflammatory
response.
•

Free radical attack nerve cells
In spinal cord injury, the inflammation of the spinal cord tissue signals particular cells to

overproduce free radicals. Free radicals then attack and disable molecules that are crucial for
normal cell function.
•

Nerve cells apoptosis
Apoptosis can help the body get rid of old and unhealthy cells by causing them to shrink

and implode. In normal condition, apoptosis seems to be regulated by specific molecules that
have the ability to either start or stop the process. For reasons that are not clear, spinal cord
injury sets off apoptosis, which kills oligodendrocytes in damaged area, and this damage in turn
causes the damage of the myelin sheath.
Treatment for a spinal cord injury is complex. Repairing it has to take into account all of
the different kinds of damage that occur during and after the injury. Because the molecular and
cellular environment of the spinal cord is constantly changing from the moment of injury until
several weeks or even months later, combination therapies will have to be designed to address
specific types of damage at different points in time.
The rehabilitation must begin in the early stages of recovery. During the initial stages of
rehabilitation, therapists usually emphasize maintenance and strengthening of existing muscle
function, redeveloping fine motor skills and learning adaptive techniques to accomplish everyday
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living tasks. The rehabilitation team includes physical therapist, occupational therapist,
rehabilitation nurse, psychologist, social worker, dietitian, recreation therapist, who work
together to participate in therapies and treatment.
Research on understanding the cellular and molecular mechanisms in both the healthy
and damaged spinal cord could point the way to therapies that encourage axons to grow in
injured areas, and reconnect vital neural circuits within the spinal cord and CNS. Researchers,
many of whom are supported by the National Institute of Neurological Disorders and Stroke
(NINDS), are focused on advancing our understanding of the four key principles of spinal cord
repair:
•

Protecting surviving nerve cells from further damage

•

Replacing damaged nerve cells

•

Stimulating the regrowth of axons and targeting their connections appropriately

•

Retraining neural circuits to restore body functions
Advances in basic research are also being matched by progress in clinical research,

especially in understanding the kinds of physical rehabilitation that work best to restore function.
Some of the more promising rehabilitation techniques are helping spinal cord injury patients
become more mobile. For example, modern rehabilitation therapies that retrain neural circuits
through forced motion and electrical stimulation of muscle groups are helping injured patients
regain lost function.
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2.5

Cerebral Palsy

Cerebral Palsy (CP) is caused by damage to the motor control of the developing brain
early in life before or after birth. CP describes a group of neurological disorders that appear in
infancy or early childhood and permanently affect body movement and muscle coordination. The
motor disorders of CP are often accompanied by disturbances of sensation, perception, cognition,
behavior, by epilepsy, and by secondary musculoskeletal problems [204].
The most common symptoms of CP with motor control deficits are stiff or tight muscles
and exaggerated reflexes (muscle spasticity), a crouched or “scissor” gait, a lack of muscle
coordination and balance when performing voluntary movements (ataxia), walking with one or
both legs dragging, and foot drops.
A large number of factors can damage the developing brain, such as infection
(meningitis), bleeding into the brain (intraventricular hemorrhage), damage caused by lack of
oxygen, and developmental brain malformation. The severity of the bran damage generally
depends on the type and timing of the injury.
Researchers are investigating the risk of CP occurrence in early brain development,
including genetic defects, which may be responsible for the brain malformations and
abnormalities that result in CP. Scientists are also looking at traumatic events in newborn babies’
brains, such as bleeding, epileptic seizures, and breathing and circulation problems, which can
cause the abnormal release of chemicals that trigger the kind of damage that causes CP.
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2.5.1

Classification of Cerebral Palsy

Cerebral palsy is classified into four broad categories – spastic, athetoid, ataxic, and
mixed forms. Spastic CP affects around 70 to 80 percent of patients. In spastic CP, the muscles
are stiffly and permanently contracted. Athetoid or dyskinetic CP is characterized by
uncontrolled, slow, and writhing movements, caused by damage to the cerebellum or basal
ganglia which are responsible for processing the signals that enable coordinated movements as
well as maintaining body posture. About 10 percent of children with cerebral palsy have athetoid
CP. Ataxic CP is described as low muscle tone and poor coordination of movements. Damage
affects the sense of balance and depth perception. About five percent of children are diagnosed
with this form of CP. Children with ataxic CP look very unsteady and have a lot of shakiness like
a tremor, especially when they are trying to handle small objects such as a pen. Mixed CP is the
form that the children with CP have more than one type of cerebral palsy mentioned above. For
example, some patients have spastic CP with athetoid movements. About five to ten percent of
children with CP have the mixed type cerebral palsy.
Spastic CP is the most common type of cerebral palsy. This abnormally high muscle tone
creates difficulty with voluntary and passive movement, and generally creates stress over time,
depending on the severity of the condition in the individual, the constant spasticity ultimately
produces pain, muscle/joint inflammation including tendinitis and arthritis, contractures, spasms,
and progressively worse deformities misalignments of bone structure around areas of the
tightened musculature as the time progress.
Generally, spastic CP is sub-classified into three types: hemiplegia (affects limbs on one
side of the body), diplegia (affects both sides, either arms or legs), and quadriplegia (affects all

38

limbs). Spastic diplegia is the most common of all CP cases, with the lower limbs affected. A
typical sign of spastic diplegia is “scissor” gait.

2.5.2

Prevalence and Incidence of Cerebral Palsy

Cerebral palsy is one of the leading causes of childhood disability with the greatest
burden found worldwide. The incidence of cerebral palsy is about two per 1,000 live births [3].
In the United States, approximately 10,000 infants and babies are diagnosed with CP each year,
and 1,200 are diagnosed at preschool age [246]. Furthermore, there is a high default rate with
majority of children lacking ready access to medical care and education in developing countries
[128]. The major reasons for default were financial constraints.
The ability to live independently with CP varies widely depending on the severity of each
case. Some individuals with CP will require personal assistance for all activities of daily living.
Others can lead semi-independent lives, needing support only for certain activities. A few can
live in complete independence. In most cases persons with CP can expect to have a normal life
expectancy and reproductive function.
Because of the physical disability, CP children or adults have usually difficulties to
achieve the normal role in society commensurate with age and socio-cultural milieu. There is an
urgent need for improvement in medical services and social support for children with CP and
their families.
Last but not the least, there is an incredible financial burden on CP patients and their
families. In 2003, the Center for Disease Control [CDC] estimated that the average lifetime cost
of caring for a child with cerebral palsy totals over $921,000. This is much more than the cost of
caring for a healthy individual.
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2.5.3

Treatments and Rehabilitation of Cerebral Palsy

To date, there is no cure for cerebral palsy. It is only that life can be made more bearable,
more meaningful for the child. Early diagnosis and an immediate therapy regimen will help
reduce the impact of the disabilities and discomfort caused by CP. For example, seizures and
spasticity are the most common discomforts of cerebral palsy. Drug therapy can reduce these
discomforts. For seizures, anti-convalescents work well, while muscle relaxants are prescribed
for spasticity. Surgery may be recommended to handle extreme contractures, which can inhibit
movement, balance and coordination.
Physical rehabilitation must start as soon as a diagnosis is made, and need to be adjusted
to suit the changing needs of the child. In additional to physical therapy, psychological
rehabilitation also assumes great significance in CP patients. The behavioral therapy helps to
reduce destructive behavior, and increase self-reliance through motivation. The occupational
therapy works at improving the child’s simple physical skills, which make him/her more
independent, while speech therapy helps improve the social life. The professionals are faced with
a diversity of problems in the child and family (physical, psychological, communicative, and
social), so a multidisciplinary approach for treatment is needed.

2.6

Summary

This chapter addresses the most important neurological disorders: stroke, multiple
sclerosis, spinal cord injury, and cerebral palsy. These common disorders were discussed with
respect to causes, symptoms, classifications, treatment and rehabilitation. The WHO has realized
that the burden on disability adjusted life years (DALYs) for these common disorders, estimated
according to prevalence, duration and mortality rates, is higher than other diseases. And physical,
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emotional, social and economic burden of these neurological disorders in patients, their families,
and the public health services has gained awareness by the professionals and public health
organizations.
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Chapter 3: Background of Neurological Rehabilitation

3.1

Principals of Neurological Rehabilitation

Rehabilitation has been defined by WHO in 1980 as an active process by which those
disabled by injury or disease achieve a full recovery or, if a full recovery is not possible, realize
their physical, mental and social potential and are integrated into their most appropriate
environment. The American Society of Neurorehabilitation (ASNR) announced the mission of
the rehabilitation as to: 1) promote the medical and social well-being of persons with disabling
neurological disorders; 2) advance training and research in the basic and clinical sciences that
can lead to functional recovery of neurologically impaired persons; and 3) disseminate the
knowledge of rehabilitation research among professionals and the general public.
Rehabilitation requires the active collaboration of professionals and patients to achieve
desired outcomes. An outcome may be improvement or it may be prevention of deterioration.
Rehabilitation is not only focused on the person with the impairment, but also dependants,
relatives, friends and colleagues are involved in collaboration with a number of professionals.
Medical rehabilitation usually involves a professional team based on a specialized rehabilitation
unit or center [108]. The professional team provides physical, behavioral, cognitive and social
rehabilitation.
A number of inpatients within typical comprehensive rehabilitation hospitals are those
with neurologic injuries such as stroke, spinal cord injury, and traumatic brain injury. It is
evident that neurological rehabilitation helps to rebuild lives. Rehabilitation helps the patient
regain muscle strength, joint rang-of-motion (ROM), balance, coordination endurance, and
functional mobility.
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3.2

Mobility, Exercise Training, and Functional Recovery

Studies in animals have demonstrated that exercise training enhanced brain functional
recovery by increasing neurogenesis, neurotrophic factors, and neuronal survival. Some human
studies have indirectly supported this notion with observations of improved neuromuscular and
cognitive function and attention in people who participate in regular physical activity and who
have higher cardiovascular fitness.
Meeteren et al. (1997) investigated that exercise training enhanced the return of
sensorimotor function in the early phases of recovery after sciatic nerve crush lesions in rats, and
the effects persisted in the late phase of peripheral nerve regeneration. The research group further
studied the effects of different exercise trainings on functional recovery after the nerve lesion in
rats. They found out that treadmill training after the lesion significantly deteriorated the gradual
return of motor function [160, 161].
The task-specific training improves functional outcomes after stroke. Additional, clinical
trials have provided insights into methods such as trunk-restraint that promote adaptations within
the nervous system that correlate with improved walking and upper extremity function after
stroke. Exercise training paradigms, such as constraint-induced movement therapy, have also
been shown to be effective in the management of cerebral palsy [43]. CP patients typically have
lower cardiopulmonary fitness levels and abnormal muscle strength. It is especially important for
them to maintain normal muscle strength into adulthood since the functional consequences of
even a small loss can lead to loss of mobility and independence. Patients with spastic diplegic CP
were able to increase their strength through isokinetic and repetitive exercise [155]. With
exercise, quadriceps strength may increase to normal levels, which may also improve gait
abnormalities, such as ‘scissor’ gait.
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3.2.1

Gait Rehabilitation

Gait rehabilitation is a major aspect of neurological rehabilitation since neurologic
impairment often causes severe disability that produces a wide variety of deficits on the lower
extremity. Modern concepts of motor learning favor a task specific training, i.e. to relearn
walking. The restoration of gait for patients with impairments of the CNS, e.g. stroke, spinal cord
injury, and traumatic brain injury, is integral part of rehabilitation and often influences whether a
patient can return to daily life or work. Current rehabilitation concepts have aimed at the
restoration of physiological gait pattern [205]; and rehabilitation devices such as the partial body
weight support treadmill training and the gait trainer (GT1). These devices have been designed to
enable the patients train pre-programmed trajectories during all phases of gait.

3.2.2

PWBTT and Conventional Gait Trainers
One of the primary goals of patients that suffer a mobility-related disability is to achieve

some kind of independent ambulation. This may be partially achieved by enrolling into physical
therapy programs, inpatient as or outpatient or a combination of both, to help achieve the
Activities of daily living (ADL). The traditional intervention of physical therapies relies on the
gait therapists and nurses as the means to deliver the desired training gait to the patients. This is
accomplished through a “hands-on” method where the therapist holds the patient’s
arms/legs/trunk and moves the limbs when walking between the parallel bars or overground
corridors (see Figure 3-1). There are number of limitations and drawbacks to this therapistassisted rehabilitation: 1) it is labor intensive and physically demanding; 2) it requires and relies
on the best knowledge of expertise; 3) it is time inefficient; and 4) it is difficult to follow up the
session-to-session repetition and consistency.
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Figure 3-1: Therapist-assisted training using the parallel bar.

Therapy by treadmill training with partial body weight support (PWBTT) evolves as a
very promising treatment concept over many years. It enables severely affected patients the
repetitive practice of complex gait cycles and thus follows modern aspects of motor learning that
favor a task-specific approach. Several studies have shown its potential in patients after stroke
[76, 85, 166, 237, 249], spinal cord injury [46, 53, 55, 195, 256], multiple sclerosis [56],
Parkinson [168] and cerebral palsy [158, 212], by improvement of range-of-motion (ROM),
muscle strength, walking velocity, postural instability, coordination and balance.
The key capabilities needed in a PWBTT device to provide effective gait therapy include
[206].
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•

A machine (harnesses) to support the patient and adjust the weight-load placed on the
lower extremities during therapy, ranging from on load (the machine bears the full weight
of the patient) to full load (the patient supports his/her full weight).

•

A treadmill or similar device that allows the patient to walk in place.

•

The ability to assist the patient’s lower extremities to train in an effective overground gait
pattern that is energy-efficient.
PWBTT makes gait training possible for people who are unable do have safety during

overground gait training, and intervention may be initiated earlier than conventional methods.
This method also has the advantage of eliminating the fear of falling that is common in the early
stage of the therapy.

Figure 3-2: Treadmill training with partial body-weight support.
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3.2.3

Gait Trainers with Robotic Devices

The PWBTT relieves the working load of the therapist, but it still requires the expertise
and therapist(s) to assist the training, Figure 3-2. This also requires at least two therapists during
the gait training. Two therapists sitting alongside the patient have to place the paretic limbs
manually while sometimes a third therapist is needed to stand behind the patient to assist the
lateral weight shifting and trunk erection. Despite these measures, accurate and repetitive gait
motions still are unachievable through PWBTT. As the therapists fatigue, the patient’s gait can
become asymmetrical, therefore losing the benefit of sustained practice. With the provision of
assistance of this nature the pattern of sensory input to the CNS may vary greatly between
trainers and sessions. As a remedy to the problems associated with using therapists to provide the
desired gait, some investigators attempted the robotic devices – gait trainer to help patient’s
replicate normal walking patterns. In addition, current research focuses on the different
unloading systems for the patients partial body weight support at treadmill training, which
enables non-ambulatory patients to practice complete gait cycles as soon as possible.
The first electromechanical gait trainer, the Gait Trainer Version I was built and patented
in Germany in 1997 [206]. Using the gait trainer, GT1, the patient is supported with a harness
and the feet are placed either on motor-driven footplates or on the treadmill. The patients walk
according to a pre-programmed physiological gait pattern and/or an exoskeleton-type robot. A
Cochrane Review of the electromechanical-assisted training for walking after stroke reported
that the use of the gait trainer, GT1, could reduce dependency in walking by 25% [162].
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3.2.3.1 Robotic Gait Trainer Versions I and II

Modern concepts of gait rehabilitation favor a task-specific repetitive approach. In
practice, the required physical effort of the therapists limits the realization of this approach.
Therefore, a mechanized gait trainer enabling non-ambulatory patients to have the repetitive
practice of a gait-like movement without overstraining therapists was constructed at the Free
University in Berlin, Germany, in 1997 [243, 244]. The gait trainer version I used a driven
mechanism with an electric motor and a gear system to move footplates. The gait cadence was
controlled by the speed of the drive mechanism. Stride length was adjusted and produced a 50/50
stance/swing phase of the gait cycle. A short time later, the second version of the gait trainer
(Gait Trainer Version II, Figure 3-3) was built and patented in Germany with much improvement
over the version I. The device consists of two footplates just like the version I, and connected to
a double crank and rocker system. An induction motor drives the cranks via a planetary gear
system. The rear ends of the footplates follow an ellipsoidal-like movement. Different gears can
be incorporated to vary stride length and stride time. The planetary gear system also moves the
patient harness in a gait-like trajectory through two cranks attached to suspension ropes. The
torque generated by the motor is sensed and displayed on a monitor to provide a biofeedback to
the patient. This advanced gait trainer provide a gait-like movement simulating stance and swing
phases with an actual lifting of the foot during swing, and a ratio of 60/40 percent between the
two phases, which characterized the actual human gait. In addition, it controls the center of mass
(COM) in vertical and horizontal directions, and effectively reduced physical demands on the
therapists.
Many studies have shown that the advanced gait trainer (Gait Trainer Version II) allowed
more effective training sessions, where patients could train up to 1000 steps within a typical

48

training session of 15-20 minutes, whereas during conventional gait training only approximate
100 steps per session were performed [213].

Figure 3-3:

Robotic Gait Trainer Version II.

3.2.3.2 Lokomat and AutoAmbulator

The Lokomat (Figure 3-4) is a motorized exoskeleton worn by the patients during
treadmill walking; some literature called it the Driven Gait Orthosis (DGO). The major
difference of the Lokomat from the Gait Trainer Version II, GT1, is that the patient’s feet are
placed on the treadmill instead of the two separate footplates. The exoskeleton device has four
rotary joints that accommodate hip and knee flexion and extension for each leg movement. The
weight of the exoskeleton is supported by a parallelogram mechanism that moves in the vertical
direction and is counterbalanced by a gas spring. The hip and knee motions can be preprogrammed to drive the legs along gait-like trajectories. The device is fully instrumented,

49

allowing the trainers to track a patient’s functional recovery and utilize biofeedback in the
therapy sessions.
The other DGO robotic device is the AutoAmbulator. The device as illustrated in Figure
3-5, is intended to replicate a normal walking pattern. The patient is supported by a hoist, and the
limbs are secured in a pair of aluminum rotating arms located above a treadmill. The motion of
the joints, forces/torques of the segments, walking speed, body weight, and wiring voltage are
automatically monitored during the treadmill training.

Figure 3-4:

Driven Gait Orthosis - Lokomat
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Figure 3-5:

Driven Gait Orthosis - AutoAmbulator

The revolutionary new devices replicate the walking patterns by using advanced robotic
designs and computer technology. They are, in essence, the highly specialized and instrumented
treadmills with sophisticated features including: an overhead harness safety system to
partially/fully support the patient; programmable exoskeleton/braces to move the patient’s limbs;
numerous sensor detected biofeedback by tracking important movement features; and most
importantly the patient’s progress of the treadmill training can be viewed from the computer
monitor during the session, which will motivate the patients for rehabilitation.

3.2.4

Other Therapeutic Interventions for Task-Specific Training

Therapeutic interventions leading to functional improvement emphasize intensive taskspecific practice to facilitate training induced neuroplasticity [92]. Task-specific means the best
way to relearn a given task and to train specifically for that task. Repetitive task-specific training
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is a treatment in which a series of specific movements are repeated over and over again to
improve functional recovery. A recent systematic review specifically investigated the effects of
exercise intensity as measured by time in therapy on ADL, walking, and dexterity in patients
with stroke [123-126]. The results of this meta-analysis suggests that more intensive therapy that
includes approximately 16 hours of additional task-specific training in the first six months postbrain injury particularly dedicated to lower limb and ADL activities is more effective than
standard therapy programs.
Rehabilitation is directed to the restoration of motor control in gait and gait-related
activities, improvement of upper extremity function and trunk muscle strength, teaching the
patient to cope with existing deficits in ADL and enhancement of participation in general. It has
been shown that there is some improvement in treadmill training with or without body weight
support and also in use of the robotic training in gait-specific rehabilitation. Strong evidence was
also found for therapies that administered functional training, such as constraint-induced
movement therapy, aerobics for cardiovascular fitness, external auditory rhythms during gait and
neuromuscular electrical stimulation for glenohumeral subluxation [189].
Constraint-induced movement therapy (CIMT) forces the use of the affected side by
restraining the unaffected side. CIMT was developed by Dr. Edward Taub of the University of
Alabama at Birmingham [230-234]. Taub argues that, after a stroke, the patient stops using the
affected limb because they are discouraged by the difficulty. As a result, a process that Taub
called “learned non-use” sets in, furthering the deterioration [230]. A number of studies have
shown that the CIMT produced major and sustained improvement in motor function in
neurologic injuries such as hemiplegic stroke [231], traumatic brain injury [216], and cerebral
palsy in children with hemiparesis [233]. The American Stroke Association has written that
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Taub’s therapy is “at the forefront of a revolution” in what is regarded possible in terms of
recovery for stroke survivors [Constraint-induced movement therapy].
Rhythmic behavior of movement such as gait results from complex, dynamic, interconnections of the CNS. When an individual suffers a stroke for instance, the neural circuitry is
damaged, and rhythmicity in motor skills is altered. The coupling between an external rhythm
and rhythmic movement can be an effective tool for improving motor performance. There is
enough evidence to show that gait training with an external auditory rhythm leads to improved
rhythmic and reciprocal movement of the legs in persons who have suffered a cerebrovascular
accident (CVA) or stroke. Spatial-temporal characteristics of walking have improved [239].
Neuromuscular electrical stimulation is commonly known as functional electrical
stimulation (FES). It can be divided into two categories: (i) stimulation of muscles to treat
muscle atrophy, and (ii) enhancement of functional activity in neurologically impaired
individuals. FES devices use electrical impulses to activate paralyzed or weak muscles in precise
sequence and have been utilized to provide spinal cord injury patients with the ability to walk.
Klose, et al. [115] in 1997 showed that the FES enabled person with thoracic-level SCI to stand
and ambulate short distances but with high degree of performance variability across individuals.
In addition to the enhancement of walking abilities, FES has also had some success in improving
ventilatory function in adult patients with SCI [58, 59].

3.3

Rehabilitation Management and Rehab Cycle

Rehabilitation management can be characterized by a coordinated and iterative problemsolving approach along the continuum of care from the hospital to the community. Such
approach, based on the International Classification of Functioning, Disability and Health (ICF),
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can be described as a rehabilitation cycle or Rehab Cycle [225], with its four steps: assessment,
assignment, intervention and evaluation. The Rehab Cycle facilitates the structuring,
organization and documentation of the rehabilitation process. It enables all professionals
involved in patient care to coordinate their actions. Specific rehabilitation interventions include
those related to physical medicine, orthopedic-reconstructive surgery, pharmacology and
nutrition, psychology and behavior, education and counseling, occupational and vocational
advice, social and supportive services, engineering and other interventions. Rehabilitation
services are like a bridge between isolation and exclusion. They often the first step towards
achieving fundamental rights.
The goals of a neurological rehabilitation program include helping the individual to
return to the highest level of function and independence, and improve the overall quality of life
for that individual – physically, emotionally, and socially. A typical neurological rehabilitation
program helps to accomplish and/or may include the following:
•

Assistance with ADLs such as eating, dressing, reaching, and manipulation, bathing,
making bed, using the toilet, handwriting, cooking, basic housekeeping, and other
activities critical to an independent and effective lifestyle

•

Speech therapy to retrain the communication skills

•

Counseling to deal with anxiety and depression

•

Bladder and bowel retraining

•

Improve control and muscle strength in the trunk, pelvis, and shoulder girdle

•

Gait and balance retraining

•

Social skills retraining

•

Education regarding the disease and therapy
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•

Activities to improve cognitive impairments, such as attention, memory and difficulties
with concentration and poor judgment.

•

Short- and long-term goal setting involving the patient and family members
The Rehab-CYCLE is applied on two levels. The first refers to the guidance along the

continuum of care and the second to the provision of a specific service [225]. From the first level,
the assessment step includes the identification of the person’s problems and needs, the evaluation
of rehabilitation and prognosis and the definition of long-term service and goals of the
intervention program. The assignment step refers to the assignment to a service and an
intervention program. The evaluation step refers to service and the achievement of the
intervention goal. From the second level, the assessment step includes the identification of a
person’s problems, the review and potential modification of the service or goals of the
intervention program and the definition of the first Rehab-CYCLE goals ad intervention targets.
The assignment step refers to the assignment of health professionals and interventions to the
intervention targets. The intervention step refers to the specification of the intervention
techniques, the definition of indicator measures to follow the progress of the intervention, and
the definition of target values to be achieved within a predetermined time period. The evaluation
step refers to the evaluation of the achievement of the goal with respect to the specified target
values of the indicator measures, the Rehab-CTCLE goals and ultimately the goals of the
intervention program. It also includes the decision regarding the need for another intervention
cycle based on a reassessment [225].
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3.4

Summary

This chapter introduced the definition and principle of neurological rehabilitation from
the World Health Organization, WHO. Neurorehabilitation is the nature of the adaptive system
to perform the optimization of functional recovery. It indicates the importance for intensive taskspecific training approach for functional recovery and neuroplasticity, and a number of devices
have been introduced to illustrate the different therapeutic interventions for this approach.
Finally, the Rehab Cycle for neurological rehabilitation management was introduced and
recommended by WHO.
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Chapter 4: Biomechanical Model on Human Locomotion

4.1

Human Gait – Basic Concepts and Terminology

The human gait is a pattern of locomotion, which is achieved using synchronization of
the skeletal, neurological and muscular systems of the human body [47]. Over the past several
decades, the evolution of gait science has produced an array of terms and concepts relating to
observational and computational gait analysis. The terminology of human walking began with
descriptive phrases obtained as a result of observational and kinematic analysis of normal
subjects. These include terms such as “heel strike” and “toe off”. Many more contemporary
terms described events and functions that were not apparent through observation but could be
measured through instrumentation in gait laboratories [190]. The conceptual knowledge of
human locomotion and related terminology will facilitate an optimal treatment plan for the
patient, and enhance communication to the physician and relevant communities.
The term “normal gait” is used to present those patterns that have been generalized across
sex, age, genetic predisposition and anthropometric variables. When the basic principles of
normal walking are understood, a more penetrating grasp of pathological gait becomes possible.

4.2

Gait Cycle and Gait Phases

Walking is the rhythmic and repetitious movements of the limbs which result in the
forward movement of the body. A number of events follow each other continuously and
smoothly. A gait cycle or a gait stride is normally from the initial contact of one foot to the
following contact of the same foot. Each gait cycle is divided into two periods, stance (from
initial contact to toe-off) and swing (from toe-off to the initial contact again). For a typical
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healthy subject, the stance phase approximately covers the first 60% of the gait cycle while the
swing phase represents the remaining 40% [190]. Each of these periods is then subdivided for the
functional phases of gait, as shown in figure (4-1) [41].

Figure4-1: Functional phases within the gait cycle. Consequence changing functional phases of
a single gait cycle from right-foot contact to the next right-foot contact.

The functional phases of the stance period are described below with their associated
typical gait cycle percentages [190]:
•

Initial Contact (0~2%): the moment when the foot just touches the floor.

•

Loading Response (0~10%): from the initial contact and continue until the other foot toeoff.

•

Mid Stance (10~30%): from the other foot toes off until body weight is aligned over the
forefoot.

•

Terminal Stance (30~50%): from the end of the mid-stance until the opposite foot contact.

•

Pre Swing (50~60%): begins with the initial contact of the opposite foot and ends with
ipsilateral toe-off.
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Similarly, the swing period components are [10]:
•

Initial Swing (60~70%): from the toe-off even until the maximum knee flexion occurs.

•

Mid Swing (70~85%): from the maximum knee flexion until the tibia is in a vertical
position.

•

Terminal Swing (85~100%): from the vertical tibia to the ipsilateral foot contact.

4.3

Kinematics Approach

4.3.1

Spatial-Temporal Gait Parameters

Apart from the gait cycle, the nature of walking may be expressed as spatial-temporal
terms such as stride/step length, stride/step width, stride/step time, stance phase, swing phase,
double-supported phase, walking speed, and cadence. Stride length can be defined as the linear
distance between the initial contacts of the same foot, while the step length is usually defined as
the distance between the opposite feet, as shown in figure (4-2). Cadence is number of steps per
minute, and velocity is the product of cadence and step length, expressed in meters per second.

Left Step Length

Figure 4-2:

Right Step Length

Schematic diagram that reveals the stride length, step length, and step width.
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Numerous studies have shown that gait variability of spatial-temporal parameters was a
quantifiable feature in clinically relevant gait disorders, such as age-related falling and
neurodegenerative disease (e.g. Parkinson’s and Huntington’s disease) [71, 211, 217].

4.3.2

Joint Kinematics
Joint kinematics includes rotations/velocity/acceleration of the body joints in their sagittal,

coronal, and transverse planes. Figure 4-3 illustrates a typical joint motion of the hip, knee, and
ankle angle in a sagittal plane.

Figure 4-3:

Typical joint rotation of the lower extremity on sagittal plane during a full gait

cycle during free walking. A: hip flexion-extension; B: knee flexion-extension; C: ankle flexionextension. Black line denotes the means from number of strides, and grey lines denote the upper
and lower limit of the standard deviation.

60

4.4

Dynamic Kinetics

Gait kinetics involves the forces that produce movements including joint reaction forces,
ground reaction forces (GRF) and muscles activities. The major tools for kinetic measurement
are force plate or foot pressure distribution (FPD) plate, and electromyography (EMG).

4.4.1

Ground Reaction Forces

Kinetics is the study of forces that cause movement. Forces generated can be internal
(such as muscle activity, friction in muscles and joints, or ligamentous constraint) and external
such as ground-reaction forces (GRF) created from the external loads.
The rotational potential of the forces acting on a joint is called torque or moment (N-m).
The internal joint moment is the net result of all of the internal forces acting about the joint. The
moments usually are normalized to the subject’s body mass, expressed as N-m/kg.
The ground-reaction force is the external force acting on joints during gait. GRF is
obtained from a force platform or force plate, which is a transducer set into the floor or under the
treadmill to measure the forces and torques applied by the foot to the ground. GRF is comprised
of three-dimensional components (Fig. 4-4): 1) vertical, 2) mediolateral and 3) anterior-posterior.
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Figure 4-4: Ground Reaction Force. The typical ground reaction force during stance phase
with its three components: Fz – Vertical force; Fx – Mediolateral sheer; Fy – Anterior-posterior
sheer. All GRF values were normalized by body weight (88 kg in this example), and the data
represented as % BW.

In normal dynamic kinetics, human muscles must be controlled to maintain the weight
shifting during gait [262]. Force data will show variations with walking speed, shoe wear, and
compensatory mechanisms of gait, such as the avoidance of weight bearing on a painful
extremity. The components of the ground reaction force in gait can be an indication of dynamic
aspects of gait. For examples, the vertical GRF tends to increase in magnitude and higher
frequency content with increasing velocity and decrease with lower velocity or lower extremity
pain; and changes in medial-lateral shear component is an indicator of balance control as in
scoliosis [219].

4.4.2

Foot Pressure Distribution

Modern foot pressure distribution (FPD) plate and/or shoe insoles could be an alternative
to traditional force plates for quantitative gait analysis, thereby providing the clinician with
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objective data on the gait while unraveling the loading of different regions of the foot during the
stance phase. Figure 4-5 shows a typical 3D distribution pattern during walking.

Figure 4-5: 3D presentation of foot pressure distribution pattern while walking.

Measurement of FPD is clinically useful because it can identify anatomical foot
deformities, guide the diagnosis and treatment of gait disorders and falls, as well as lead to
strategies for preventing pressure ulcers in diabetes with peripheral neuropathy. Age-related
anatomical and physiological changes in foot bone and ligament structure affect FPD during gait
[201]. Gait analysis in geriatric study has revealed decreased stride length and step force, and
increased variability in gait parameters. Age was independently associated with lower pressure
under the heel, mid-foot, and hallux in the multivariate analysis [172].

4.5

Surface Electromyography

Electromyography (EMG) is a technique for detecting the electrical potential generated
by muscle cells (fibers) when these fibers are active or at rest. EMG signals have many clinical
and biomedical applications, including identifying neuromuscular disease, assessing lower back
pain, biofeedback of prosthetic devices, kinesiology and sports applications.
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The surface EMG (SEMG) is a technique for detecting the neuromuscular activity in
dynamic movement. The SEMG is noninvasive and easy to perform but exhibits some
limitations based on its causative factors that affect the quality of the signals. De Luca (1997)
categorized these causative factors into two groups: extrinsic and intrinsic. The extrinsic factors
are electrode configuration, location of the electrodes and orientation of the detection surfaces;
the intrinsic factors are the number of active motor units, fiber type composition, blood flow in
the muscle, fiber diameter, depth and location of the active fibers and the amount of fatty tissue
between the muscle and the electrode. The intrinsic factors cannot be controlled due to the
limitation of current knowledge and technology [34].
EMG can be plagued with poor signal-to-noise ratios (SNR) and one result of this poor
SNR is increased within- and between-subject variability of quantified EMG variables. Methods
that can reduce within- and between-subject variability can increase the statistical power of an
experimental design and aid in the functional interpretation of experimental results. Therefore, a
proper method for EMG signal processing must be selected to reduce the signal artifacts [34];
and the EMG signals are recommended to be normalized for study of comparative diagnosis.
EMG signals during gait provide insight into muscle recruitment patterns and
neuromuscular control of walking. Diagnostic assessment and treatment decisions may be based
on the EMG behavior associated with the dynamics of gait [62]. Previous researches have shown
that EMG activity was repeated consistently over a locomotion gait cycle during preferred
walking speed in normal adults [7, 258] and children [62]. The muscles differ from the peak
activity at each of the various phases of the gait cycle.
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4.6

Summary

This chapter reviewed the terminology of gait cycle with its functional sub-phases,
defining the spatial-temporal gait parameters, joint kinematics, dynamic kinetics, and EMG
activity. These are very important parameters today for studying in neurological impairments and
locomotor recovery.
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Chapter 5: State-of-the-Art in Human Locomotion

5.1

Analytical Techniques for Automated Gait Assessment

Gait analysis commonly involves the measurement of the dynamic movement of the body
expressed as the kinematics, kinetics, and muscle activity. Kinematics can be recorded using
optical motion capture and reflective marker system, and/or variety inertial sensors (goniometers,
gyroscopes, accelerometers). Dynamic kinetics can be measured using either force sensor
platforms for overground walking or an instrumented treadmill [127]. Muscle activity as
mentioned in section 2.6, can be measured using inner or surface EMG.
For the last two decades, gait analysis in healthy, geriatric, and impaired conditions has
been studied widely from gait pattern classification to gait variability. Computer and
mathematical expertise investigated different algorithms to classify the different abnormalities
from normal gaits, and/or classify different stages within one disease. Classification of gait
abnormality can be done by dynamic programming, neural networks, cluster statistical analysis,
or by Hidden Markov Models (HMMs) for gait recognition. Study of gait variability will be
discussed in details in section 5.3.

5.2

Classification of Gait Abnormalities

Gait pattern classification was studied particularly in the sagittal plane, the kinematic,
because abnormalities of flexion or extension occur mostly in this plane and therefore, most
therapeutic interventions address sagittal abnormalities. Gait abnormalities and their etiologies
may be summarized for each of the three planes (sagittal, coronal, transverse) at each joint or
segment level. Once all these parameters are considered, more precise solutions for classification

66

of the pathology can be offered [34]. Pathologic gait can range from temporary gait deviations in
one plane to complex chronic deviations in all planes of motion. The primary reason for
misinterpretation of gait disorder on assessment is “out of plane”, i.e. missing information on
coronal and transverse planes. In many cases, pathologic gait is characterized by reduced motion
in the sagittal plane and increased motion in the coronal and/or transverse planes [48]. In the
coronal plane for example, the principal joint disturbances in cerebral palsy are adduction
contracture, which causes a scissoring gait, and abductor insufficiency of the stance limb which
results in a pelvic drop compounding foot clearance problems. Transverse plane abnormalities
occur in patients with idiopathic femoral anteversion and tibial torsion with associated knee pain,
and they also occur in many patients with cerebral palsy. In addition, mediolateral (coronal plane)
postural instability has recently been identified as a risk factor for falls in the elderly communitydwelling population. However, few clinical tests involve challenges to stability limits in
mediolateral direction.
At this time, exact technical parameters and gait analysis models have not been
established. For example, O’Byrne (1998) has identified eight groups from 237 cerebral palsy
patients using statistical cluster algorithm. However, the classification was made based on the
kinematic abnormalities of flexion or extension in the sagittal plane. The more accurate
description of the various patterns of gait is possible if the patterns of movement of the three
dimensional planes and EMG also were evaluated. One prospective controlled study investigated
whether computerized gait analysis could differentiate patients with dyskinetic CP from those
with spastic CP and those with normal gait [32]. The study evaluated a diagnostic model based
on three parameters: step width, step profile, and maximal lateral acceleration. Only step profile
and maximal lateral acceleration differentiated CP types. The model accurately predicted 87% of
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patients with dyskinetic CP and 71% of patients with spastic CP. The computerized classification
of gait can distinguish between normal and spastic or dyskinetic gait depending on the gait
parameters. Fuzzy logic classification system was used by Yardimci (2007) to discriminate
healthy subjects from patients using kinematic three-axial acceleration inputs, but with the
limitations imposed on the input he could not classify the patients with different stages of stroke
[264].
It is evident that only by combining data obtained from clinical examination and
kinematic/kinetic and EMG data can functional pathology be classified. Overall, with the single
or limited number of input variables, classification of the gait abnormalities becomes difficult or
unreliable.

5.3

Gait Variability Study

The study of gait variability involves the stride-to-stride fluctuations in walking, an
important indicator of impaired mobility in adults. Previous work has suggested that measures of
gait variability may be more closely related to falls, a serious consequence of many gait disorders,
than are measures based on the mean values of other walking parameters [60, 63, 72, 238, 257].

5.3.1

Spatial-Temporal Parameters Variability

Gait variability is an index of how much gait parameters change from one to the next
during walking. In healthy subjects, the variability is relatively small and the coefficient of
variations of many gait variables (stride length, stride width, stride velocity, stride time, etc) is
on the order of very small percentages. Any fine-tuned physiologic factors regulating gait such
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as CNS/PNS control, muscle function and postural control, may be perturbed, motor control may
be impaired leading to increased stride-to-stride fluctuations.

5.3.2

Stride Variability with Elderly Fallers

In studies of healthy young adults and healthy older adults, there was no age effect on
stride variability, even though gait speed was reduced in the older adults while stride times were
similar [52, 61, 70]. Another investigation demonstrated that whereas both healthy older controls
and patients with a higher-level gait disorder walked more slowly in reduced lighting, only the
latter’s stride variability increased [112]. All those investigations suggested that any increases in
variability of gait parameters must be due to pathology.
In one of the first quantitative studies of geriatric and rehabilitation research, Guimareaes
and Isaacs [64] suggested that elderly fallers walked with increased gait variability, both in terms
of step length and step time, compared to non-falling older adults. This age-related fall risk
causing increased gait variability was further studied by Hausdorff and other researchers [70, 73,
164]. They investigated that stride-to-stride temporal variations were significantly increased in
elderly fallers, and Hausdorff concluded that gait variability is an important marker for fall risk
in the geriatric group [68].

5.3.3

Stride Variability in Neurodegenerative Disorders

The basal ganglia are thought to play an important role in regulating motor control
programs involved in gait and sequencing of movement. Parkinson’s disease (PD) and
Huntington’s disease (HD) are two major basal ganglia disorders.
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Patients with PD often experience freezing of gait which the subject suddenly becomes
unable to start walking or to continue to move forward. The pattern of subjects who experience
freezing of gait was not different from those of other PD patients who do not experience the
same episodes of freezing of gait. However, researchers found that although average stride time
was similar in subjects with and without freezing, stride-to-stride variability was markedly
increased among PD subjects with freezing of gait compared to those without freezing of gait
[211]. Furthermore, stride time variability significantly improved in response to levodopa
treatment in non-fallers of PD subjects, but remained increased in fallers [211].
Huntington’s disease (HD) patients had a decreased gait velocity (bradykinesia) and a
decreased stride length (hypokinesia). In addition, fallers with HD had increased stride length
variability and a significantly greater trunk sway in medio-lateral direction compared to nonfallers [64]. From study of fMRI, greater variability of step length was associated with greater
prevalence of infarcts in the basal ganglia.
Previous studies also found that there was an increase in stride length variability in
Alzheimer’s disease (AD) at all walking speeds (self-selected slow, natural, and fast) which may
contribute to the increased incidence of falls in AD. The gait speed and average stride length
were significantly related to fear of falling, but not to fall risk. In contrast, stride length
variability was associated with fall risk, but not with fear of falling. This finding also applied in a
study of the effects of dual tasking on the gait of subjects with Alzheimer’s disease [217].
Amyotrophic lateral sclerosis (ALS) is a disorder marked by loss of motor neurons [6].
The gait of patients with ALS, HD, and PD shared common features of altered stride dynamics.
The gait stability and the stride-to-stride control are also affected in ALS.
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5.4

Summary

In recent approaches, pattern recognition of gait within a repeated cycle has been heavily
studied in the sagittal plane. The analysis lacks the information on other two planes, which may
consist of important signs for pathologic gait. Spatial-temporal gait kinematic parameters often
used in gait variability approach. There is limitation on other parameters due to lack of complete
knowledge of technologies of signal detection, data processing, and advanced analysis
techniques.
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Chapter 6: Current Devices for Diagnosis and Therapy

6.1

Importance of the Quantitative Measurement for Diagnosis

In general, the state of health or geriatric condition with aging can be recognizable by gait.
For example, people generally walk more slowly when they are getting older and may start to
shuffle. In pathological conditions, people who suffered a stroke for example, may drag one of
their legs that making the asymmetrical gait. To date the observational gait analysis still plays an
important role to characterize most gait impairments. It is still the experienced clinician who
continues to perform functional gait assessment. The clinical research would recognized the
importance of gait information many years ago and today there are numerous groups worldwide
doing research and writing articles to discuss issues that relate gait profiles to medical conditions.
However, the benefit of these research and development activities is not being received by
clinical practitioners. Current modern technologies that involve sophisticated kinematic and
kinetic analyses have not been applied widely in clinical assessments and diagnosis. Instead, a
set of functional gait-related tests (such as usual and maximal gait speed, 6-Minute walk test,
long-distance corridor walk, gait abnormality rating scale –GARS, timed up and go test, and
performance-oriented mobility assessment - POMA) have been widely used as semi-quantitative
assessments [68]. Compared to modern computerized assessments, these are easy to perform, do
not require expensive equipment and long testing time. However, those semi-quantitative
assessments could not accurately detect the optimal rehabilitation and evaluation of treatment
effects.
There are numerous reasons why those modern technologies are not being applied. First,
the improvement of the reliable and quantifiable method is required to monitor the gait
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parameters in a normal environment. A second major limitation of the computerized assessment
is lack of the knowledge to perform and analyze the acquired data from those instrumented
equipment. With recent methods of assessment, the level of support for scientific evidence was
usually insufficient to make very strong recommendations to the clinic. Finally, a good
communication between scientific researches or engineering and clinical expertise is required to
improve the quality of the diagnosis and/or assessment. Scientists, engineers, and doctors must
merge their knowledge together to serve the public community. The scientific literature has to
be intended as a communication format between doctors, scientists, and other health
professionals.
The following will discuss the most recent motion analysis technologies that are applied
to monitor the gait for objective and quantitative assessment of the treatment, and the devices
that are used for neurological rehabilitation.

6.2

Motion Analysis Technologies

Gait analysis can provide significant information regarding the kinetic and kinematics of
human motion. Such an analysis has become a standard collaboration of engineers and medical
professionals determining force and motion characteristics of individuals coming to a gait
analysis laboratory for evaluation. Current motion analysis technologies offer a variety of
methods for recording movements of interest. Tools such as motion capture system or
wearable/wireless sensors, force platforms or pressure sensor distribution devices, and EMG are
necessary for a full analysis. Each method offers unique advantages for achieving these goals. In
the past two decades advances in computers, electronics and opto-electronics have led to the
development of many different systems for acquiring motion analysis data. Many of the
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commercially available movement recording systems are complex, expensive and require
technically trained operators. Software and hardware innovation in recent years are obviating the
need for technical ability while reducing processing time. Human motion data is most often
presented quantitatively as anatomic plane graphs showing relative joint rotation angles. Some
current software packages now allow acquired motion data to be displayed as a moving 3D
skeletal model permitting an enhanced physical appreciation for the motions being performed.

6.2.1

Optical Motion Capture System with Passive Reflective Markers

Motion construction has revolutionized computer animation in the last decade. The
success is readily apparent in films such as Lord of the Rings, which transfer expressive
performances of real actors onto digital characters both real and fantastic. Numerous commercial
companies have merged and induced this technology into biomechanical research. Numbers of
optical or video motion acquisition systems are used for motion analysis today (e.g., VICON:
http://www.vicon.com/ , SIMI: http://www.simi.com/, and Motion Analysis Corporation:
http://www.motionanalysis.com/).
Optical/Video motion capture (MC) systems tend to utilize proprietary video cameras to
track the motion of reflective markers (passive, Figure 6-1) attached to particular locations of the
subject’s body (Figure 6-3). Numbers of high-speed (up to 2000 frame per second) and high
resolution (up to 16 megapixels) cameras (at least 2 or more) are used for full-body 3D capture.
Reflective optical MC systems use typically Infra-red (IR) LED’s mounted around the camera
lens, along with IR pass filters placed over the camera lens. Figure 6-2 shows a typical cameras
system with IR mounted around each from VICON motion capture system. The centers of the
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marker images are matched from the various camera views using triangulation to compute their
frame-to-frame positions in 3D space.

Figure 6-1: Reflective markers are used to track the motion. These markers are lightweight
spheres covered with reflective Scotchlite tape (3M Corporation, St. Paul, MN). The tape is
designed to reflect incident light directly back along its line of incidence.

Figure 6-2: High-speed cameras system with Infra-red LED’s around, VICON motion
capture system
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(A)

(B)

(C)

Figure 6-3: SIMI motion system. (A). Marker placement in SIMI Motion 3-D Capture System
(www.simi.com ). 12 blue markers are static markers, and will be removed before the dynamic
trail are performed. (B). Schematic diagram of three-coordinate planes: X-coronal, Y-sagittal, Ztransverse. (C). Three coordinates plots throughout a three-minute walking trail.
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6.2.1.1 Inverse Dynamics

In traditional kinematics analysis, the measured locations of the joint center and the end
effectors are used to calculate the corresponding body joint angles locally and globally. This can
be done using the commercial software packages such as VICON, Visual 3D, and/or SIMI 3D
motion analysis.
An important aspect of human movement biomechanics involves the determination of net
joint reaction forces and moments-of-force (torques). Inverse dynamic analysis is used to
evaluate the reaction forces transmitted between adjacent segments and to calculate the net
moments-of-force that result from the muscle activity about each biomechanical joint. Inverse
dynamics is a method for computing forces and/or torques based on the motion kinematics, body
segment parameters and the external forces such as ground reaction force (GRF) vectors. The
process used to derive the joint moments involves differential calculations of the position and
angle trajectories of the body segments in order to obtain the accelerations required for the
applied forces.

6.2.1.2 Objective Gait Analysis and Quantitative Assessment of Rehabilitation

Motion capture (MC) system is among the first complete quantitative gait analysis
technique used in objective documentation of normal gait as well as identifying the underlying
causes for gait abnormalities in patients with cerebral palsy, stroke, brain injury and other
neuromuscular disorders. MC system usually offers state-of-the-art, high resolution, accurate
systems to acquire, analyze and display 3D dynamic data. The system is also integrated with
analog data acquisition systems to enable simultaneous acquisition of force plate and
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electromyographic data. Therefore, it can display and analyze kinematic, kinetic and
electromyographic data in forms that are easy to interpret.
Quantitative assessment of function is important in determining the functional status of
patients immediately after neurological injury to aid in the determination of a pharmaceutical or
physical therapeutic treatment regimen. Optical motion capture offers unrestricted movements
for determining a patient’s function, allows us quickly and easily to measure performance and to
determine the patient’s functional outcome.

6.2.2

Markerless Motion Capture

The most popular technique for human motion capture uses markers placed on the skin,
despite some important drawbacks including the impediment to the motion by the presence of
skin markers and relative movement between the skin where the markers are placed and the
underlying body segments. This makes it difficult to estimate the actual motion of the body
segments and joints, which is the variable of interest for biomechanical and clinical applications.
The markerless motion capture is model-based natural motion of human body being
captured and analyzed without attaching reflective markers or straps. Markerless motion capture
is an active field of research in computer vision and graphics. In contrast to commonly used
marker based approaches, the analysis for markerless methods is based on image data without
special preparation of the subject. The goal is to determine the position and orientation as well as
the joint angles of a human body from image data. Markerless motion capture offers an attractive
solution to the problems associated with marker based methods. However, the use of markerless
methods to capture human movement for biomechanical or clinical applications has been limited
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by the complexity of acquiring accurate three-dimensional kinematics using a markerless
approach.
The general problem of estimating the free motion of the human body without markers,
from multiple camera views, is underconstrained without the spatial and temporal
correspondence that tracked markers guarantee. Generic models typically lack accurate joint
information and thus lack accuracy for movement analysis. However, biomechanical and, in
particular, clinical applications typically require knowledge of detailed and accurate
representation of 3D joint mechanics. Some of the most challenging issues in whole-body
movement capture are due to the complexity and variability of the appearance of the human body,
the nonlinear and non-rigid nature of human motion, a lack of sufficient image cues about 3D
body pose, including self-occlusion as well as the presence of other occluding objects, and
exploitation of multiple image streams.

6.2.3

Wearable Inertial Sensors

Over the years, the evolution of methods for the capture of human locomotion has been
motivated by the need for new information on the characteristics of normal and pathological
human movement. However, the majority of current acquisition systems including the optical
motion capture system inhibit broader use of motion analysis by requiring data collection within
restrictive lab-like environments. Furthermore, the acquisition using lab-based capture system
normally takes about 1 to 3 minutes per trail, but with one or more hours for preparation;
recording the activities, routines, and motions of a human for long time or even an entire day like
24-hour portable ECG monitoring detector, is still challenging. There is an emerging trend in
biomechanics to measure outside of the laboratory setting, ideally in the everyday environments
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as the subject, either for ambulation or for upper-limb motion. This has led to the recent
development of several motion-measuring devices based on portable inertial sensing, combining
accelerometers, gyroscopes, electrogoniometers and magnetometers.
Inertial sensing technology is widely spread in several application domains, which
involve motion sensing of vehicles, planes, spacecrafts, cars and robots. In recent years, inertial
sensing has also been regarded as a means to sense human movement with some advantages in
comparison with well-established sensing technologies, e.g. optical/video motion sensing. Those
inertial sensors are usually lightweight and small size often called micro-electromechanical
systems (MEMS), the smallest sensors are less than 1g in mass and have dimensions smaller than
1cm × 1cm × 1cm, and they are low costs compare with optical motion capture systems. The most
important advantage is that they lead to direct measurements of kinematics such as angular
velocity and segment acceleration using gyroscopes and accelerometer respectively. Moreover,
temporal parameters of gait are also determined by classification of accelerations and angular
velocities through these direct measurements [132].

6.2.3.1 Accelerometers

Accelerometers are attached to the object and measure the acceleration of the object
directly at the point of attachment. A triaxial accelerometer measures three accelerations along
three different axes at right angles to each other. The orientation of the accelerometer determines
the direction of the acceleration measured.
Accelerometer systems have been pervasively evolving as a technology, with multiple
industry applications such as the automotive industry for safety approach [175]. The use of
accelerometers has a long tradition in biomechanics measurement. Accelerometer systems have
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been demonstrated for gait evaluation in different environments [154, 170, 171, 181].
Accelerometer systems have also been used to measure metabolic energy expenditure, physical
activity levels, balance and postural sway, and to detect falls [22]. The accelerometer and
footswitch component synthesis enabled the device to contrast temporal attributes of gait. Some
preliminary testing and evaluation of basic wireless accelerometer applications have already
been conducted [133]. With the growing interest and increasing use, validation of the accuracy
and reliability of the sensors needs to be more clearly established.
Advantages of accelerometers over other biomechanical devices primarily are expressed
by their miniature size, they are generally small and would offer limited restrictions to their
anatomical placement and provide minimal impediment to movement. Therefore, they can be
used as wearable biosensors to measure gait parameters in real world situations without the
limitations inherent to more immobile laboratory approaches such as camera systems. However,
accelerometer signals alone do not contain information about the rotation around the vertical and
therefore do not give a complete description of orientation. There are suggestions that the
limitation can be recovered by integrating the angular velocity measured from gyroscope.
Orientation can be estimated by combining the sensor signals from gyroscopes, accelerometers,
and magnetometers [147]. However, an error in measured angular velocity and magnetometers
will result in increasing inaccuracy in the estimated orientation. In particular, a relatively small
offset on the gyroscope signal will give rise to large integration errors [147]. In addition, the use
of magnetometers as a compass for stable orientation measurements could give large errors in the
vicinity of ferromagnetic materials.
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6.2.3.2 Gyroscopes

A gyroscope directly measures the angular velocity or joint rotational rate without the
signal being affected by gravity as is the case with the accelerometers. If the drift or offset is
compensated, the gyroscope signal can be used to measure rotational velocity (directly and
precisely) or angular excursions (by integration of the gyroscope signal).
Gyroscopes are compact in size and can be easily fixed to the skin, and are therefore
suitable for a portable gait analysis system. Data could be collected from these signals using
either a portable computer or data logging device with appropriate interfacing. The signals from
gyroscopes can provide a range of useful information for gait analysis ant the signals are highly
correlated with the signals from the motion analysis system.
In the past, gyroscopes have been used for several purposes in the field of biomedical
rehabilitation. Henty et al., for example, placed a gyroscope on the foot above the metatarsals in
order to distinguish two phases in the gait cycle, the swing and the stance phase. Further, he
calculated the hip, knee and ankle flexion angles during the gait cycle by placing a gyroscope at
the thigh, at the shank, and at the foot and by integrating the differences of gyroscope signals
[75]. Gyroscopes together with accelerometers were used for even detailed gait event
identification on person with dropped foot [132]. Gyroscopes could also be used on other body
segments, in particular the pelvis and the trunk, to provide useful information on pathological
gait patterns.

6.2.3.3 Electrogoniometers

Electrogoniometers are computerized versions of simple goniometers, which are
commonly used in clinical practice to assess joint range of motion or angular displacement of a
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joint. An electrogoniometer consists of one or more potentiometers placed between two bars,
with one bar strapped to the proximal limb segment and the other strapped to the distal limb
segment. The potentiometer, which is placed over the joint, provides a varying electrical impulse,
depending on the instantaneous angle between the two limb segments. This electrical impulse
information is then interfaced to an analog-to-digital converter in a PC to plot joint angle
information over time. Despite the limitations (discussed in chapter 7), electrogoniometers
remain the most convenient and least expensive means of measuring hip, knee and ankle angular
motions during walking. Another significant advantage of electrogoniometers is the immediate
availability of the data, which facilitates the functional interpretation in real-time.
Triaxial electrogoniometers are usually placed between two linear segments meeting at a
joint e.g. hip, knee, and ankle, to measure the flexion/extension, abduction/adduction, and
vertical rotation movements. The joint angle measurements have been identified as important
feedback signals for both mechanical and functional electrical prostheses. Studies on range of
angular motion of healthy individual for different walking speed can be used for developing
prosthetic control algorithm to provide swing stance stability [122].

6.2.4

Electromyography and Nerve Conduction Velocity (NCV)

In section in 4.2, the technique of the electromyography for evaluation of the electrical
activity of muscles was discussed. In fact, there are two types of electromyography: surface
EMG (most commonly used for clinical research) and intramuscular (needle or fine-wire) EMG.
A needle EMG contains two fine-wire electrodes which are inserted through the skin into
the muscle tissue. A trained EMG professional (physiatrist or neurologist) is required to perform
and observe the electrical activity while testing. The electrical activity when the muscle is at rest
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or static state can be studied using needle EMG. The presence, shape, size and frequency of the
resulting action potentials produced on the oscilloscope provide information about the ability of
the muscle to respond to nervous stimulation. Abnormal spontaneous activity might indicate
some nerve and/or muscle damage. Needle EMG is an invasive process that most the patients
find unpleasant and discomforting. Since skeletal muscles are often large, several needle
electrodes may need to be placed at various locations to obtain an accurate electrical activity.
A nerve conduction velocity (NCV) test is often done at the same time as a needle EMG.
The nerve is electrically stimulated while a second electrode detects the electrical impulse downstream from the first. Paired surface patch electrodes are placed on the skin over the nerve at
specific locations. One electrode stimulates the nerve with a very mild electrical impulse. The
resulting electrical activity is recorded by the other electrodes. The distance between electrodes
and the time it takes for electrical impulses to travel between electrodes are used to calculate the
speed of impulse transmission. A decrease speed of transmission indicates nerve disease. EMG
and nerve conduction studies are done together to give more complete information.
Because of some drawbacks of the needle EMG, surface EMG (SEMG) is used more
often as a diagnostic tool for neurologic disorders. SEMG measure muscle activity noninvasively
using surface electrodes placed on the skin overlying the muscle. SEMG electrodes record from
a wide area of muscle territory, have a relatively narrow frequency band (20 to 500 Hz), have
low signal resolution, and are highly susceptible to movement artifact [196].
Recent commercial SEMG products (Delsys http://www.delsys.com/ and BTS
http://www.zflomotion.com/) contain preamplifier electronics that lessen the need for low skin
resistance and improve the signal-to-noise ratio. SEMG can record both voluntary and
involuntary muscle activity in addition to externally stimulated muscle action potentials such as
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motor evoked potentials after central or peripheral nerve stimulation. SEMG signals are used as a
diagnostic tool for identifying neuromuscular diseases, assessing low back pain and disorders of
motor control [196]. In recent research, SEMG signals are used as a control signals for electronic
bio-devices such as prosthetic hands, arms, and lower limbs.

6.2.5

Measurement of Ground Reaction Force and Moments

Ground reaction force (GRF) can be measured using instrumented treadmill or
overground force plate(s), e.g. Kistler http://www.kistler.com/ and Bertec http://bertec.com/.
These devices can measure three components of the ground reaction force: vertical, mediolateral
and lateral anterioposterior, as well as the force moments in three-dimensional orientation. The
GRF is a “reflection of the total mass-times-acceleration product of all body segments and
therefore represents the total of all net muscle and gravitational forces action at each instant of
time over the stance phase” [258]. Therefore, accurate measurement on GRF can provide
significant information for the study of normal and pathologic gait. Normally, joint reaction
forces are relatively small in the lower extremity, at least during stance phase. Clinicians can use
the GRF itself to understand the forces that human muscles must control during the stance phase
in the gait cycle.
Over the past decade, a number of researchers have emphasized treadmill training to
increase ambulatory ability for functional recovery of neurological disorders. There are a number
of advantages of training and studying locomotion on treadmill. First, walking on a treadmill
allows patients to walk over long distances without moving far in the real world. Second,
multiple aspects of locomotor skills can be trained safely within a confined space. Many
therapies use some degree of body-weight support through harness devices. The harness can be
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easily mounted on the treadmill, so that patients can be partially supported with. Finally, the
experimental walking speeds can be controlled accurately and the ground reaction forces and
moments will be digitized for data-processing in this study.
GRF can also be measured using the pressure distribution devices such as In-shoe Footscan (F-Scan® system) or Floor mat (Walkway™) from Tekscan Inc. (http://www.tekscan.com/).
The great advantage of the In-shoe Foot-scan measurement devices are evaluated for use in
portable measurement system that will allow for the complete measurement of human gait
outside of the laboratory settings. It is a cost-effective measurement of in-shoe plantar pressures.
The In-shoe Foot-Scan captures foot pressure distribution during walking or running using an
ultra thin, disposable sensor, which is placed inside the patient’s shoes as an insole, shown in
Figure 6- . Despite some limitations, In-shoe Foot-Scan is a tool for providing quantitative
information to determine orthotic efficacy, identify areas of potential ulceration, screen diabetic
and other neuropathic patients and observe gait abnormalities.

Figure 6-4: F-Scan sensor inserted into patient’s shoe.

Takscan Walkway™ as discussed in chapter 4, is a floor mat that captures barefoot
plantar pressures distribution and vertical force during walking. It can be used in conjunction
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with a force plate. It is a few meters long and contains over eight thousands sensing elements.
Both Takscan Fscan and Walkaway softwares provide automated calculation of an array of gait
parameters. Individual gait stance phase information such as foot strike and toe-off are detected
and spatial-temporal parameters are calculated. In addition, the pressure maps of pressure
distribution on plantar surface are displayed in a colored scheme graph both in 2D and 3D.

6.3

Summary

This chapter introduced the most recent technologies including optical motion capture
system, markerless motion capture, different inertial sensors, EMG , and ground reaction force
and foot pressure, to monitor the human locomotor for objective and quantitative measurement
and/or assessment of the therapeutic treatment.
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Chapter 7: Limitations of Current Technology

7.1

Limitations of Optical/Video Motion Capture System

The standard method for human analysis is the optical motion analysis using high-speed
cameras to record human 3D motion, but there are number of limitation in this laboratory set-up.
•

It requires expensive devices.
Most motion capture devices range from US$100,000 to US$350,000; this makes motion

capture an option available only for some research labs with financial capabilities. During
complicated motions, more cameras haveto be used to increase the ability of a system to
faithfully track a marker through a full motion path in three-dimensional space.
•

It also requires large indoor space.
Motion capture system produces excellent indoor motion analysis, but offer no

comparable solution for acquisition in everyday environments. The acquisition usually takes
place in a motion analysis laboratory environment.
•

It contains time-exhausted data processing.
Although the ability of track multiple markers has been remarkably improved (some

systems now tracking over 100 markers simultaneously) in recent years, but in general, tracking
process still remains time-extensive.
•

The line of sight from camera to marker can be blocked, resulting in incomplete data.
Movement of limbs causes occlusion of data recorded, making the optical motion

analysis unpractical. This marker occlusion becomes even worse in data acquisition on subjects
with locomotion impairments using walkers, harness, or many other body-weight support
equipments.
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•

It is light sensitive.
The CCD (charge-coupled device) is light-sensitive that use an array of pixels to capture

light, and then measure the intensity of the light for each pixel, creating a digital representation
of the image. The intensity of the light and the reflection from surrounding objects may affect the
accuracy of the acquired data.
•

It requires calibration process
The optical system must be calibrated by having all the cameras track an object with

known dimensions the software is able to recognize. By combining the views from all cameras
with the known dimensions of the object, the exact position of each camera in space can be
calculated. If a camera is bumped even slightly, a new calibration must be performed. Ideally,
the system should be calibrated every few minutes of capture since any kind of motion or
vibration can shift the position of a camera, especially if the lab is located in a multi-storey
building.
•

It is sometimes difficult for pathological conditions.
Common motion capture systems acquire static/reference marker position, asking

subjects to strengthen their body segments to enable the visibility of all markers at the same time.
This, sometime become difficult for some patients such as stroke patients with constrained limb
movement and joint extension.
•

Optical motion analysis cannot be done in real-time for analysis.
Normally, optical motion capture system is not a real-time process. It requires most of the

time to “fill-in” the missing data due to occlusion. Although some systems tout “real-time” data
analysis, user intervention is required to ensure the accuracy of data collection.
•

Low reliability due to noise introduced from differentiation.
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The optical motion capture system measures the angular displacements of the anatomical
body segments. In gait dynamics, the forces and torques a subject is able to generate is
significant for rehabilitation. This stands to reason that the measured angles are then
differentiated twice to obtain the accelerations required to determine the forces through inverse
dynamics calculations. The differentiation, however, introduces unwanted distortions, noise and
other parameters like the phase-shifts with respect to the angular displacements. These
uncertainties corrupt the objectivity in the measured quantities, and affect the reliability of the
system.
•

The motion capture system with reflective markers leads to unnatural motion patterns.
Marker-based systems are designed to track the motion of the markers themselves and

thus it must be assumed that the recorded motion of the markers is identical to the motion of the
underlying human segments. Since human segments are not truly rigid, this assumption may
cause problems, especially in highly dynamic movements in sporting activities and impaired
movements of the patients. Cappozzo et al. [18] examined five subjects with external fixator
device and compared the estimates of bone location and orientation between coordinate systems
embedded in the bone and coordinate systems determined from skin-based marker systems for
walking, cycling and flexion-extension activities. Comparisons of bone orientation from true
bone embedded markers versus clusters of three skin-based markers indicate a worst-case root
mean square artifact of 7°.
•

Low sampling rates
With multiple cameras used for complicated motion analysis, one limitation is the

relative slow sampling rate. The number of velocity measures per second between six and eight
cameras is usually 70 frames or less.

90

•

Impractical for certain conditions.
Some able-bodied subjects have certain skin conditions such as allergy from the double-

sided tape, and wet/oily skin type and sweating while moving that cause the markers dropping
during the experiment, making the marker-based motion capture impractical.

7.2

Weakness of the Wearable Sensor Detection
Since inertial sensors are compact and light, they have been a popular choice for

application in human locomotor analysis. However, the highest quality inertial sensors also
exhibit limitations. These include problems with drift from data integration, error introduced
from improper body attachment of the sensors causing movement of sensors during data
collection, and errors introduced from the assumption of rigid behavior of human limbs.
Moreover, problems can become cumbersome and difficult to use if multiple sensors are required
for accurate motion capture, subjects may feel uncomfortable wearing so many sensors.
•

Bias of the inertial sensors cause output errors.
In inertial sensors the output is usually non-zero even in the absence of any input (zero

acceleration or angular velocity ideally). This error is called sensor offset that is added to the
actual measured signal. The most important problem with this offset is that it drifts depending on
time, temperature and stochastic factors. The error is relatively small, the miniature measurement
(measuring distance between sensors) and combination of inertial sensors with an extended
Kalman Filter can be used to minimize the offset and sensor noise [147].
•

Cumulative drift due to single or double integrations.
One common problem of the inertial sensors is cumulative drift through integrations.

After the single integration (e.g. to find the angle from angular velocity) the error due to noise
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grows proportionally to the square root of time. After double integrations (e.g. to find position
from acceleration), the error due to noise grows proportionally to t3/2.
•

Physical, anatomical and physiological errors.
Inertial sensors with low sensitivity may fail to detect smaller movements such as in

human tremors. A common error shared by accelerometers and other inertial sensors for motion
measurement based on skin-mounted sensors is the movement of the soft tissues covering the
bones. If the sensors are attached to the body segments using straps, the straps may lead to free
motion of the sensors. Furthermore, sensors may be hit or vibrated during heel strike.
•

Problems with inertial sensor placement.
Multiple inertial sensors (wearable or wireless) are often attached to various locations on

the human body for gait analysis, especially at the hip, trunk, neck and head, for the best
recognition of human movement. However, location of the sensor and attachment of multiple
sensors become difficult in most of the data collection. Placement is often imprecise. Because of
these difficulties, wearing multiple sensors is not an immediate and pragmatic solution for data
collection in real-life. Furthermore, due to individual variations, exact orientations may not be
consistent between individuals.
•

Poor accuracy of Electrogoniometer
Cross talk is a potential limitation to triaxial electrogoniometers. If the axes of the

potentiometers are not fully aligned with the axes of the joint motion, the cross talk becomes
apparent and the potentiometers’ readings do not correlate with clinical rotations. When the
angle in the coronal or transverse plane equaled 10° or more there is a significant error in sagittal
motion [17], based on the assumption that the three-dimensional dependency is consistent with
computer corrections of the data have been formulated. Clinically, the cross talk would not be
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significant in normal subject who has minimal coronal or transverse motion, but values obtained
on patients with hypermobility require the added calculations.
A major disadvantage of current electrogoniometers is relatively poor accuracy because
they are difficult to apply, particularly about the hip and ankle. Measurement of hip motion for
example should be between the pelvis and thigh, but this rarely occurs with electrogoniometers.
It is only possible with thin subjects to keep a strap around the pelvis. In the slender person with
a normal gait, there is so little trunk motion that no significant error is introduced. Patients with
incompetent hip musculature however, frequently use large arcs of trunk motion to substitute for
their limitations. Hence, the electrogoniometer is not a useful instrument at the hip when
pathological function leads to significant displacement of the trunk.

7.3

Limitations of Surface EMG
There is limited approach for gait studies based on SEMG analysis due to the noisy

character and inconsistency of the signal. The reliability of the SEMG signal is mostly affected
by movement artifacts in the study of the dynamics. Cross-talk from other muscles including
antagonists also results in trial to trial variations. In addition, the inconsistency can be caused by
electrode placement and skin/muscle interface impedance (particularly when the active muscle is
10 mm or more below the skin surface) [51]. Researchers tried to avoid this inconsistency by
reporting EMG in percentages of a baseline maximal voluntary isometric contraction (MVC),
and other researchers study the EMG “on and off” “peak-to-peak” time durations.
In normal subjects, normalized EMG is not always associated with changes in muscle
force. The relationship is consistent and linear when muscle action is isometric [220], consistent
with muscle length during rhythmic movement, and increased muscle forces by increasing their
motor neuron firing rate, not by recruiting additional motor units.
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These bring the doubt of validity of the EMG: do variations in EMG signal reflect real
variations in on-and-off” time, and muscle tension? The on and off times may be distorted by
movement artifact which can be eliminated or reduced using smoothing and averaging
techniques. However, the on-and-off times and muscle tension may also be distorted by
electromechanical delay. Winter explains electromechanical delay in terms of muscular anatomy.
Because the muscle’s contractile proteins develop force in parallel with elastic and viscous
elements, muscle force must elongate these elastic and viscous proteins in their fluid
environment before tension is registered in tendon. Electromechanical delay may vary inversely
with the velocity of muscle shortening.
So far, research and extensive efforts have been made in the area, developing better
algorithms to cope with the noisy signals and hence make precise decisions, upgrading existing
methodologies for data processing, improving detection techniques to reduce noise, and to
acquire accurate EMG signals. Recent advances in technologies to signal processing and
mathematical models have made it practical to develop advanced EMG detection and analysis
techniques. Various mathematical techniques and Artificial Intelligence (AI) have received
extensive attraction. Mathematical models include wavelet transform (WT), time-frequency
approaches, Fast Fourier Transform (FFT), and multiple statistical approaches. AI towards signal
recognition includes Artificial Neural Networks (ANNs), Dynamic Recurrent Neural Networks
(DRNNs), Fuzzy Logic System (FLS), and Genetic Algorithm (GA).
The main reason for the interest in EMG signal analysis is in clinical diagnosis and
biomedical applications. The patterns and firing rates of Motor Unit Action Potentials (MUAPs)
in EMG signals provide an important source of information for the diagnosis of neuromuscular
disorders. Once appropriate algorithms and methods for EMG signal analysis are readily
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available, the nature and characteristics of the signal can be properly interpreted for various
applications.

7.4

Limitation of GRF measurements
Ground reaction force measurement is important in the analysis of human locomotion.

Drawbacks of the existing measurement systems discussed in chapter 6 are the restriction to a
laboratory environment and poor accuracy of the measurement.
•

Drawbacks of the overground force platform.
First, the subjects are required to place their feet completely on the force plates (each

with maximum size of 60cm x 60cm) in order to perform a correct force measurement. However,
successful trials are harder to achieve, making for a longer and more frustrating process. Some
subjects try to adjust their gait before getting to the plate to obtain a successful trail, which leads
to a restriction on the natural gait pattern. This becomes even more complicated with some
neurologic patients such as cerebral palsy with scissoring gait. Second, only one or two steps can
be measured during a trial, so cumbersome process of multiple successive trials are required to
get an average gait pattern. The gait speed varies between trials. In addition, both left and right
forces are often looked at individually, especially with pathologic conditions. Therefore, the
process can be very tiring and fatigue affecting gait performance becomes an issue. Third, it
could not record the force of each foot if both feet are standing on one plate. Finally, the force
platform in the laboratory is time and financially expensive. The entire testing procedure,
including patient preparation, commonly takes two hours at minimum to complete, limiting the
lab in number of evaluations that can be run in a day. The force platform is normally expensive
and requires engineers to mount force plates flush with the floor. The force plate is fixed on the
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floor in the gait laboratory, which means a relative large space is required, and the measurements
cannot be done in every life environment.
•

Drawbacks of the instrumented treadmill.
The force measurement system is incorporated into treadmill, making so called

instrumented treadmill with force platform(s) under the belt (or dual-belt) of the treadmill. The
instrumented treadmill eliminates many limitations that the overground platform has. It allows a
decrease in the data collection time and the space required, and to record GRF at constant gait
speeds. Despite its numerous advantages, the instrumented treadmill however has several
disadvantages. First, walking on a treadmill is more dangerous and some patients become
overanxious. The patient has to be made familiar with the treadmill walking before the
assessment. Second, a major error introduced into force data is the instrumental noise due to
vibrations and the moving artifact during walking and running on the treadmill. Third, the single
belt instrumented treadmill records the summed GRFs from both feet. Although a simple
algorithm allows the separation of the individual foot vertical forces before computing joint
moments, this is still unsuitable for the assessment of joint moments. One solution is to use split
belts treadmill and force transducers. However, it compels the subject to walk with a wider base
of support. Finally, walking on the treadmill does not realistically simulate everyday life
conditions for most of the patients. Clinicians are sometimes suspicious of gait analyses results
collected on a treadmill, arguing that treadmill gait is different from over ground gait.
•

Poor accuracy of in-shoe Foot-scan
The in-shoe Foot-scan system lacks durability and suffers significant calibration error.

Woodburn and Helliwell showed the creep (19%) and hysteresis (21%) properties of Foot-scan
were poor [261]. Within- and between-sensor variability in output was demonstrated and overall
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repeatability was poor. Furthermore, adjusting the sensor size adversely affected output. They
concluded that Foot-scan has a limited capability for absolute accuracy but could still be used for
quantitative studies outside the laboratory while its limitations are noted.
•

Walkaway Floor Mat force distribution is time and space costing
The Floor Mat force distribution system is just a few meters in length, only two or three

strides per trial can be captured. Therefore, numbers of trials are required to increase the
statistical power for gait analysis studies. It also requires a large space just like the overground
force platform that makes the measurement impractical a daily activity environment.

7.5

Summary
Computerized gait analysis provides the tools necessary to evaluate both normal and

pathological gait. Through the study of normal gait, it is possible to understand pathological gait
and to prescribe more effective treatments. Recent advances in technology have allowed the
measurement of gait variables more precisely and in a timely manner. There is no single method
of measurement, however, that provides a complete analysis of gait. And each device contains its
own strengths and weaknesses. The usefulness of each device should be judged not solely on its
own disadvantages or advantages but on the balance of the two. Sophisticated gait measurement
is possible with a basic knowledge on which specific information collected, processed and
calculated. These sophisticated gait measurement will be very useful information as the control
tool to assist the design of the treatment devices.
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Chapter 8: Design of Research Activities

This research included both theoretical and experimental analyses of the central and
segmental interaction between motor and sensory control mechanisms and the biomechanical
structures of the lower extremities in healthy, and motor and sensory impaired persons. A
wearable miniature sensor array enables efficient, reliable, and real-time analysis of functional
impairments in human locomotion.
Fuzzy Relational Logic
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Figure 8-1: Sensor fusion driven computational intelligence scheme.

This dissertation work introduces three innovative technologies as illustrated in Figure 81: a) an unobtrusive combination of wearable sensors for the acquisition of locomotor data in
multiple domains (kinetic, kinematic and electromyographic, b) a sensor data fusion scheme for
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combining information from multiple sensors and sensor types in order to increase efficiency and
reliability, reduce uncertainty and ambiguity inherent in making decisions based on a single
information source, thus increasing accuracy and resolving ambiguities in the knowledge about
the complexity of gait dynamics, and c) a rapid and reliable data analysis system based on fuzzy
inferential logic algorithms-capable of identifying, differentiating and quantifying clinically
relevant variations from morphometrically adjusted normal gait.

The final product of this research work is a sensor fusion driven computational
intelligence scheme whose structure is illustrated in Figure 8-1. This final product enables the
effective, reliable and differential monitoring and assessment of gait disorders.

8.1

Fusion of Multiple Sensor data

The application of the single-sensor single-algorithms, like the EMG device or the force
plate sensor, in monitoring functional impairments in mobility-related behaviors of human
subjects, may offer only marginal results. This is because the single-sensor single-algorithm
systems may work well in situations where the environment is structured and the objects are well
known, but are severely limited in their ability to resolve ambiguities in complex systems like the
human locomotor system that involves multi-body dynamics, biomechanics, physiology and
other factors that obscure the interactions between the vestibular, somatosensory and visual
inputs for postural control.
Acquiring signals from multiple sensors and providing correlated data from multiple
domains leads to dramatic and practical improvement over current methods for automated gait
analysis. A novel analysis system utilizing principles of fuzzy inferential logic will integrate
information from different sensory sources; coordinate and guide the observations made by each
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sensor; and improve the reliability of automated assessment by reducing the uncertainty and
ambiguity inherent in making decisions based on only a single type of information. This fusion
of multiple sensor data is critical to the efficient recognition and differentiation of aberrations’ in
gait dynamics for the objective determination of functional impairment and fall risk due to
disease severity, medication effect, and the like. This integration of inputs is also essential to the
efficient monitoring of therapeutic interventions because it enables objective measurement of
responses, and response variability.
This research work has developed a novel intelligent system that linked the physiological
and biomechanical responses underlying human gait, to recognize, quantify and differentiate the
functional components of normal and impaired locomotion. It has provided adequate knowledge
of the patient and characteristics of the impairments that determined the functional outcome. This
way, the system contributes to a better understanding of functional recovery in general and
patient characteristics that may allow for an early reliable prediction of the final outcome in
particular. It also enables individually tailored optimal treatment programs to be designed and
implemented.
Whereas the current gait rehabilitation paradigm drives subjects’ limbs through predetermined interventions based on qualitative assessments, the new system in this dissertation
work will generate tailored interventions responsive to each subject’s immediate and objectively
determined abilities and effort. Because this can be applied across all mechanisms of gait
impairment, this research can benefit any person who has acquired gait-related disability but that
retains a potential to stand and ambulate.
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8.2

Fuzzy Inferential Logic
A goal of this dissertation work was to develop an innovative system to assist clinicians

reliably assess, at an early post-insult stage, the degree of disability the patient will ultimately
experience. Physician decision processes offered to date, especially those relative to diagnosis
and patient treatment, suffer from the inability to incorporate all useful data on the patient. A
fuzzy inferential logic has been developed to aid the physician to categorize the complete
representation of information emanating from the measured kinetic, kinematics and
electromyographic data from the patient.
One way of dealing with the functional impairments in locomotor systems may be
qualitative, non-numerical and imprecise in nature. The ratings of the physician may be
influenced by qualitative factors such as emotion, perception, shifting and imprecise knowledge
states, etc. One way of unscrambling the data or partitioning the weighted evaluation points into
subsets is via the approach of cluster analysis. The subsets can be distinct or fuzzy. However, in
situations such as the foregoing, it is instructive to analyze the data via fuzzy clustering
techniques. The application of cluster analysis is centered on the formulation of relationships for
the variables (kinetics, kinematics and electromyographic data)

under consideration, fuzzy

relational mappings.
In this research work, a fuzzy rule-based system (relational mappings) for the
categorization of different types of neurologic disorders was designed to cope with uncertainty
and perform approximate reasoning. In the following sections, the fuzzy set theory, fuzzy
inference system (FIS), and fuzzy rule-based matrix formation will be explained.
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8.2.1

The Fuzzy Sets Theory
Fuzzy logic systems form a class of production systems that map R n → R p and that are

based on an extension of classical logic, in which truth values are continuous between 0 and 1.
A fuzzy logic system is a rule-based system that maps an input domain X ⊂ R n to an
output domain Y ⊂ R p . The rule base is composed of fuzzy rules (or associations) that associate
fuzzy conditions to fuzzy conclusions. Each condition fuzzy set A (resp. conclusion fuzzy set B)
is defined as a "membership function" mA (resp. mB) over X (resp. Y) that assigns to every

x∈ X

(resp.

y ∈ Y ) a value between 0 and 1 representing the degree to which x belongs to A

(resp. y belongs to B).

8.2.2

Fuzzy Set Definition

Let X be a space of points (objects), with a generic element of X denoted by x, [X is
often referred to as the universe of discourse]. A fuzzy set (class) A in X is characterized by a
membership (characteristic) function mA(x) which associates with each point in X a real number
in the interval [0,1] with the value of mA(x) representing the "grade of membership" of x in A.
Thus, the nearer the value of mA(x) to unity, the higher the grade of membership of x is in A.

8.2.3

Fuzzy Relations

Relations represent and quantify associations between objects. Let x in a fuzzy set X with
its membership function µ X (x) , and y in a fuzzy set Y with its membership function µY ( y ) ,
the fuzzy relation

ℜ from a set X and a set Y is a fuzzy set of the Cartesian product written as

ℜ : X × Y → [0,1]
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(8.1)

Where

( x, y ) , x ∈ X , y ∈ Y is the collection of the ordered pairs. ℜ is characterized by a

membership function

µ R ( x, y ) and is expressed as
µ R ( x, y ) = Min{µ X ( x), µY ( y )}

(8.2)

µ R ( x, y ) = µ X ( x ) µ Y ( y )

(8.3)

Or

The membership function of

ℜ

for pair ( x, y ) , ℜ( x, y )

and y are fully related. On the other hand,

= 1 denotes that the two elements x

ℜ( x, y ) = 0

means that these elements are

unrelated while the values in between, 0 < ℜ( x, y ) < 1 underline a partial association (a
degree of belonging of a degree of similarity).

8.2.4

Fuzzy Relation Matrix

When determining the presence or absence of association, interaction or interconnection
between the elements of the kinetic, kinematic and electromyographic data and gait phases, the
mapping is usually non-fuzzy. But when the severity level of an element of the gait functions
must be determined, fuzzy sets are often involved in the mapping. Comparison between
mappings is a pattern analysis procedure. Figure 8-2 illustrates the feature extraction and
classification for pattern analysis.
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Figure 8-2: Feature Analysis.
Feature Extraction:

The extraction of features in this cluster analysis is centered on the formulation of
relationships for the variables under consideration. Fuzzy clustering provides a richer description
of the geometric structure of the data set in many cases, and has a lesser tendency to get stuck in
local minima. The fuzzy relational matrix depicts the feature extraction, i.e. it establishes
membership functions between the measured variables. It can be interpreted as degrees of
typicality or degrees of sharing.

Classification:

The essential concept of pattern recognition may be expressed by a mapping from feature
space to decision space. The design of a classifier consists of two parts: one part to collect data
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samples from various classes and to find the boundaries which separate the classes. This process
is called classifier training, or the learning. The other part is to test the designed classifier by
feeding the samples the class identities of which are known.
The classification stage involves assigning the examining variables to the appropriate classes
based on the properties of the variables.
Let

x ∈ X , where X = {x1 , x2 ,Λ , xi } , and y ∈ Y , where Y = { y1 , y2 ,Λ , y j }, then a

relation

µ R , also called the Cartesian Product, X × Y , can assume the matrix form with the

following entries and in a corresponding matrix notation as:

 µ R ( x1 , y1 ) Λ µ R ( x1 , y j )

µ R ( x, y ) = 
Μ
Μ
Μ 
 µ R ( xi , y1 ) Λ µ R ( xi , y j ) 
in which the

(8.4)

(i, j )th element is the value of µ R ( xi , y j ) . For a finite universe of discourse, a

matrix notation is useful. In this case, fuzzy relation ℜ can be represented as a

(i × j ) matrix

with the entries taking values between 0 and 1.

The matrix depicts a feature space (a rule base) that describes the association, interaction or
interconnection between the elements of the x and y.

8.2.5

Fuzzy Similarity

The application of the fuzzy similarity measure enables the comparison between the
relation matrices, as described by
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µ ref *test

min[ µ R ( xi , y j ), µT ( xi' , y 'j )]
=
= similarity
max[ µ R ( xi , y j ), µT ( xi' , y 'j )]

(8.5)

where the symbol “*” represents the fuzzy cross-correlation operator, “Min” represents the fuzzy
logic intersection, “Max” represents the fuzzy logic union and the
similarity between the test-subject

( x' , y ' ) ,

µ ref *test

and the reference-subject

is the grade of

( x, y ) ,

whereby the

grade of similarity ranges between 0 and 1. The application of the grade of similarity in this work
enables the quantitative and differential comparison between various types of functional
impairments.

8.3

Experimental Determination of Gait Dynamics

•

Dynamic approach in stride-to-stride fluctuation

Quantitative studies of gait have typically focused on properties of a typical or average
stride, ignoring the stride-to-stride fluctuations and considering these fluctuations to be noise.
Work over the past two decades has demonstrated however, that the alleged noise actually
conveys important information. The magnitude of the stride-to-stride fluctuations and their
changes over time during a gait dynamics may be useful in understanding the physiology of gait,
in quantifying age-related and pathologic alterations in the locomotor control system, and in
augmenting objective measurement of mobility and functional status. Indeed, alterations in gait
dynamics may help to determine disease severity, medication utility, and fall risk, and to
objectively document improvements in response to therapeutic interventions, above and beyond
what can be gleaned from measures based on the average pattern of stride [69].
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To study the intrinsic stride-to-stride dynamics and its changes with neurologic
impairment, the standard deviation of each time series and the coefficient of variation (CV), an
index of variability normalized to each subject’s mean cycle duration, are computed. Both the
standard deviation and the CV provide a measure of overall variations in gait timing during the
entire walking task, i.e., the amplitude of the fluctuations in the time series with respect to the
mean.
•

Pattern Analysis Scheme

Reference Pattern
R (x, y)

Input Pattern
R’ (x’, y’)

Feature
Matching

…

Reference Pattern
…

…

Input Pattern
…

Feature
Matching

Feature
Analysis

Result of
differential analysis

Figure 8-3: Differential pattern analysis scheme.

In Figure 8-3, a pattern analysis scheme for the differentiation of the gait patterns is
illustrated. The reference pattern features are extracted from the averaged biomechanical data
(ground reaction force, EMG, and acceleration) for all able-bodied subjects, and stored as the
knowledge-base. The input patterns are obtained from the measurements of the mobility-related

107

impaired patients using the same feature extraction procedure. Through feature matching, the
patterns are analyzed and may be used to: 1) differentiate gait patterns of the right and left limbs
for establishing any level of symmetry within a patient; 2) differentiate the severity of the
attributive features of the impairment between patients with the same disease; and 3)
differentiate amongst different disease characteristics, and also amongst same diseases.

108

8.4

Participant Recruitment

This study was approved by the University of Texas at El Paso (UTEP) Institutional
Review Boards (IRB), El Paso, Texas, USA. Twenty-two (twelve male and ten female) ablebodied subjects (18 years old and above) were recruited from the campus of UTEP. Patients with
neurological disorders including cerebral palsy, multiple sclerosis, stroke, spinal cord injury,
traumatic brain injury, idiopathic neurologic conditions were recruited from the local hospitals
and rehabilitation clinics. In addition, injured subjects as well as elderly fallers were recruited
from the community. All able-bodied subjects at the time of data collection declared no
orthopedic or neurological pathology, injury or illness likely to affect locomotion or balance.
Patients were fully or partial ambulatory which may or may not require partial body weight
support (harness) during the experiment. All subjects provided informed consent prior to
inclusion in the study according to institutional policy on human research.

8.5

Design Activities

8.5.1

Specific Aim – 1:

To investigate stride-to-stride fluctuations in gait to increase our understanding of the
neural control of locomotion.
•

Objectives

The measurement of the variability and fluctuations in the timing and length of gait
phases could assist in providing more specific information regarding the type of impairment and,
therefore, determine appropriate treatments. The study included:
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1) How different control mechanisms produce the variability of gait, the magnitude of the
stride-to-stride fluctuations, the stride dynamics, how stride fluctuates with time, independent of
the magnitude.
2) How time between heel strikes, i.e. the stride interval or stride time, may function as a
gait “clock” and reflect the internal rhythmicity of the locomotor system. Thus, examination of
the fluctuations in the stride interval would theoretically provide insight into the organization,
regulation, interactions and stability of the entire locomotor system.

•

Stride Variable Extraction Methods

The stride-to-stride fluctuations present in twenty-two able-bodied subjects were
evaluated in order to gain insight into normal locomotor function and its control mechanisms, in
order to enhance our understanding of “pathological” deviations.
In this study, the temporal stride variables including stride time, stance ratio, swing ratio,
and double-stance ratio were used. The purpose was to determine whether the impairment or
disorders and/or individuals with the same disorder among different severity provoke significant
gait changes with respect to the mean, standard deviation and coefficients of variation of these
stride parameters.
Data from ground reaction forces were smoothened using second order Butterworth low
pass filter to remove the noise above 20 Hz. The heel strike was then determined using a
threshold-based criterion, i.e. the heel strike was defined as the period when the magnitude of the
vertical force (Fz) exceeded the threshold [91]. In this case, the stride interval time (or gait cycle
duration) series is obtained simply by taking the difference of the temporal data between the
consequence heel strikes. Similar method was applied for extracting stance time (i.e. difference

110

of the temporal data from heel strike to toe-off of the same foot), swing time (i.e. difference of
the temporal data from toe-off to the following heel strike of the same foot), and double-stance
time (i.e. difference of the temporal data from heel-strike of one foot to toe-off of the other foot).
Figure 8-4 illustrates the examples of these temporal stride variables.
First, the 100 strides from the three-minute walking data were extracted from each ablebodied subject. The number of strides from patient’s data varies and depends on their walking
speeds. Second, the ratio of the stance phase/swing phase/double stance phase in each gait cycle
was calculated. Finally, the mean and standard deviation of both healthy and patient subjects
were calculated. The magnitude of the stride-to-stride fluctuations in the gait cycle
duration/stance ratio/swing ratio/ double-stance ratio was also calculated, and the coefficient of
variance (CV) of each subject was also calculated. The coefficient of variance is a normalized
measure of dispersion of a probability distribution. It is defined as the ratio of the standard
deviation σ to the mean µ , written as

CV (%) = 100 ×

Std ( σ )
Mean ( µ )

The statistical results were reported as mean ± standard deviation and CV (%).
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(8.6)

Figure 8-4: Temporal Stride Variables. (StanceT: Stance Time; SwingT: Swing Time; DST:

Double Stance Time).

8.5.2

Specific Aim – 2:

To gain knowledge of gait dynamics in a specific pattern to increase our understanding of
the neurophysiology/biomechanics of gait, and augment objective measurements of mobility and
functional status.
•

Objective

Perform studies to acquire and analyze complex and multidimensional motion-related
physiologic data and use this to demonstrate specific effects of defined states of diseases, injuries,
and aging. The acquisition and quantification of gait dynamics will augment objective
measurement of mobility and functional status.
•

Pattern Analysis Methods

Twenty-two able-bodied subjects were used to create the reference or normal gait pattern
in ground reaction force (GRF), electromyography (EMG) and segmental acceleration. The
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methods for feature extraction will be discussed in detail in the following sections, and the same
methods will be applied on each patient.
Ground Reaction Force – ( mediolateral Fx , anterior-posterior Fy , vertical Fz )

An instrumented treadmill was used to record the consecutive left and right forces in
mediolateral ( Fx ), anterioposterior ( Fy ) and vertical ( Fz ) planes. Information about the
characteristics of the normal force pattern within gait cycle (mean of 100 strides) was obtained
from the able-bodied subjects (i.e. averaging GRF data within a gait cycle from ten healthy
female subjects, and averaging GRF data within a gait cycle from twelve healthy male subjects),
whereas the characteristics of the force pattern in a gait cycle (mean of number of strides, it may
be noted that this number varied between patients) from each patient was also extracted. In order
to allow comparison of the GRF among different subjects, the GRF values were normalized by
body weight of individuals (i.e. the GRF data are represented as percentage of body weight %BW).
The relationship between the GRF with respect to the seven gait phases defined in Figure
4-1 is established. Hence, fuzzy sets of the GRF of healthy subjects are described as the ground
reaction

forces

in

three

planes

x

from

a

GRF

collection,

X,

expressed

as

x ∈ X with X = { Fx , Fy , Fz } , where Fx indicates mediolateral GRF, Fy indicates

anterioposterior GRF, and Fz indicates vertical GRF. The fuzzy sets for the seven gait phases
are expressed as the gait phase, y out of a number of gait phases, Y, expressed as y ∈ Y , with
Y = {p1 p 2

p3

p4

p5

p6

p7}; where p(i) indicates gait phases from one to seven.

A fuzzy relation among healthy subjects, R, is established between the fuzzy sets X and Y
using the Cartesian product. This relationship models the connectiveness of the two fuzzy sets
into a fuzzy rule base. The Cartesian product X × Y , a relational matrix, is then expressed as
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R( x , y )

µ R ( x, y ) is

 µ R ( x1 , y1 ) Λ µ R ( x1 , y7 ) 
Μ
Μ
Μ 
=


 µ R ( x3 , y1 ) Λ µ R ( x3 , y7 )

(8.7)

defined as a membership function (the grade of belonging), this means, the

relationship between GRF with respect to the gait phase of an able-bodied subject. The
membership function is expressed as

1 n
µ R ( x , y ) = ∑ µ (i)
n i =1

(8.8)

where x represents the GRF in the seven gait phases, and y is the seven gait phases, n is the
number of data frames within a phase,

µ(i) is the normalized GRF.

The actual measurements of an impaired subject can be compared with the reference data
in the fuzzy rule-based system through inferencing. This procedure is called the fuzzy similarity
analysis, and it provides an outcome measure in aggregation. The application of the fuzzy
similarity measure enables the comparison between the rule base of GRF and a impaired
subject’s GRF, expressed as:

µ

R

∗ µ

T

=

Min [ µ R ( x i , y j ), µ T ( x ' i , y ' j )]
= similarity
Max [ µ R ( x i , y j ), µ T ( x ' i , y ' j )]

(8.9)

where the symbol “*” represents the fuzzy cross-correlation operator, “Min” represents the fuzzy
logic intersection, “Max” represents the fuzzy logic union and the
similarity between a patient subject

( x' , y ' ) ,

µ R ∗ µT

is the grade of

and the rule base or reference ( x, y ) , whereby

the grade of similarity ranges between 0 and 1.
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EMG data

Filtered EMG signals (eight on each side of the lower extremity) within a gait cycle were
extracted from twenty-two healthy subjects, and the mean of the 100 strides were calculated. In
order to compare the EMG signals among different subjects, the EMG signals were normalized
by the maximum of the EMG values. The average of EMG data of ten healthy female subjects
and the average of EMG of twelve male subjects were calculated to create the fuzzy rule base of
healthy subject’s EMG pattern. The same methods were used to extract the EMG data from each
patient’s data set (Note: the number of strides varied between patients).
The relationship between the electrical activities of the muscles with respect to the seven
gait phases is established. Hence, fuzzy sets of the EMG signals are described as the muscle type

x from a muscle collection, X , expressed as x ∈ X
with X = {Sol TA LG VL RF

BF

Gmed

ES } , where {…} indicates muscles and Sol –

soleus; TA – tibialis anterior; LG – gastrocnemius lateralis; VL – vastus lateralis; RF – rectus
femoris; BF – biceps femoris; Gmed – gluteus medius; ES – erector spinae.
The fuzzy sets for the seven gait phases are expressed as the gait phase, y out of a
number of gait phases, Y , expressed as

y ∈Y ,

with Y = {p1 p 2

p3

p4

p5

p6

p7};

where p(i) indicates gait phases from one to seven.
A fuzzy relation, R, is established between the fuzzy sets X and Y using the Cartesian
product. The Cartesian product X × Y , a relational matrix, is then expressed as

R( x , y )

 µ R ( x1 , y1 ) Λ µ R ( x1 , y 7 ) 
Μ
Μ
Μ 
= 
 µ R ( x8 , y1 ) Λ µ R ( x8 , y 7 )
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(8.10)

Therefore, the fuzzy relational matrix represents the fuzzy rules or the fuzzy rule base.
The actual EMG measurements of the impaired subject are compared with the reference data
within the rule-base through inference engine (the similarity measure in Equation 8.5.).

Acceleration data

Acceleration data in a gait cycle were extracted from twenty-two healthy subjects, and
the mean of the 100 strides were calculated. In order to compare the acceleration signals among
different subjects, the accelerations were normalized by the maximum values. The average of
acceleration of ten healthy female subjects and the average of acceleration of twelve male
subjects were calculated to create the fuzzy rule base of healthy subject’s acceleration pattern.
The same methods were used to extract the acceleration pattern from each patient’s data set
(Note: the number of strides varied between patients).
The relationship between the acceleration with respect to the seven gait phases is
established. Hence, fuzzy sets of the EMG signals are described as the muscle type x from a
muscle collection, X , expressed as x ∈ X , with

X = {Ftx , Fty , Ftz , Skx , Sky , Skz ,Thx ,Thy ,Thz , Hipx , Hipy , Hipz } where

{…}

indicates

acceleration and Ftx – mediolateral acceleration of foot; Fty – anterioposterior acceleration of

foot; Ftz – vertical acceleration of foot; Skx – mediolateral acceleration of shank; Sky –
anterioposterior acceleration of shank; Skz – vertical acceleration of shank; Thx – mediolateral
acceleration of thigh; Thy –anterioposterior acceleration of thigh; Thz – vertical acceleration of
thigh; Hipx – mediolateral acceleration of hip; Hipy – anterioposterior acceleration of hip; Hipz
– vertical acceleration of hip.
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The fuzzy sets for the seven gait phases are expressed as the gait phase, y out of a
number of gait phases, Y , expressed as

y ∈Y ,

with Y = {p1 p 2

p3

p4

p5

p6

p7};

where p(i) indicates gait phases from one to seven.
A fuzzy relation, R, is established between the fuzzy sets X and Y using the Cartesian
product. The Cartesian product X × Y , a relational matrix, is then expressed as

R( x , y )

 µR ( x1 , y1 ) Λ µR ( x1 , y7 ) 
Μ
Μ
Μ 
=


µR ( x12 , y1 ) Λ µR ( x12 , y7 )

(8.11)

Therefore, the fuzzy relational matrix represents the fuzzy rules or the fuzzy rule base.
The actual acceleration measurements of a patient are compared with the reference data within
the rule-base through inference, the similarity measure in Equation 8.5.
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Chapter 9: Data Acquisition

9.1

Ground Reaction Force Measurement

Each subject walked on an instrumented treadmill (Bertec Corporation, USA) at free
speeds (self-selected natural speed) for three minutes. The instrumented treadmill is a dual-belt
type with two independent force plates mounted beneath the belts (see Figure in Appendix I).
Each force plate independently measures six load components - the three orthogonal components
of the resultant force and the three components of the resultant moment in the same orthogonal
coordinate system. The point of application of the force and the couple acting can be readily
calculated from the measured force and moment components independently for each half of the
treadmill. Figure 9-1 shows example of force digital output from signal acquisition in 3-D.
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(A)

(B)

(C)

(D)

(E)

(F)

Figure 9-1: Ground Reaction Force (GRF) measurement. (A): Mediolateral force; (B):

Anterioposterior force; (C): Vertical force; (D): Mediolateral moment; (E): Anterioposterior
moment; (F): Vertical moment. Red and green colors represent right and left respectively.
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9.2

Elctromyographic Data Acquisition

Surface electromyographic data were recorded using Delsys Myomonitor® Wireless
EMG systems (Delsys Inc., Boston, MA, USA). This EMG system consists of 16 channels, each
channel has 41 x 20 x 5 mm electrode with two 10.0 x 1.0 mm contacts and -92 dB CMRR
(Common Mode Rejection Ratio). All channel data are synchronized through a Tethered Trigger
Module to the Myomonitor. As a wireless transmitter the Myomonitor sends EMG data over a
wireless local area network (WLAN) to the host computer for real-rime display and storage. The
complete EMG system components can be found in Appendix II.

9.3

Acceleration Measurement

An important aim of biomechanical analysis of gait is to know the amount of force
generated (or moment of force about a joint) from the muscles. This internal force can be
calculated from accelerations. As mentioned before, acceleration can be measured directly using
triaxial accelerometers. In this study, a triaxial accelerometer (ADXL330, 4×4×1.45 mm, Analog
Devices, Inc.), was used to measure linear accelerations in three sensitive planes – X, Y, and Z.
It measured acceleration with a minimum full-scale range of ±3g. The output signals are analog
voltages that are proportional to acceleration and it measured the static acceleration of gravity in
tilt-sensing applications, as well as dynamic acceleration resulting from motion or vibration. All
acceleration sensors were orthogonally aligned. The sensor system also contained a data logger
(NI-DAQTMmx) that simultaneously records the all tri-axial acceleration data at a sampling rate
of 100Hz. Detailed information is shown in Appendix III.
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9.4

Sensor Placements

The complete sensor placements including surface EMG and triaxial accelerometers are
illustrated in Figure 9-2.
•

Surface EMG electrode placements
The Delsys Myomonitor® wireless EMG system (Delsys Inc., Boston, MA, USA) was

used for measuring the dynamic activities of the muscles on both sides of the lower extremity.
The placement of the electrodes on the subjects was performed based on [Cram 1998] and the
signals were tested before the data acquisition. The acquisition process was performed with the
Delsys EMGworks® Software at a sampling frequency of 1000 Hz. The following eight muscles
for each side were recorded: soleus (Sol), tibialis anterior (TA), gastrocnemius lateralis (LG),
vastus lateralis (VL), rectus femoris (RF), biceps femoris (BF), gluteus medius (Gmed), and
erector spinae (ES). Table 9-1 shows the detailed EMG electrode placement of each muscle.
The electrode-skin interface generates a D/C voltage potential, mainly caused by a large
increase in impedance from the outermost layer of skin, including skin hair, dead skin material
and oil secretions. Therefore, proper skin preparation is essential for collecting a quality EMG
signal. This was explained in the informed consent form. Each subject was asked to shave the
area where the electrode would be placed to. Alcohol swab was used to rubble off the dead skin
material and oil secretions.
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Table 9-1: EMG Electrode Placement of Eight Muscles in the back and lower extremity.

Muscle

Placement

The electrode is placed on the lateral, posterior side of lower leg.
Soleus

The electrode is placed in a near vertical plane relative to the
ground so that they run parallel to the muscle fibers.
The electrode is placed about a third of the distance from the knee

Tibialis anterior

to the ankle, lateral to the tibia on the anterior surface of the lower
leg. The electrode is oriented in a vertical plane relative to the
ground.

Gastrocnemius
lateralis

The electrode is placed laterally, on the upper half of the posterior
aspect of the calf. The electrode is placed in a vertical plane
relative to the ground.
The electrode is placed on the lateral surface of the lower third of

Vastus lateralis

the thigh, approximately 6cm above the kneecap. The electrode is
oriented laterally at approximately a 20 degree angle from
vertical.
The electrode is placed on the medial anterior surface of the thigh,

Rectus femoris

approximately half the distance between the hip and the knee. The
electrode is placed in a vertical plane from the ground.
Biceps femoris locates in posterior thigh. The electrode is placed

Biceps femoris

half way between the ischial tuberosity and the lateral epicondyle
of the tibia.
The electrode is placed in the proximal third of the distance

Gluteus medius

between the iliac crest and the greater trochanter. The electrode is
placed in a vertical plane to the ground.

Elector spinae

Elector spinae is originated in lumbar region of the spine. The
electrode is placed at two finger width lateral from medial L1.
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•

Accelerometer placements

A custom array of accelerometer system was developed in the UTEP’s Human Motion
Analysis and Neurorehabilitation Laboratory for the detection of the acceleration of body
segments during walking. The system’s sensing device consists of ADXL330 iMEMS® Tri-axial
accelerometers (Analog Devices Inc.) and 12-bits analog to digital (A/D) converters (National
Instruments Inc.). The sensors measure the dynamic acceleration resulting from motion.
The placement of accelerometers on human subject is an issue of importance to accuracy
and reliability of the devices and has received some attention in the literature. The location of the
accelerometers for example is important for the accuracy of measurement. It is suggested that
accelerometers should be attached to those parts of the body where they would register the most
activity, i.e. the legs during walking [131, 252].
In fact, the output of a body-fixed accelerometer is the net measurement including the
actual physical activities of the body and external distortions. The actual physical activity
measurements from the accelerometer are acceleration due to body movement, and gravitational
acceleration. The external distortions include external vibration especially from the instrumented
treadmill, and acceleration not produced by the body itself (acceleration due to motion of the
skin under the accelerometer or jolting of the sensor on the body due to loose attachment).
Further, due to individual variation, exact orientation may not be consistent between
individuals or types of activities. For example, the hip placement becomes difficult since there is
no flat surface for most of the subjects; the orientation varies dramatically between subjects.
The tri-axial accelerometers were placed on the surface of the body-segments from down
to the top: foot, shank, thigh, and hip with 3M Corporation (Minnesota Mining and
Manufacturing Company) double-sided tape. For hip acceleration measurement, the
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accelerometer was attached to the belt, hence increased the flat surface area and unsure the
constant measurement between subjects.
Side View

Hip
Accelerometer

Front View

Rectus Femoris

Rear View

Erector Spinae

Gluteus Medius
Thigh
Accelerometer

Vastus Lateralis
Biceps Femoris

Shank
Accelerometer

Tibialis Anterior
Gastrocnemius
Lateralis

Foot
Accelerometer

Force Plates
Soleus

Figure 9-2: Surface EMG and Tri-axial accelerometer placements for Data Acquisition.

9.5

Synchronization of Multi-Portable Sensors

•

LabView Software synchronization for data acquisition

Two tri-axial accelerometers were connected to one TI data logger. There were four data
loggers connected through a USB hub, then to the PC with LabView software installed. The
instrumented treadmill is also connected to the same PC through a USB cable. The LabView
software was then used to synchronize the data acquisition of accelerometers and forces. The
acceleration and force data have sampling frequency of 100 Hz.
•

Wireless network connection and EMG Triggering Module

The wireless connection between the Myomonitor and the EMGworks Acquisition on
host PC is enabled by the D-Link WUA-1340 Wireless USB Adapter. Delsys EMG trigger
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Module was used to triggering with Start/Stop and Input/Output signals in order to synchronize
the all acquired data including acceleration, force and EMG.

9.6

Data Acquisition Procedures

Each subject wore running shorts and comfortable T-shirt during the experiment.
Subjects were allowed to become familiar with the walking track on the treadmill before running
the experiment. For impaired subjects, partial body-weight support (harness) fixing on the
instrumented treadmill could be applied if it was necessary throughout the experiment. Clinical
doctors or nurses could attend the experiment if the patients had severe medical conditions such
as diabetes. Two experimental-staffers stood on each side of the treadmill for safety. The patients
rested for 20 to 30 minutes or more frequently when necessary depending on their physiological
condition.
The self-selected natural speed is a subjective speed selection (comfortable speed via
instruction to “walk at a comfortable pace”) by the subject. The speed of the treadmill was
incrementally increased or decreased to determine the participant’s comfortable walking speed.
Sixteen surface EMG electrodes were placed on the prepared skin on the lower limbs and
back of the subject. Each EMG signal was tested carefully before the walking trial. Eight triaxial accelerometers were also placed carefully at the half-way of segments on both legs (feet,
shank, thigh, and hip). Since an accelerometer measures the sum of acceleration of the
movement and gravitational (the white noise component ignored), therefore, ten seconds of static
acceleration was measured before walking. The real acceleration of the movement was defined
by subtracting the mean static acceleration. Every subject was instructed to walk three minutes
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on the instrumented treadmill continually. Therefore, the ground reaction force and moment,
EMG and acceleration signals were collected simultaneously.

9.7

Anthropometric Measurement

Anthropometric data of each subject were recorded including: age, height and weight
(and/or Body Mass Index - BMI), body fat, lower extremity segment length and circumference,
etc. (see Appendix IV). The anthropometric measurements allowed cross-sectional analysis of
the relationship between the normal subjects and patients. Furthermore, mass of body segments
could be determined from the anthropometric measurements [258] and hence force generated
from each segment could be calculated.
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Chapter 10: Data Processing

10.1

Ground Reaction Force Data Processing

There is white noise introduced into force data due to vibrations and the moving artifact
during walking on the treadmill. Ground reaction force and moment data were smoothened using
second order Butterworth low pass filter to remove the noise above 20 Hz. Figure 10-1 illustrates
the right and left vertical ground reaction forces (Fz) before and after filtering process.
(A)

(B)

Figure 10-1: Comparison before (A) and after (B) filtering on vertical GRF.
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10.2

EMG Data Processing

Surface EMG data of sixteen muscles were collected using Delsys EMGacquisition®, and
processed using Delsys EMGworks® Software. The following steps describe the manipulation of
EMG data from an able-bodied subject’s left soleus.
Step 1: Raw EMG data from acquisition
The raw EMG data were acquired at a sampling frequency of 1000 sample/sec. Figure
10-2 depicts a three-second EMG raw data without DC offset.
0.0003

Soleus - Left

0.00025
0.0002
0.00015
0.0001
5e-005
0
-5e-005
-0.0001
-0.00015
-0.0002
0

0.5

1

1.5
Time [s]

2

2.5

3

Figure 10-2: Raw EMG data from Soleus muscle of an able-bodied subject. The X axis

represents the time in second and Y axis represents the amplitude in Volts.
Step 2: EMG filtering
In order to reduce the noise such as motion artifacts and treadmill vibration, a band pass
filter process was used. De Luca in 1997 showed the most significant power of EMG was located
between 20 and 400 Hz. In this experiment the power spectrum density (PSD) of the raw data
shown in Figure 10-3 (A) clarify that the power of EMG was located between 20 and 200 Hz.
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Second order Butterworth band-pass filter was applied to the raw EMG data between 20 and 200
Hz, shown in Figure 10-3 (B).
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Figure 10-3: EMG data filtering. (A): Power spectrum density (PSD) for raw EMG data, the X

axis represents the frequency in Hz and Y axis represents the PSD in Volts2*sec; (B): Filtered
EMG data, the X axis represents the time in seconds and Y axis represents the amplitude in Volts.
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Step 3: Full-wave rectification
The filtered data were then full-wave rectified to generate the absolute value of the EMG
as shown in Figure10-4.
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Figure 10-4: Full-wave rectified EMG data. The X axis is the time in seconds and Y axis is the

amplitude in Volts.

Step 4: Linear envelope
Linear envelope is a common way to manipulate EMG signal [De Luca, 1997; De Luca,
2006]. It can be called also as moving average. The linear envelope was produced by using an
FIR (finite impulse response) second order Butterworth low-pass digital filter with a cutoff
frequency of 7 Hz to the full-wave rectified EMG signal, see Figure 10-5.
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Figure 10-5: Linear envelope of EMG data. The X axis is the time in seconds and Y axis is the

amplitude in volts.

Step 5: Averaging over strides
The strides were specified based on the GRF. 100 strides were selected from the three
minutes walking [Arsenault et al. 2001]. The stride time varied among strides. Therefore, a resampling technique was used to unify the length of strides [De Stefano et al., 2003]. The EMG
signals of 100 strides were extracted and re-sampled to 1000 samples per stride, and then the
mean and the standard deviation (SD) of all strides were calculated during one gait cycle. Figure
10-6 depicts an example of EMG mean± SD over 100 strides.
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Figure 10-6: Mean of soleus EMG signal. The X-axis is one gait cycle, and the Y-axis is the

amplitude in volts. Blue line represents mean of EMG in a gait cycle. Red line represents upper
and lower standard deviation (SD) in a gait cycle.

Step 6: EMG normalization
In order to allow comparison of the EMG signal among different subjects, EMG data
were normalized for each subject based on the maximum of EMG signal (mean of EMG signal),
so that the EMG amplitude ranged between 0 and 1. Figure 10-7 shows eight normalized EMG
signals of eight muscles for one gait cycle.
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Figure 10-7: Normalized EMG signals within gait cycle. The X axis is one full gait cycle, and

the Y axis is the normalized amplitude. Sol – Soleus; TA – Tibialis Anterior; LG –
Gastrocnemius Lateralis; VL – Vastus Lateralis; RF – Rectus Femoris; BF – Biceps Femoris;
Gmed – Gluteus Medius; ES – Erector Spinae.
10.3

Acceleration Data Processing

The gravitational baseline signal (zero g offset) was first subtracted from the dynamic
raw data to make the signal offset at zero. Then, second order Butterworth low pass filter with
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cutoff frequency of 6 Hz was applied to lower the noise and improve the resolution of the
accelerometers [229, 258]. Figure10-8 describes the processing procedures of the acceleration.
(A)

(B)

(C)

Figure 10-8: Acceleration signal processing. . The signal in the figure represents the sagittal

acceleration of foot segment. The X axis is the time in seconds, and the Y axis is the amplitude
in g. (A): Raw sagittal acceleration signal; (B): Raw signal after subtracting the baseline offset;
(C): Filtering, 2nd Butterworth low pass filter with cutoff frequency of 6 Hz.
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Chapter 11: Case Studies and Analysis

This chapter contains experimental case studies on both healthy and impaired subjects in
relation to stride variability approach and pattern comparison methods. The experimental
procedure and feature extraction were explained in Chapter 8. Experimental results of these
impairments are presented and discussed.

11.1

Healthy and Patient Participants

Twenty two healthy adults (ten female subjects and twelve male subjects) were recruited
from the campus of University of Texas at El Paso (UTEP) after having given their written
informed consent. These adults reported no physical and mental disorders, and no medications at
the time of data collection. Patients with different types of gait impairments were recruited, they
included:
•

six relapsing remission multiple sclerosis (RRMS) patients (two female and four male
patients)

•

four spastic diplegic cerebral palsy (SDCP) patients (one female and three male patients)

•

two female hemiparetic stroke patients

•

a male patient with spinal cord injury (SPI)

•

a male patient with traumatic brain injury (TBI),

•

a male elderly faller

•

a female patient with idiopathic neurologic disorder.
The following chapter will discuss the case studies involving the subjects with Multiple

sclerosis and cerebral palsy. The other case studies may be found in the Appendix III-Appendix
XVII.
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Table 11-1 shows the anthropometric data for all able-bodied subjects, and Table 11-2
shows the anthropometric data for all the impaired subjects.

Table 11-1: Anthropometric data of able-bodied subjects

Age

Weight

Height

BMI

Age

Weight

Height

BMI

(yrs)

(kg)

(cm)

(kg/m2)

(yrs)

(kg)

(cm)

(kg/m2)

F_1

37

58.0

165.0

21.3

M_1

20

71.3

170.5

24.5

F_2

26

49.0

162.0

18.7

M_2

24

83.7

180.0

25.8

F_3

21

63.0

173.0

21.0

M_3

25

56.6

157.5

22.8

F_4

22

56.0

166.5

20.2

M_4

21

61.2

163.0

23.0

F_5

23

63.4

163.5

23.7

M_5

22

67.0

176.0

21.6

F_6

21

70.7

170.0

24.5

M_6

23

71.6

171.0

24.5

F_7

28

61.0

169.0

21.4

M_7

24

66.6

170.0

23.0

F_8

22

56.0

161.0

21.6

M_8

20

65.7

164.0

24.4

F_9

23

57.0

157.0

23.1

M_9

22

45.7

163.0

17.2

F_10

35

76.5

167.0

27.4

M_10

25

56.6

169

19.8

M_11

24

78.3

185

22.9

M_12

23

88.1

181

26.9

Female

Male

BMI (Body Mass Index) kg/m2; Note: Speed of female subjects has range from 0.85 to 1.5 m/s
(1.12±.21), and speed of male subjects has range of 0.98 to 1.17 m/s (1.02±.07).
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Table 11-2: Anthropometric data of mobility-related impaired subjects

Patient

Age

Weight

Height

BMI

Speed

(yrs)

(kg)

(cm)

(kg/m2)

(m/s)

Sex

MS_1

F

55

66.1

150.0

29.4

0.65

MS_2

F

40

61.2

165.0

22.5

0.65

MS_3

M

62

77.7

162.0

29.6

0.50

MS_4

M

37

130.7

181.0

39.9

0.35

MS_5

M

45

124.2

178.0

39.2

0.75

MS_6

M

28

82.5

194.5

21.8

0.50

CP_1

F

26

44.9

151.0

19.7

0.50

CP_2

M

17

69.5

162.0

26.5

0.15

CP_3

M

18

68.3

164.0

25.4

0.30

CP_4

M

55

88.9

172.0

30.1

0.45

Stroke_1

F

37

68.0

160.0

26.6

0.10/0.30*

Stroke_2

F

53

48.3

156.0

19.8

0.60

SCI

M

48

67.5

167.0

24.2

0.85

TBI

M

35

89.2

173.0

29.8

0.75

Elderly Faller

M

76

85.7

170.0

29.7

0.30

IND

F

58

83.5

158.0

33.4

0.10

MS = Multiple Sclerosis); CP = Cerebral Palsy; SPI = Spinal Cord Injury; TBI = Traumatic
Brain Injury;
IND = Idiopathic Neurologic Disorder. * Speed of the first visit/speed of the second visit after
two month.
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11.2

Data Acquisition

The measurement of the kinematic, kinetic and electromyographic data was performed
using the inertial sensor array (tri-axial accelerometers – ADXL330 iMEMS), the dual-belt
instrumented treadmill (Bertec Corporation, USA), and a surface EMG system (Delsys Inc.,
Boston, USA), respectively.
Subjects wore running shorts and comfortable T-shirts. Since a number of subjects had
never walked on the treadmill, each of them was allowed to become familiar with the walking
track before running the experiment. In order to reduce the error of the EMG signals, the skin
was shaved and cleaned with alcohol swabs on the area where the surface EMG electrodes would
be placed on. Sixteen surface EMG electrodes were placed on the back and both side of the
lower extremity, and eight tri-axial accelerometers were also placed on the body, refer to Table
9-1 and Figure 9-2.

11.3

Results of Temporal Stride Variability

Table 11-3 concludes the stride variability with stride time, stance phase, swing phase,
and double-stance phase for all able-bodied subjects.
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Table 11-3: Stride Variability of Able-bodied Subjects
Stride Time (sec.)

Stance Phase (%)

Swing Phase (%)

mean±SD

CV

mean±SD

CV

mean±SD

CV

mean±SD

CV

F_1

0.875±.015

1.71

58.06±1.13

1.95

41.94±1.12

2.67

10.29±0.80

7.78

F_2

1.060±.016

1.51

61.10±1.01

1.65

38.90±1.01

2.60

12.03±0.78

6.48

F_3

1.009±.011

1.09

58.58±1.22

2.08

41.42±1.22

2.95

10.24±1.31

12.79

F_4

1.160±.023

1.98

61.75±1.80

2.92

38.25±1.71

4.47

12.53±0.87

6.94

F_5

1.050±.016

1.52

61.64±0.96

1.56

38.36±0.96

2.50

12.83±0.75

5.85

F_6

1.140±.023

2.02

62.57±1.31

2.09

37.43±1.31

3.50

13.44±0.72

5.36

F_7

1.154±.019

1.65

63.51±1.13

1.78

36.49±1.13

3.10

14.03±1.12

7.98

F_8

1.093±.018

1.65

62.30±1.02

1.64

37.70±1.12

2.97

13.55±0.98

7.23

F_9

0.978±.020

2.05

61.57±1.34

2.18

38.43±1.34

3.49

11.95±0.72

6.03

F_10

0.977±.011

1.13

60.75±0.98

1.61

39.25±0.98

2.50

11.38±0.72

6.33

M_1

1.135±.022

1.94

62.01±1.06

1.71

37.99±1.06

2.79

12.58±0.73

5.80

M_2

1.158±.021

1.81

62.58±0.89

1.42

37.42±0.89

2.38

13.07±0.54

4.13

M_3

1.100±.021

1.91

62.27±1.48

2.38

37.73±1.48

3.92

11.42±0.76

6.66

M_4

0.993±.018

1.81

62.27±1.25

2.01

37.73±1.25

3.31

13.13±0.68

5.18

M_5

1.139±.026

2.28

62.24±1.86

2.99

37.76±1.86

4.93

13.65±0.82

6.01

M_6

1.071±.021

1.96

61.90±1.17

1.89

38.10±1.17

3.07

13.25±0.99

7.47

M_7

1.063±.018

1.69

61.38±0.91

1.48

38.62±0.91

2.36

12.12±0.70

5.78

M_8

1.074±.021

1.96

63.92±1.32

2.06

36.08±1.32

3.66

14.47±0.74

5.11

M_9

1.055±.014

1.33

62.79±0.88

1.40

37.21±0.88

2.37

13.74±0.56

4.08

M_10

1.000±.016

1.60

62.74±1.13

1.80

37.26±1.13

3.03

13.31±0.89

6.69

M_11

1.130±.020

1.77

61.54±1.17

1.90

38.46±1.17

3.04

12.16±0.92

7.57

M_12

1.142±.019

1.66

62.21±1.03

1.66

37.79±1.10

2.91

13.41±0.77

5.74

Ablebodied
subjects

Double-stance Phase (%)

Note: The values of stride time/stance phase/swing phase in the table are the average of right and
left for each able-bodied subject.
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Table 11-4 concludes the stride variability with stride time, stance phase, swing phase,
and double-stance phase for all patient subjects.
Table 11-4: Stride Variability of Mobility-related Impaired Subjects
Double-stance
Stride Time (sec.)

Stance Phase (%)

Swing Phase (%)
Phase (%)

Patient
subjects

CV
±SD

±SD

±SD

±SD

CV

CV

CV

Mean

Mean

Mean

Mean

R

1.085±.032

2.95

67.33±2.48

3.68

32.67±2.48

7.59

15.97

L

1.086±.036

3.32

61.99±1.92

3.10

38.01±1.92

5.05

(1.10)

R

1.181±.035

2.96

70.94±2.67

3.76

29.06±2.67

9.19

18.79

L

1.181±.039

3.30

64.03±2.22

3.47

35.97±2.22

6.17

(1.83)

R

1.850±.092

4.97

84.79±3.63

4.28

15.21±3.63

23.87

36.89

L

1.854±.113

6.10

82.81±4.14

5.00

17.19±4.14

24.08

(6.37)

R

2.103±.145

6.90

74.10±2.17

2.93

25.90±2.17

8.38

23.85

L

2.104±.161

7.65

71.02±2.37

3.34

28.98±2.37

8.18

(1.93)

R

1.133±.032

2.84

64.78±2.62

4.04

35.22±2.62

7.44

14.78

L

1.133±.034

3.00

63.57±2.12

3.34

36.43±2.12

5.82

(1.09)

R

1.427±.084

5.89

67.99±4.34

6.38

32.01±4.34

13.56

19.61

L

1.426±.085

5.96

69.70±3.39

4.86

30.30±3.39

11.19

(2.62)

R

1.269±.060

4.73

63.78±2.10

3.29

36.22±2.10

5.80

13.97

L

1.269±.059

4.65

66.58±2.48

3.73

33.42±2.18

6.52

(1.21)

R

2.654±.144

5.43

77.22±1.59

2.06

22.78±1.59

6.98

25.85

L

2.658±.173

6.51

70.52±2.63

3.73

29.48±2.63

8.92

(2.65)

R

1.834±.059

3.22

78.52±1.51

1.92

21.48±1.51

7.03

27.64

L

1.835±.056

3.06

77.16±1.63

2.11

22.84±1.26

5.52

(1.38)

R

1.632±.054

3.31

67.23±1.82

2.71

32.77±1.82

5.55

19.89

MS_1

6.89

MS_2

9.74

MS_3

17.27

MS_4

8.09

MS_5

7.38

MS_6

13.36

CP_1

8.66

CP_2

10.25

CP_3

CP_4

4.99
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7.59

L

1.632±.053

3.25

65.69±1.39

2.12

34.31±1.39

4.05

(1.51)

R

2.975±.191

6.42

80.48±1.58

1.96

19.52±1.58

8.09

55.46

L

2.975±.193

6.49

86.24±1.17

1.36

13.76±1.17

8.50

(3.05)

R

1.636±.050

3.06

70.29±1.85

2.63

29.71±1.85

6.23

28.12

L

1.636±.049

3.00

76.37±1.29

1.69

23.63±1.29

5.46

(2.01)

R

1.227±.044

3.59

67.74±3.51

5.18

32.26±3.51

10.88

16.53

L

1.227±.042

3.42

66.05±2.95

4.47

33.95±2.95

8.69

(1.36)

R

1.079±.025

2.32

63.75±1.91

3.00

36.25±1.91

5.27

16.07

L

1.079±.026

2.41

66.47±2.05

3.08

33.53±2.05

6.11

(1.32)

R

1.186±.039

3.29

67.73±2.57

3.79

32.27±2.57

7.96

16.70

L

1.187±.044

3.71

64.68±1.94

3.00

35.32±1.94

5.49

(1.33)

Elderly

R

1.346±.064

4.76

76.31±1.79

2.35

23.69±1.79

7.56

29.60

Faller

L

1.346±.076

5.65

73.22±2.40

3.28

26.78±2.40

8.96

(2.12)

R

3.640±.502

13.79

90.83±2.94

3.24

9.17±2.94

32.06

42.71

L

3.643±.448

12.30

85.93±5.10

5.94

14.07±5.10

36.25

(21.03)

Stroke1-1

5.50

Stroke1-2

7.15

Stroke2

8.23

SCI

8.21

TBI

7.96

7.16

IND

49.24

MS = Multiple Sclerosis); CP = Cerebral Palsy; SPI = Spinal Cord Injury;
TBI = Traumatic Brain Injury; IND = Idiopathic Neurologic Disorder.

11.4

•

Study of Multiple Sclerosis

Multiple Sclerosis Case #1 (MS1)

Subject is a 55 year old female who was diagnosed with fairly mild multiple sclerosis
four years ago (2006). From observation at this point of time, she had some amount of
wobbliness in her gait. She received medical treatment for Relapsing-Remitting MS and
secondary progressive MS with relapses, the Beta interferon injection for every other day. This
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patient was tested with barefoot walking on the instrumented treadmill without any assistive
devices or harness support at a speed of 0.65 m/s.
Figure 11-1 illustrates the stride-to-stride fluctuations over 100 strides of this MS subject
(MS1), compared with a healthy female subject. In the figure, the stride variables change from
one stride to the next.

Figure 11-1: Stride variability of healthy subject and a multiple sclerosis case 1.

MS1- Multiple Sclerosis Case 1
Figure 11-2 shows the ground reaction force pattern (GRF) in a gait cycle of the MS1
subject, compared with the averaged GRF in ten healthy female subjects. The magnitudes of the
GRF were normalized based on the body mass of each subject (%BW).
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Figure 11-2: Right and left ground reaction forces in 3-D in MS1. Mediolateral

(Fx)/anterioposterior (Fy)/vertical (Fz), compared between averaged healthy-female subjects and
a female multiple sclerosis (MS-1). Note: the y axis is the normalization of the magnitudes of
force values by body weight of the each subject (%BW), and the x axis is a full gait cycle in %.

Fuzzy similarity relationships are obtained from Equation 8.5 and illustrated in Figure
11-3, which shows the fuzzy similarity relationships (the mean values of the force signals during
the seven gait phases of the gait cycle) of a female subject with Multiple Sclerosis (MS1), for
comparison of left and right symmetrical approach.
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Figure 11-3: Comparison of grade of similarity between right and left GRFs in MS1.

Figure 11-4 shows the electrical muscle activity pattern in a gait cycle of the MS1,
compared with the averaged muscle activity in ten healthy female subjects. Both right and left
EMG signals of the MS1 subject are shown in this figure.
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Figure 11-4: Average EMG activity of the eight muscles in a gait cycle in MS1 compared to

averaged healthy female control group. (Note: the EMG sample frequency was 1000 Hz.)

Fuzzy similarity relationships are obtained from Equation 8.5 and illustrated in Figure
11-5, which shows the fuzzy similarity relationships (the mean values of the EMG signals during
the seven gait phases of the gait cycle) of a this female subject with Multiple Sclerosis, for
comparison of left and right symmetrical approach.
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Figure 11-5: Comparison of grade of similarity between right and left EMG in MS-1.

Figure 11-6 shows the acceleration pattern in a gait cycle of the MS1, compare with the
averaged acceleration signal pattern in ten healthy female subjects. Both right and left
acceleration signals of MS1 subject were shown in this figure. Figure 11-7 shows the fuzzy
similarity relationships (the mean values of the acceleration signals during the seven gait phases
of the gait cycle) of this female subject with Multiple Sclerosis, for comparison of left and right
symmetrical study.
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(A)

(B)
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(C)

(D)

Figure 11-6: Comparison of acceleration signal pattern in a gait cycle between healthy subjects

and MS1. (A) right and left foot acceleration pattern; (B) right and left shank acceleration pattern;
(C) right and left thigh acceleration pattern; and (D) right and left hip acceleration pattern.
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Figure 11-7: Comparison of grade of similarity between right and left acceleration in MS1.

Analysis:

(A) Temporal stride variability
The effects on stride variability are shown in Figure 11-1. Although this multiple
sclerosis subject (MS1) has very mild symptoms, the stride-to-stride variability is increased
compared with the healthy subject. Both the SD and CV were larger in MS1 compared with all
the healthy subjects (Table 11-3 and Table 11-4). In addition, the variability increased
dramatically after 60 strides during a three-minute walking trail. This may lead to the suspicion
of some indications of occurrence of fatigue to increase variability between 60 to 100 strides.
Finally, her gait had higher stance phase (67.33 on right leg) and double stance phase (15.97)
than the healthy subjects (range 58.5~63.5% in stance phase, and 10.5~14.0% in double-stance
phase), which also indicated some level of instability and/or walking with caution, and the
severity of the symptoms on her left leg.
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(B) 3-D ground reaction forces
The ground reaction forces of healthy subject and of the female subject with multiple
sclerosis (MS1) are shown in 3-D in Figure 11-2. The force curve in the vertical direction, Fz,
indicates that the MS1 has a flat foot contact, compared with the healthy subjects with clear fist
and second peaks forming this typical M-shape force pattern in the vertical direction. The
vertical force curve also shows the longer ground contact duration on the right foot (the stance
phase) in MS1. The able-bodied subjects depict a clear force curve that illustrates the weight
transfer from the heel to the mid-foot and the mid-foot to the ball of the foot for push-off. The
MS1 subject shows smaller slope at the end of the stance phase or pre-swing phase which
indicates the MS subject has no clear toe-off (foot clearance problems). By comparing the
magnitude of the anterior-posterior force of the healthy subjects, the MS1 subject revealed the
magnitude of this force was much lower. There was a significant difference between right and
left in the mediolateral force that the curve of the right force in the MS1 subject was below the
force in the healthy subject, and the curve of the left force in the MS1 subject was above the
force in healthy subject.
Figure 11-3 depicts the grade of similarity for the MS1 subject. There were moderate
similarities in vertical and mediolateral force, but much lower similarities in the anteriorposterior force, especially the left side force, showing the sever effect on that side of the her gait.
(C) EMG activity patterns
Whereas the muscle contraction is very rapid in the able-bodied subjects, the Figure 11-4
shows that the MS1 subject exhibits some long-latency stretch reflex in the soleus muscle. EMG
activity was found to be significantly greater in the MS1 subject compared to the healthy group
during the initial swing phase of the gait for both right and left lateral gastrocnemius. The tibialis
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anterior activity was significantly greater during early double-stance and early swing phase. The
increased EMG activity that was apparent in the ankle plantar-flexor muscles in the MS subject
is thought to be a mechanism to counteract balance deficits and may have implications for both
fatigue and spasticity [109]. The EMG activity of the Erector Spinae was found to be greater in
the MS1 than in healthy subjects, which is likely to be a factor in the instability during stance
phase, as well as serving to reduce the risk of falling.
Figure 11-5 shows that there is least similarity of right rectus femoris/ biceps femoris in
the pre-swing phase, the least similarity of right vastus lateralis in the initial swing phase.

(D) Acceleration pattern analysis
The acceleration curves in figure 11-6 show a gradual smooth progression through
consecutive walking cycles for the able-bodied subjects, whereas there is an occurrence of a very
sharp turning during transition events of the cycle with MS1 subject. Table 11-5 concludes the
characteristics of each segment’s accelerations compared with average healthy subjects.

Table 11-5: Characteristics of segment’s accelerations in MS-1

Right

Left

Foot x

Sharp rise in initial contact, much lower
acceleration in swing phase.

Sharp rise in initial contact, no
acceleration in swing phase.

Foot y

No deceleration phase after toe-off.

Lower magnitude during entire cycle

Foot z

Early sharp rise in initial contact and sharp
rise in the terminal swing.

Lower acceleration in initial contact,
early acceleration in terminal swing.

Sharp rise in initial contact, small rise in
mid-stance phase and pre-swing phase,
Shank x
lower and delayed acceleration in swing
phase.

Same as right shank + some unstable
acceleration in mid-stance phase.

Shank y Sharp rise in initial contact, early rise in mid- Sharp rise in initial contact, early
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stance phase and delayed deceleration on
toe-off, small rise in terminal swing phase.

rise in mid-stance phase, small rise
in terminal swing phase, instable
acceleration during the mid- and
terminal stance phase.

Shank z

Sharp rise in initial contact, delayed
acceleration on toe-off, less acceleration in
terminal swing phase.

Sharp rise in initial contact, less
acceleration on toe-off, less
acceleration in terminal swing
phase.

Thigh x

Sharp rise in initial contact, instable during
mid- and terminal stance phase, delayed
sharp rise on toe-off, sharp rise in terminal
swing phase.

Sharp rise in initial contact, instable
in mid- and terminal stance phase,
sharp rise in terminal swing phase.

Thigh y

Sharp deceleration in early stance
Large deceleration in early stance phase,
phase, sharp rise in mid-stance
instable during entire stance phase, sharp rise
phase, early rise in terminal swing
in terminal swing phase.
phase.

Thigh z

Sharp rise in initial contact, instable
throughout the rest of the stance phase,
continue decrease in swing phase without
terminal rise which can be seen in healthy
subjects.

Sharp rise and decrease in initial
contact, instable during the rest of
the stance phase, early deceleration
in swing phase without terminal rise.

Hip x

Sharp deceleration in initial contact, delayed
sharp rise on toe-off.

Sharp deceleration in initial contact,
early sharp rise on toe-off.

Hip y

Sharp deceleration in initial contact, instable
in stance phase, delayed acceleration in
swing phase, there is a rise on the end of
terminal swing phase.

Sharp deceleration in initial contact,
instable in stance phase, early
deceleration in terminal stance
phase, and early acceleration after
toe-off, rise on end of terminal
swing phase.

Hip z

Sharp rise in initial contact, delayed
deceleration on toe-off, delayed acceleration
in swing phase.

Early sharp acceleration in initial
contact, early rise on toe-off.
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Figure 11-7 shows the least similarity on both right and left thigh vertical accelerations in
terminal swing phase. There are small similarities on right shank x in the mid-swing phase and
right hip x in the mid-stance phase. The rest shows moderate to high similarities through entire
gait cycle, which indicate the mild symptoms of this female multiple sclerosis patient.
•

Multiple Sclerosis Case #6 (MS6)

Subject is a 29 year old male, was diagnosed with multiple sclerosis in September 2009.
He was a basketball player before diagnosis. He had right leg tremor. Medication was Naltrexon
4.5mg per day for the treatment of multiple sclerosis by preventing relapses and reducing the
progression of the MS. The temporal stride variability, pattern of GRF, EMG, and acceleration,
and their similarity of MS6 are shown in the Appendix IX (Figure AIX-1 to Figure AIX-7, and
Table AIX-1).
(A) Summary of Stride variability
In Figure AIX-1, the stride-to-stride variability was greatly increased in all temporal
stride variables (stride time, stance phase, swing phase, and double-stance phase) in the MS6
subject, especially after 30 strides during the three-minute walking trail. This shows the higher
level of the instability and severity of the symptoms in MS6, compared with the female multiple
sclerosis patient (MS1). In addition, the subject’s gait has longer stance and double-stance phase,
just like that of the MS1.
(B) Summary of GRF
In Figure AIX-2, MS6 subject shows flat foot contact without two peaks in the vertical
GRF. In anterior-posterior plane, there are much lower magnitudes of GRF compared with the
healthy subjects. In mediolateral plane, GRF of MS6 has a delayed rise at the time of initial
contact.
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In Figure AIX-3, MS6 subject shows smaller grade of similarities during swing phases in
anterior-posterior GRF (caused by lower magnitudes of GRF), and smaller similarities during
initial and mid-swing phases in the vertical GRF (caused by longer stance phase) on both right
and left legs.
(C) Summary of EMG patterns
Figure AIX-4 shows there is a longer latency stretch reflex in the left soleus, and some
levels of spasticity in the right soleus. EMG activity was found to be significantly greater in MS6
during the initial swing phase for both right and left tibialis anterior. There was greater EMG
activity in MS6 for both right and left lateral gastrocnemius. There was a greater EMG activity
on left vastus lateralis during the single-support stance phase. There was a level of spasticity for
both right and left rectus femoris during initial swing. There was greater EMG activity in MS6
for right and left biceps femoris during terminal swing. There was greater EMG activity in on
both right and left gluteus medius during stance phase, and greater activity in right gluteus
medius during swing phase. The erector spinae muscles show much greater activities compared
with the healthy subjects.
Figure AIX-5 shows the grade of similarity of all EMG activities of MS6. The left tibialis
anterior, vastus lateralis, and biceps femoris shows significant small similarities during mid- and
terminal stance phases, whereas right rectus femoris and gluteus medius shows small similarities
during initial swing and mid-swing phases.
(D) Summary of acceleration
The characterization of acceleration in MS6 subject can be found in the Table AIX-1 in
Appendix IX. In Figure AIX-7, both right and left thigh and hip show much lower similarities in
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the anterior-posterior plane and mediolateral plane, respectively. The rest have moderate to high
grades of similarities during seven gait phases.

•

Conclusion of Multiple Sclerosis

Feature analysis for multiple sclerosis are concluded in Table 11-6, based on all six MS
subejcts (MS-2, MS-3, MS-4, and MS-5 and shown in Appendix V, VI, VII, VIII, respectively).
The table describes the important characteristics of MS found from the results and analysis in
this study.
Table 11-6: Characteristics of Multiple Sclerosis
Feature

Characteristics

MS has increased variability, the more or less depends on the
severity of the symptoms. Stride variability dramatically increased
from the occurrence of the functional fatigue. This increased
temporal variability indicates that the MS subjects have some levels
Stride Variability
of fall risks or walking with cautious due to common symptoms of
foot-drops and tremors. Study of stride variability has the most
advantages that it is easy to find out the time of functional fatigue
occurring in each individual MS subjects.
In vertical direction, MS subjects have no M-shaped GRF showing
in the healthy subject. MS patients showed more or less flat-foot
Ground Reaction Force
contact the ground with shortened duration of the peak seen in the
(GRF)
sever cases.
In anterior-posterior direction, MS subjects show lower GRF than
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healthy subjects. This may be due to the slower speed in MS
patients, but may also indicate the less force generated from muscles
(for example the quadriceps muscle group) and other internal forces.
In mediolateral direction, MS also shows some lower force
compared with healthy subjects. The mediolateral postural
instability has been suggested as a risk factor for falls, the weak
GRF in this direction may also be one of the reasons that the stride
variability was increased in MS subjects.
Soleus and gastrocnemius are ankle plantar flexors, and thought to
be stabilizing the foot and knee during the stance phase of the gait.
MS subjects show increased EMG activity in the stance phase which
may be a mechanism to counteract balance deficits.
Tibialis anterior is an ankle dorsiflexor and most active at heel strike
and prevent “foot-slap”. There was a delay in maximum tibialis
anterior activity at heel strike in MS patients which may be a factor
in the instability during stance phase, and there were also weakness
of the activity in the single support time as contributing to foot drop.
Electromyography
In addition, in most of MS subjects, tibialis anterior activity was
(EMG)
significant greater during early swing phase when it supposes to
assists the toes in clearing the floor.
Vastus lateralis and rectus femoris are extensor muscles of the knee
and hip flexor. There was spasticity occurring in the single support
time of the stance phase in most of the MS subjects.
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Biceps femoris is flexor of the knee. There was also spasticity in the
stance phase in most of the MS subjects.
Gluteus medius is hip abductor and stabilizer. There was increased
EMG activity in mid-stance phase and early swing phase in some
MS subjects.
Erector spinae in the lower back is a group of stabilizers. There were
higher activities in the loading response and initial swing phase
which might due to the compensation mechanism for instable gait in
most of the MS subjects.
A sharp rise in acceleration or deceleration in the initial contact and
terminal swing phase appears in most of MS subjects which could
be the results of foot-drop and a mechanism to counteract balance
deficits.
Inconsistent and lower acceleration occurs in affected in particular
Segmental Acceleration
shank and thigh in anterior-posterior direction, especially with MS
tremor subjects.
In general, the acceleration pattern is closely associated with the
GRF and EMG activity patterns. It is difficult to analyze them
separately.
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11.5

•

Study of Cerebral Palsy

Cerebral Palsy Case #2 (CP2)

Subject is a 17 year old male with spastic diplegic cerebral palsy. He had left hip arthritis
and bilateral flat feet deformity. He had 5 degrees knee flexion contracture bilateral. Patient
walked bare-foot on the treadmill with harness support at speed of 0.5 m/s.
Figure 11-8 illustrates the stride-to-stride fluctuations over 100 strides of this CP2 subject,
compared with a healthy male subject. In Figure 11-8, the stride variables change from one stride
to the next.

Figure 11-8: Stride variability of healthy subject and a male cerebral palsy case 2 (CP-2).

Figure 11-9 shows the ground reaction force pattern (GRF) in a gait cycle of the CP2
subject, compare with the averaged GRF in twelve healthy male subjects. The magnitudes of the
GRF were normalized based on the body mass of each subject (%BW).
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Figure 11-9: Right and left ground reaction forces in 3-D in CP-2: mediolateral

(Fx)/anterioposterior (Fy)/vertical (Fz), compared between averaged healthy-male subjects and a
male cerebral palsy patient (CP-2). Note: the y axis is the normalization of the magnitudes of
force values by body weight of the each subject (%BW), and the x axis is a full gait cycle in %.
Fuzzy similarity relationships were obtained from Equation 8.5 and illustrated in Figure
11-10, which shows the fuzzy similarity relationships (the mean values of the force signals
during the seven gait phases of the gait cycle) between healthy subjects and the CP2 subject, for
comparison of left and right symmetrical approach.
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Figure 11-10: Comparison of grade of similarity between right and left GRFs in CP-2.

Figure 11-11 shows the electrical muscle activity pattern in a gait cycle of the CP-2, compare
with the averaged muscle activity in twelve healthy male subjects. Both right and left sides EMG
signals of CP-2 were shown in this figure.

Figure 11-11: Average EMG activity of the eight muscles in a gait cycle in CP-2 compared to

averaged healthy control group.
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Fuzzy similarity relationships are obtained from Equation 8.5 and illustrated in Figure
11-12, which shows the fuzzy similarity relationships (the mean values of the EMG signals
during the seven gait phases of the gait cycle) of CP-2, for comparison of left and right
symmetrical approach.

Figure 11-12: Comparison of grade of similarity between right and left EMG in CP-2.

Figure 11-13 shows the acceleration pattern within a gait cycle for the CP-2 subject as
compared with the averaged acceleration pattern in twelve healthy female subjects. Both right
and left EMG signals of CP-2 subject were shown in this figure. Figure 11-14 shows the fuzzy
similarity relationships (the mean values of the acceleration signals during the seven gait phases
of the gait cycle) of CP-2 subject for comparison of left and right symmetrical study.
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(A)

(B)
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(C)

(D)

Figure 11-13: Comparison of acceleration signal pattern in a gait cycle between healthy subjects

and CP-2. (A) right and left foot acceleration pattern; (B) right and left shank acceleration pattern;
(C) right and left thigh acceleration pattern; and (D) right and left hip acceleration pattern.
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Figure 11-14: Comparison of grade of similarity between right and left acceleration in CP2.

Analysis:

(A)

Temporal stride variability

There were only 60 strides found in three-minute walking trail from this cerebral palsy
subject (CP2) due to the slow walking speed (0.5 m/s). Figure 11-8 depicts the higher variability
of all these stride variables, compared with healthy subject. The subject exhibits much longer
stride time, stance phase, and double-stance phase, whereas there were much shortened swing
phase. The increased variability indicates the severe instability of this subject’s gait even with
the support of the harness.
(B)

3-D ground reaction forces

Figure 11-9 depicts the ground reaction force pattern of the CP2 subject as compared with
averaged healthy subjects. In the vertical direction, this CP2 subject has much longer stance
phase which causes the least grade of similarity in initial and mid-swing phases, and with only
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one short-time peak around the time of 30% of the gait cycle, indicates that he has no smooth
ground contact from heel to toe. In anterior-posterior direction, the CP2 subject shows much
lower forces throughout the full gait cycle. In mediolateral direction, the left leg had much lower
force than his right leg, which indicated he had some severity of deformity on his left extremity
or pain on the left side (i.e. left hip arthritis refer to the description of CP-2).

(C)

EMG activity patterns

Table 11-7: Description of EMG patterns of CP-2
Right

Left

Spasticity appears in the initial contact and continues

Same as right Sol,

with higher muscle activity until toe-off. Significant

but with more

small similarity appears in swing phases due to longer

serious instability

duration of the stance.

EMG signals.

Soleus

Muscle weakness appears from in the initial contact to
the end of the stance phase. Spasticity appears

Same as right TA.

Tibialis
immediately after toe-off. This typical EMG pattern
Anterior (TA)
causes significant small similarity in initial and initialswing phases.
Spasticity appears initial contact, mid-stance and swing
Gastrocnemius
phases, which results in significant small similarity
Lateralis (LG)
during these phases.
Vastus

Weakness appears in the initial contact and terminal
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Same as right LG.

Lateralis

swing phase, spasticity appears after single support in

(VL)

Same as right VL.

the stance phase which results in significant small
similarity appears in phase 3,4, and 5.

Rectus

Same as right VL

Same as right RF.

Femoris (RF)
Spasticity appears begins in the initial contact, and
continues till the end of the stance phase, which results
Biceps
in small grade of similarity in later stance phase.

Same as right BF.

Femoris (BF)
Muscle weakness appears in the terminal swing phase.
Note this weakness is more serious than the left leg.
Muscle weakness appears in the loading response.
Gluteus
Spasticity appears about 20~85% of the gait cycle.

Same as right

Medius (Gmed)
Significant small similarity appears in phase 1, 3, and 4. Gmed.
Spasticity appears almost the entire gait, especially the

Same as right ES.

Elector
last 40% of the gait cycle. Significant small similarity
Spinae (ES)
appears in mid-swing phase.

(D)

Acceleration pattern analysis

Table 11-7 concludes the characteristics of each segment’s accelerations of CP-2, compared with
average healthy subjects.
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Table 11-8: Characteristics of segment’s accelerations of CP-2
Right

Left

Foot x

Sharp rise in initial contact, much lower
magnitude in swing phase which results in small
similarity in terminal swing phase.

Sharp rise in initial contact, lower
acceleration in swing phase.
Significant small similarity in
terminal swing phase.

Foot y

Sharp rise in initial contact, delayed and lower
magnitude in swing phase.

Same as right foot y.

Early sharp rise in initial contact and lower
magnitude through the rest of the cycle.

Sharp rise and continue with high
magnitude in stance phase,
causing smaller similarity in midand terminal stance phases, sharp
rise in terminal swing phase.

Foot z

Sharp rise in initial contact, lower magnitude in
the rest of the gait cycle, significant differences
Shank x
from the healthy in the terminal stance and preswing phase.

Same as right shank x.

Sharp rise in initial contact, lower level of
magnitude with instability in the rest of the gait
Shank y
cycle. Most significant differences appear in
phase 4.

Same as right shank y.

Shank z

Sharp rise in initial contact, lower magnitude in
the rest of gait cycle. Significant small similarity
appears in sub-phases in swing.

Thigh x

Sharp rise in initial contact, lower magnitude with
Same as right thigh x. Significant
some level of instability through the stance phase,
small similarity appear in prerise in terminal swing phase. Significant small
swing and mid-swing phases.
similarity appears in terminal stance phase.

Thigh y

Sharp rise in initial contact, high magnitude in
mid-stance phase, early rise in the terminal swing
phase. Significant differences appear in midstance phase.

Same as right thigh y.

Thigh z

Sharp rise in initial contact, lower magnitude in
swing phase. Significant differences appear in
initial swing.

Same as right thigh z, note the
magnitude is lower than right
during stance phase.
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Same as right shank z.

Hip x

Sharp rise in initial contact, higher magnitude
with instability throughout the rest of the gait
cycle. Significant small similarity appears in midand terminal stance phases.

Same as right hip x with much
more instability might due to the
deformity and pain from the
arthritis.

Hip y

Instable magnitude in the beginning of stance
phase, sharp rise at 15% of the cycle, lower
magnitude in the rest of the gait cycle. Significant
small similarity appears in initial contact, midand terminal stance, and mid-swing phase, which
indicates the serious hip problems on this CP
patient.

Same as right hip y with much
lower magnitude in terminal
swing phase, again results from
the deformity and pain on the left
hip.

Sharp rise in initial contact, instable magnitude
throughout the rest of the gait cycle.

Much lower magnitude in the
initial contact due to the
deformity which results in the
small similarity in loading
response, instable and higher
magnitude in the rest of the gait
cycle.

Hip z

•

Conclusion of Cerebral Palsy

The feature analyses for cerebral palsy subjects are illustrated Table 11-9, based on all
four CP subjects (CP-1, CP-3, and CP-4 are shown in Appendix X, XI, XII, respectively). The
table describes the important characteristics of CP found from the results and analysis in this
study.
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Table 11-9: Characteristics of Cerebral Palsy
Feature

Characteristics

CP has also increased variability, the more or less depends on the
severity of the symptoms and with or without the assistance such as
Stride Variability

harness. This increased temporal variability may due to the joint
deformity and abnormality of muscle tones, such as hypertonia and
hypotonia. We can further investigate from the pattern analysis of
GRF, EMG, and acceleration.
In vertical direction, All CP subjects showed a much shortened peak
in the stance phase which indicates the typical toe-walking gait. In
anterior-posterior direction, CP subjects showed lower GRF than

Ground Reaction Force
(GRF)

healthy subjects. This may be due to the slower speed in CP
subjects, but may also indicate the less force generated from muscles
and other internal forces from the joints in this direction.
In mediolateral direction, CP subjects also showed some lower force
compared with healthy subjects.
Soleus and Tibialis anterior are agonist-antagonist muscle pair for
ankle plantarflexation and dorsiflexition, respectively. All CP
subjects showed opposite muscle activities of these two muscles to
the healthy subjects. This could be the major deforming factor of the
ankle in cerebral palsy, which causes toe-walking.
Spasticity appears in the initial contact and rest of the stance phase

Electromyography
(EMG)

or early swing phase in most of the CP subjects. Gastrocnemius was
thought to be the primary equinus deforming factor of the ankle in
cerebral palsy.
Vastus lateralis and rectus femoris (muscle in the quadriceps) are
extensor muscles of the knee and hip flexor. Spasticity of these two
muscles occurs in the stance phase and early swing phase in most of
the CP subjects.
Biceps femoris is flexor of the knee. There was also spasticity in the
mid-stance phase and early swing phase in most of the CP subjects.
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Gluteus medius is hip abductor and stabilizer. There was increased
EMG activity in swing phase in most of CP subjects.
Erector spinae in the lower back is a group of stabilizers. There were
higher activities in the loading response and initial swing phase
similar to MS subjects.
A sharp rise in acceleration or deceleration in the initial contact and
terminal swing phase appears in most of CP subjects which could be
the results of toe-walking (smaller surface contacting ground which
results in more force generated in initial contact).
Unstable acceleration occurs in particular thigh and hip in most of
Segmental Acceleration

the CP subjects which indicates some levels of knee and hip
contractures in these subjects.
In addition, all CP subjects had some levels of foot clearance
problems showing particularly in foot y acceleration at toe-off time,
which might be result from a pelvic drip due to abductor
insufficiency.
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Chapter 12: Comparative Analysis and Discussion

In the last chapter, the case studies of multiple sclerosis and cerebral palsy were shown
separately. In this chapter, the two mobility-related impairments will analytically be compared.
The characteristic of each disorder is categorized and explained in detail.
There will also be the analysis of another stroke subject, hemiparetic stroke subject, who
make two visits for testing in an interval of two months (before and after the hydrotherapy).

12.1

•

Multiple Sclerosis (MS3) vs Cerebral Palsy (CP3)

Comparison of Ground Reaction Forces

Figure 12-1: Comparison of ground reaction force and grade of similarity between MS-3 and

CP-3.
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•

Comparison of EMG Muscle Activity

Figure 12-2: Comparison of EMG patterns and grade of similarity between MS-3 and CP-3.
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•

Comparison of Acceleration Patterns
(A)

(B)
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(C)

(D)

Figure 12-3: Comparison of segment’s acceleration and similarity between MS-3 and CP-3. (A)

Foot acceleration and similarity; (B) Shank acceleration and similarity; (C) Thigh acceleration
and similarity; and (D) Hip acceleration and similarity.
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•

Analysis in table form
Table 12-1: Comparative Analysis between MS and CP

Feature

Multiple Sclerosis

•
GRF

Cerebral Palsy

Delayed and single peak

ground contact.

•

A single peak ground contact, but

appears earlier than MS, which shows
typical toe-walking gait.

•

Muscle weakness in the

stance phase on Soleus.
•

•

Spasticity appears in the stance

phase on Soleus and Gastrocnemius,

Slightly higher activities in

the initial contact on Tibialis.

combined with Tibialis muscle
weakness in the loading response,

Muscle
•

Delayed activities in the

results in the toe-walking.

Activity
•

Gluteus medius.

Muscle weakness in the stance

phase and spasticity in the swing phase
results in the scissoring gait from hip
and knee contractures.
•

There is small deceleration

•

There is little or no deceleration

on the foot-clearance in the initial

in the initial swing phase on foot y,

swing phase, showing on foot y.

which shows the CP subject with more

•

There are generally lower

foot-clearance problems.

Acceleration
accelerations on thigh and hip.

•

There are very unstable

acceleration signals on shank, thigh,
and hip due to the scissoring gait
patterns.
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12.2

•

A Hemiparetic Stroke Subject (made two times visits for testing)

Comparison of Ground Reaction Forces

Figure 12-4: GRF and similarity of the stroke subject with two visits in two month interval.
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•

Comparison of EMG Muscle Activity

Figure 12-5: Comparison of EMG patterns and similarity between two times of visits with two

months interval.
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•

Comparison of Acceleration Patterns
(A)

(B)
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(C)

(D)

Figure 12-6: Comparison of segment’s acceleration and similarity between two visits of a stroke

subject. (A) Foot acceleration and similarity; (B) Shank acceleration and similarity; (C) Thigh
acceleration and similarity; and (D) Hip acceleration and similarity.
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•

Analysis in table form

Table 12-2: Comparative Analysis before and after two-month hydrotherapy in Stroke1
Feature

Comparison

The 1st visit walking speed was 0.1 m/s, whereas the 2nd visit walking speed
Walking Speed
was 0.3 m/s
The GRFs of the 2nd visit are much higher than in the 1st visit on all three
GRF
planes. The stance phase in the 2nd visit is much shorter than the 1st visit.
In her 1st visit, the muscle activities show generally weakness throughout the
Muscle Activity

entire gait cycle. In her 2nd visit, the muscle activities are improved on most
of the muscles.
The subject has improved the grade of similarities on most of the segment’s

Acceleration

accelerations. There are still problems with the foot-clearing, and instability
on the shank, thigh, and hip.
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Chapter 13: Conclusions, Outcomes and Claims of the Research

Background

The kinematics, kinetics and electromyographic data of human locomotion were
investigated, in order to increase our understanding of the neurophysiology/biomechanics of gait
for augmenting objective measurements of mobility and functional status.
Objective

The objective is to develop a measurement methodology for the efficient and reliable
analysis of human gait dynamics at a level that quantifies variations from morphometrically
adjusted normal in three dimensions.
The methodology makes the recognition, quantification and differentiation of mobility-related
impairments possible.
Outcomes of this research

This research work has introduced an innovative system that will represent a nextgeneration gait recognition, quantification and differentiation device.
The developed system provides three different operating modes: (1) gait recording; (2)

gait playback; and (3) gait training. Each mode performs a different function that serves a
different therapy purpose.

From this perspective, it can be thought of as three machines

combined into a single unit. When operating as a “gait recording machine” (Mode 1), the system
measures and records the gait characteristics of the individual using the instrumented gait
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analysis system. This generates a “data record” of the person’s gait, which is stored in the
knowledge base. Some of the benefits of this system when operated in this mode include:
•

Using this function with healthy subjects, data records can be captured that characterize

the gait patterns of “normal individuals” from a sample population.

Benefit: Statistical analysis of normal gait data is enabled.
•

Similarly, data records can be captured that characterize the gait patterns of individuals

with a particular type of gait impairment, based on a sample survey population.

Benefit: Statistical analysis of impaired gait data is enabled.
•

Using this function with one individual, data records can be captured over a series of

therapy sessions and changes in the person’s gait with time, as a result of the prescribed therapy,
can be identified and tracked.

Benefit: Measurement of effectiveness (MOE) of therapy is enabled.
•

The use of this function allows the characterization and differentiation of gait-related

impairment.
When the system is operated as a “gait playback machine” (Mode 2), stored data records
from gait recording sessions can be retrieved from the knowledge base and gait characteristics
can be reviewed using the data presentation features of the automated system. This allows for the
review and understanding of the recorded gait data by the doctor, therapist, and/or patient.
Finally, when the system is operated as a “gait training machine” (Mode 3), the stored
data within the knowledge-based instrumented analysis scheme will be used to move the
subject’s legs according to a prescribed and programmed gait motion profile.
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Claims of this research

[1]

This innovative technology is applicable across the entire spectrum of pathophysiological and biomedical etiologies of mobility impairment.

[2]

It is possible to use computational intelligence methodologies driven by a wearable
sensor array system to reliably and effectively monitor gait disability.

[3]

This innovative system provides three-dimensional, real-time analysis of functional
impairments in human locomotion.

[4]

This novel technology will revolutionize the quantification and characterization of gait
impairments and thus have immediate research applications.

[5]

This new technology increases our understanding of the development of an adaptive
compensatory system for human locomotion with the purpose of developing novel
technology for efficient and reliable acquisition and analysis of human gait.

[6]

This technology will be capable of direct real-time comparison of any ambulatory
subject’s gait pattern to a predicted, morphometrically adjusted normal pattern utilizing
fuzzy logic systems.

[7]

A new computational intelligence methodology has been developed based on fuzzy
inferential reasoning.

[8]

The new technology enables the recognition and differentiation of gait disorders.

[9]

A novel sensor data fusion algorithm has been developed using the methods of fuzzy
relational matrices.
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Chapter 14: Suggestions for Future Enhancements

The accuracy of the measurement is a critical issue to assure quality and achieve
continuous improvement of clinical gait and movement analysis. The future of gait analysis lies
in the ability to process data quickly and identify the patient’s functional deficits. There are a
number of suggestions to improve the measurement, and therefore improve the quality of the
analysis.
•

Wireless and portable sensor measurement
The future research on clinical gait is seeking to create a system to provide instrumented

wireless gait analysis outside of traditional, expensive motion laboratories. Such a system has the
potential to be highly informative by allowing data collection throughout the day in a variety of
environments, thus providing a vast quantity of long-term data not obtainable with current gait
analysis systems. First, the system has to contain the light-weight, miniature inertial sensors for
direct measurement and analysis. Second, the system has to be portable which enables the mobile
measurement in any environments. Finally, most of the components in the system have to be
wireless to reduce the errors from the cable moving effects, and improve for the time
consumption during data acquisition.
•

Sensor validation
For the reliable monitoring of gait, it is necessary to have accurate sensor information.

However, sensors may sometimes be faulty or may even become unavailable due to the
limitation or maintenance activities. The problem of senor validation is therefore a critical part of
measurement. A sensor validation scheme fulfills the tasks of detection and estimation. The
former task involves the discovery of a malfunction in a sensor while the latter task includes
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localization (establishing which sensor has failed); identification (determining the type of
failure); and estimation (indicating the effect and extent of the failure).

•

Real-time measurement
Once the measurement has been improved in a way to be portable, wireless and easy set-

up, a system needs to be developed for real-time acquisition of human locomotion. This system
will lead to greater accuracy than the current systems. These enhanced capabilities will eliminate
clustering limitations and data reduction, reduce the cost of gait analysis as a clinical treatment
planning service, and improve the turnaround and availability of information for clinical decision
making. The advantages to be realized include a real-time motion acquisition and display, higher
data sample rates, substantially increased work volumes, full body motion acquisition, reduced
data loss from occlusion, and a significant time saving for data analysis. Successful development
and commercialization of a real-time data acquisition system represents a new paradigm for
human motion analysis.
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Appendix I: Structure of Bertec Treadmill

(A)

(B)

60”

12”

(C)

(D)

The instrumented treadmill (Bertec Corporation in USA). (A): The split-belt treadmill consists
of two treads running side by side. Each tread has a 6-component force plate underneath to
measure loads exerted on the tread belts. Each tread is driven and controlled separately. (B): Two
independent surfaces, 60 inches long and 12 inches wide per belt. Note picture is not to scale.
(C): Coordinate system for load measurements on left half of the treadmill. The center of the
coordinate system is at the inner corner of the arm block with y-axis forward, x-axis to the left
outwards, and z-axis downward. (D): Coordinate system for load measurements on right half of
treadmill. The center of the coordinate system is at the inner corner of the arm block with y-axis
forward, x-axis to the left, and z-axis downward.
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Appendix II: Delsys EMG system components

3) Tethered Trigger Module

1) Myomonitor

2) EMG sensor

Delsys Myomonitor® Wireless EMG systems (www.delsys.com ).
The goal with EMG measurements is to maximize the signal to noise ratio. Technological
developments have decreased the level of noise in the EMG signal. One of the most important
developments was the introduction of the bipolar recording technique. Bipolar electrode
arrangements are used with a differential amplifier, which functions to suppress signals common
to both electrodes. Essentially, differential amplification subtracts the potential at one electrode
from that at the other electrode and then amplifies the difference. Delsys EMG electrode with its
unique parallel bar geometry ensures consistency across measurements. 1cm spacing is spatially
optimal for full-bandwidth signal detection. Fixed inter-sensor distance minimizes amplitude and
temporal variability across measurements.
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Appendix III: Description of the ADXL330
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Appendix IV: Subjects anthropometric measurement form
Anthropometric Measurement
Name
ID #
Male/Female
Date of Birth (mm/dd/yy)
Weight (kg)
Standing Height (cm)
Upper Body
(cm)
Lower Body
(cm)
Right Shoulder Ht
Right Knee Ht Seated
Left Shoulder Ht
Left Knee Ht Seated
Right Armpit Ht
Right Thigh Circum.
Left Armpit Ht
Left Thigh Circum.
Waist Height
Right Upper Leg Circum.
Seated Height
Left Upper Leg Circum.
Head Length
Right Knee Circum.
Head Breadth
Left Knee Circum.
Head to Chin Ht
Right Calf Circum.
Neck Circum.
Left Calf Circum.
Shoulder Breadth
Right Ankle Circum.
Chest Depth
Left Ankle Circum.
Chest Breadth
Right Ankle Ht Outside
Waist Depth
Left Ankle Ht Outside
Waist Breadth
Right Foot Breadth
Buttock Depth
Left Foot Breadth
Hip Breadth Standing
Right Foot Length
Right Shoulder to Elbow Ln.
Left Foot Length
Left Shoulder to Elbow Ln.
Right Ankle Width
Right Forearm Hand Ln.
Left Ankle Width
Left Forearm Hand Ln.
Right Knee Width
Right Biceps Circum.
Left Knee Width
Left Biceps Circum.
Chest Circum.
Right Elbow Circum.
Right Thigh Length
Left Elbow Circum.
Left Thigh Length
Right Forearm Circum.
Right Mid-thigh Circum.
Left Forearm Circum.
Left Mid-thigh Circum.
Right Wrist Circum.
Right Calf Length
Left Wrist Circum.
Left Calf Length
% Fat
Have you ever had injury on our lower limb? Or have you suffered from mental problem? Are
you taking any medications? If yes, please indicate. How long have you been diagnosed?

233

Appendix V: Results of Multiple Sclerosis Patient 2 (MS2)

•

Description

Subject is a 40 year old female, was diagnosed with mild symptoms of multiple sclerosis
in June 2009. She complained having left foot drop during walking. Medication includes Avonex

(Interveron beta) for relapsing remitting multiple sclerosis (RRMS). She was test bare-footed,
walking on the instrumented treadmill with the harness support for three minute continually, at
speed of 0.65 m/s.
•

Temporal Stride Variability

Figure AV-1: Stride variability of a healthy female and female multiple sclerosis subject case 2

(MS-2).

Summary:

The MS2 subject has greater temporal variability, especially shown in

stance/swing/double-stance phases, compared with the healthy female subject. She has shorter
swing phase, and longer stance/double-stance phases. The duration of the double-stance phase
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gradually increased with greater variability which indicates some levels of functional fatigue
appearing in the walking trial.

•

Ground Reaction Forces

Figure AV-2: Right and left GRF in 3-D in multiple sclerosis subject case 2 (MS-2).

Figure AV-3: Grade of similarity on right and left GRF in MS-2.
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Summary:

The force curve in the vertical direction (Fz) shows a longer stance phase than the healthy
subjects on right foot of the MS2, which indicates the affected leg was on the left (with reference
to her description). The foot drop on the left side also caused much shortened interval of two
peaks in the stance phases. In anterior-posterior direction (Fy), MS2 has lower magnitude of
force than healthy subjects for both right and left feet (left Fy < right Fy). In mediolateral
direction (Fx), MS2 has higher GRF than healthy subjects (right Fx > left Fx). The right force
has the significant small similarity on all three planes during initial swing and mid-swing phases
due to the longer loading times in the stance phase. She has quite high similarity for the rest of
the forces which indicate she has fresh and mild multiple sclerosis or in her remission stage of
RRMS.
•

EMG Muscle Activity Patterns

Figure AV-4: Comparison of EMG pattern in a full gait cycle between able-bodied subjects and

MS-2 subject.
236

Figure AV-5: Grade of similarity on right and left EMG in MS-2.
Summary:
Table AV-1: Summary of EMG activity in MS-2

Soleus
Tibialis
Anterior
(TA)
Gastrocnemius
Lateralis (LG)
Vastus
Lateralis (VL)
Rectus
Femoris (RF)

Right
Higher muscle activities appear in
stance phase. Significant small
similarity appears in the initial swing.
Spasticity appears the initial contact.
Significant small similarity appears in
initial swing due to longer loading time
in right.
Higher muscle activities appear entire
stance phase and mid-stance. Significant
small similarity appears in initial swing.

Left

Same as right Sol.

Spasticity at initial contact and
initial swing phase. Significant
small similarity appears in midstance.
Spasticity appears from initial
contact until the mid-stance phase.
Significant small similarity
appears in the loading response.
Sharp rise in the initial contact.
Sharp rise in the initial contact.
Least similarity in pre- and initial swing. Moderate to high similarity for all
gait phases
Spasticity appears in the initial contact
Same as right RF.
and initial swing phase. The least
similarity appears in mid-swing.
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Biceps
Femoris
(BF)

Gluteus
Medius
(Gmed)

Erector
Spinae (ES)

•

Muscle weakness appears in the initial
contact and terminal swing phase.
Spasticity appears in the stance phase up
to 60% of full gait cycle. Significant
small similarity starts from mid-stance
to mid-swing phases.
Muscle weakness appears in the loading
response and terminal swing phase.
Spasticity appears in initial and midswing phase. Significant small similarity
appears in pre- and initial swing.
Sharp rise in the initial contact.
Spasticity appears after 60% of the gait
cycle. Significant small similarity in
entire swing phase.

Acceleration Patterns
(A)
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Muscle weakness appears in the
initial contact and terminal swing
phase. Spasticity appears in the
stance phase up to 40% of full gait
cycle. Significant small similarity
starts from mid-stance to midswing phases.

Same as right Gmed.

Muscle weakness appears in the
initial contact, spasticity appears in
the mid-stance and terminal swing
phase. Significant small similarity
in the terminal stance phase.

(B)

(C)
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(D)

Figure AV-6: Comparison of acceleration pattern in a gait cycle between able-bodied subjects

and MS-2. (A) Foot (B) Shank (C) Thigh and (D) Hip accelerations

Figure AV-7: Grade of similarity on right and left acceleration in MS-2.
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Summary:
Table AV-2: Characterization of acceleration in MS-2
Right

Left

Sharp rise in the initial contact, lower
magnitude throughout the rest of the
stance phase, delayed and reduced
acceleration in swing phase.

Sharp and delayed rise in initial contact,
lower magnitude than right foot in stance
phase, deceleration sharply after toe-off,
delayed and sharp acceleration in terminal
swing (which cause significant small
similarity in mid-swing).

Delayed acceleration after toe-off
during the initial swing.

Delayed and lower acceleration in the
initial contact and delayed acceleration in
initial swing.

Foot z

Much delayed acceleration in loading
response which causes significant
small similarity at that time. Delayed
acceleration in pre-swing and terminal
swing.

Delayed but sharp rise in initial contact,
high magnitude during stance phase,
delayed deceleration in initial swing.

Shank x

Sharp rise in initial contact, lower
magnitude in stance phase, delayed
and reduced acceleration in swing
phase.

Sharp rise in initial contact, level of
instability showing in stance phase on this
affected leg, delayed but sharp rise in
acceleration in swing phase.

Sharp rise in initial contact, lower
magnitude during stance phase,
instable and reduced acceleration in
swing phase.

Sharp and delayed rise in initial contact,
instable acceleration during the stance
phase, delayed deceleration before toe-off
which causes significant small similarity
in pre-swing.

Sharp rise in acceleration in initial
contact, delayed acceleration on toeoff.

Sharp and delayed acceleration in initial
contact, remaining high magnitude during
stance phase, delayed deceleration before
toe-off.

Sharp rise in initial contact, instable
magnitude throughout the stance
phase, sharp rise in initial swing phase

Sharp and delayed rise in initial contact,
lower and instable magnitude in stance
phase, sharp rise and high acceleration in
swing phase.

Foot x

Foot y

Shank y

Shank z

Thigh x
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Sharp and delayed deceleration in
early stance phase, instable and lower
magnitude during stance phase, early
rise in terminal swing.

Sharp and delayed deceleration in initial
contact, instable and lower magnitude
throughout the rest of the gait cycle.

Sharp rise in initial contact, lower
magnitude in terminal swing.

Sharp and delayed rise in initial contact,
instable magnitude in stance phase, early
sharp rise in pre-swing phase.

Hip x

Sharp and delayed deceleration in
early stance phase, dramatically
decreased throughout the stance phase,
sharp rise in initial swing phase, lower
magnitude in terminal swing phase.

Much delayed deceleration in early stance
phase, and lower magnitude through the
rest of the stance phase, early sharp rise
around toe-off time, high magnitude in
mid- and terminal swing phases.

Hip y

Sharp deceleration in initial contact,
lower magnitude in stance phase,
sharp rise in swing phase, lower
magnitude in terminal swing phase.

Delayed rise in initial contact, rise in
single support time, sharp delayed rise in
pre-swing phase, and lower magnitude in
terminal swing phase.

Hip z

Sharp rise in initial contact, rise in
single support time, sharp rise in preswing phase.

Sharp and delayed rise in initial contact,
sharp rise in single support, sharp rise in
pre-swing phase.

Thigh y

Thigh z
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Appendix VI: Results of Multiple Sclerosis Patient 3 (MS3)

•

Description

Subject is a 62 year old male, was diagnosed with relapsing remitting multiple sclerosis
and type II diabetes three years ago. He started with gait instability and fell in the summer of
2006. This MS subject had more serious gait problems. From observation of this subject, he had
quite slow walking speed, and walking with left hand touching the wall occasionally along the
long corridor, and walking with left limp. He is on Rebif (interferon beta 1a) 44mcg, 3 times per
week. He apparently has moderate to severe spinal canal stenosis (narrowing of the spaces in the
spine, resulting in compression of the nerve roots or spinal cord by bony spurs or soft tissues,
such as disks, in the spinal canal) at L4-5. He has multiple white matter foci on his brain MRI,
the largest is within the right frontal lobe, in deep white matter near the convexity with a bullseye configuration, measuring 1.78×1.09×1.2 cm. His spinal fluid was positive for oligoclonal
bands (indicates that immunoglobulins are produced in central nervous system which is an
important indicator in the diagnosis of multiple sclerosis). The patient was tested with bare-foot
walking on the instrumented treadmill with harness support for stabilization at patient acceptable
speed of 0.15 m/s.
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•

Temporal Stride Variability

Figure AVI-1: Stride variability of a healthy subject compared with multiple sclerosis case 3

(MS-3).

Summary: With this lower walking speed, there were only 90 strides extracted during three-

minute walking trial in MS-3 subject. The subject has greater temporal variability for all
variables compared with a healthy male subject. He has much longer stride time due to the
slower walking speed, much shorter swing phase, and longer stance/double-stance phases. The
variability increased dramatically after 55 strides during the three-minute walking which
indicates the fatigue around that time. In addition, there was a reduction in the stance phase and a
peak increment in the swing phase, around 75 strides which indicate a falling risk happening at
that time.
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•

Ground Reaction Forces

Figure AVI-2: Right and left GRF in 3-D in MS3.

Figure AVI-3: Grade of similarity on right and left GRF in MS-3.
Summary:

The force curve in the vertical direction (Fz) shows a much longer stance phase
(approximately 85% of the full gait cycle) in MS-3 subject than the healthy subjects on both right
and left feet, which indicates his gait has serious problems on both legs. There was only one
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shortened peak time during stance phase showing that his gait had no smooth force transition
events from heel to toe which forms the ‘M’ shape with two peaks in Fz. In anterior-posterior
direction (Fy), MS-3 has much lower magnitudes of force than healthy subjects for both right
and left feet, this might due to very low walking speed with weak GRF. In mediolateral direction
(Fx), MS-3 has also constant plateau-wise form of GRF. There are significant small similarity in
anterior-posterior force and mid-swing in vertical force. This indicates the serious gait problem
with MS3.
•

EMG Muscle Activity Patterns

Figure AVI-4: Comparison of EMG pattern in a gait cycle between able-bodied subjects and

MS-3.
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Figure AVI-5: Grade of similarity on right and left EMG in MS-3.
Summary:
Table AVI-1: Summary of EMG activity in MS-3

Right

Soleus

Tibialis
Anterior
(TA)

Left

Weakness in the beginning of the stance
and small spasticity appears at the end
of stance phase. Significant small
similarity appears in loading response
and mid-swing.
Muscle weakness appears in the late
stance phase. Significant small
similarity in initial and mid-swing
phases.

Gastrocnemius Spasticity appears in the late stance
Lateralis
phase. Significant small similarity in
(LG)
initial and mid-swing phases.
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Same as right Sol but higher
spasticity appears at the end of
stance phase. Significant small
similarity appears in loading
response, initial and mid-swing
phases.
Same as right TA.

Same as right LG.

Vastus
Lateralis
(VL)

Weakness appears in the initial contact
and terminal swing, spasticity appears
after single support in the stance phase.
Significant small similarity appears in
phase 3~7.

Rectus
Femoris
(RF)

Weakness appears in the loading
response, spasticity appears after single
support and continue until end of the
stance phase. Significant small
similarity appears pre-and terminal
swing phases.

Biceps
Femoris
(BF)

Gluteus
Medius
(Gmed)

Erector
Spinae
(ES)

Spasticity appears in the stance phase
up to 30% of full gait cycle, weakness
appears in the terminal swing phase.
Significant small similarity appears in
mid-swing phase.

Muscle weakness appears in the loading
response. Spasticity appears about
20~60% of the gait cycle. Significant
small similarity appears through entire
gait cycle.
Spasticity appears in loading response,
and up to 30% of the gait cycle.
Spasticity also appears in the terminal
swing phase. Significant small
similarity appears in mid-stance phase.
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Same as right VL.

Same as right RF.

Muscle weakness appears in the
initial contact and terminal swing
phase. Spasticity appears in the
stance phase up to 60% of full gait
cycle. Significant small similarity
appears from mid-stance to terminalswing phases.

Same as right Gmed.

Same as right ES.

•

Acceleration Patterns
(A)

(B)
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(C)

(D)

Figure AVI-6: Comparison of acceleration pattern in a gait cycle between able-bodied subjects

and MS-3. (A) Foot (B) Shank (C) Thigh and (D) Hip acceleration
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Figure AVI-7: Grade of similarity on right and left acceleration in MS-3.
Summary:
Table AVI-2: Characterization of acceleration in MS-3

Foot x

Right
Sharp rise in the initial contact, lower and delayed
acceleration in swing phase which results in a
significant small similarity in terminal swing phase.

Foot y

Delayed and sharp rise in acceleration in initial
contact and swing phase.

Foot z

Shank x

Lower and shortened acceleration in loading
response, delayed but sharp rise in acceleration after
toe-off. Significant small similarity appears in initial
swing phase.
Sharp rise in initial contact, and then dramatically
decreased below the baseline of the healthy pattern in
the stance phase which results in significant small
similarity in terminal stance and pre-swing phases.
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Left
Sharp rise in initial contact, higher
magnitude in stance phase, lower
acceleration in swing which causes
significant small similarity in midswing phase.
Same as right foot y. Significant
small similarity appears in the
terminal swing phase.
Sharp rise in initial contact, lower
magnitude during the rest of stance
phase, lower acceleration in swing
phase. Significant small similarity
appears in the initial swing phase.

Same as right shank x.

Shank y

Shank z

Thigh x

Thigh y

Thigh z

Hip x

Hip y

Hip z

Sharp and delayed rise in initial contact and
continues with higher magnitude for the entire gait
cycle. Significant small similarity appears in midswing phase.
Sharp rise in acceleration in initial contact, delayed
and lower acceleration in swing phase which causes
significant small similarity in mid- and terminal
swing phases.
Lower magnitude appears entire gait cycle which
results in small similarity for the most of the phases.

Sharp rise in initial contact and higher magnitude in
early stance phase, instable and lower magnitude
during the later stance phase, early rise with lower
magnitude in swing phase. Significant small
similarity appears in pre- and mid-swing phases.
Sharp rise in initial contact, dramatically decreased
throughout the stance phase, sharp rise in swing
phase. Significant small similarity appears in terminal
stance, pre- and initial swing phases.

Same as right shank y.

Same as right shank z.

Sharp rise in initial contact, lower
magnitude in stance phase, sharp
rise in acceleration in swing phase.
Significant small similarity appears
in terminal stance, pre- and initial
swing phases.
Same as right thigh y.

Sharp rise in initial contact, higher
magnitude in stance phase, delayed
rise in swing phase. Significant
small similarity appears in terminal
swing phase.

Sharp rise in initial contact, lower magnitude in
stance phase, and increased acceleration in swing
Same as right hip x.
phase. Significant small similarity appears in terminal
stance and pre-swing phases.
Sharp deceleration in initial contact, lower magnitude
in stance phase, sharp rise after toe-off. Significant
Same as right hip y.
small similarity appears in entire gait cycle except the
loading response.
Sharp rise in initial contact, higher magnitude
throughout the rest of the gait cycle. Significant small Same as right hip z.
similarity appears in terminal stance phase.
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Appendix VII: Results of Multiple Sclerosis Patient 4 (MS4)

•

Description

Subject is a 37 year old man, was diagnosed with multiple sclerosis ten years ago. From
observation of this MS subject, he walked with instable and limp gait. Medication includes

Desyrel for conditions of depression and MS tremor. He was tested with bare-foot walking on
the instrumented treadmill for three minutes without harness support, at speed of 0.35 m/s. There
were two time fall risks during continue walking trail, patient used treadmill hand bars
occasionally as partial support.

•

Temporal Stride Variability

Figure AVII-1: Stride variability of a healthy subject and multiple sclerosis patient case 4 (MS-

4).
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Summary: there were only 80 strides found from three-minute walking trial in MS-4. The

subject has increased variability in all four temporal stride variables, compared with a healthy
subject. There was a clear greater increased stride time at 15 strides when the first fall risk
appeared.

There are gradually increased stance and double-stances phases, and gradually

decreased swing phase during the walking trial due to functional fatigue in MS-4. In addition,
there was a sharp increase in double-stance phase at around 70 strides when the second fall risk
happened.

•

Ground Reaction Forces

Figure AVII-2: Right and left GRF in 3-D in MS-4.
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Figure AVII-3: Grade of similarity on right and left GRF in MS-4.
Summary:

In the vertical direction of GRF (Fz), MS-4 subject shows a much longer stance phase
(approximately 80% of the full gait cycle) than the healthy subjects on both right and left feet,
which indicates his gait has serious problems on both legs, time of right Fz is slightly longer than
left Fz. This indicates the base support side was right leg, and the more server effective side was
left. There was a flat-foot with short contacting ground duration in stance phase, especially on
the left foot. In anterior-posterior direction (Fy), MS-4 has lower magnitudes of GRF than
healthy subjects for both right and left feet. In mediolateral direction (Fx), MS-4 has lower and
delayed magnitude of GRF (left Fx < right Fx). There is significant small similarity in anteriorposterior GRF and swing phase in vertical force.
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•

EMG Muscle Activity Patterns

Figure AVII-4: Comparison of EMG in a gait cycle between able-bodied subjects and MS-4.

Figure AVII-5: Grade of similarity on right and left EMG in MS-4.
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Summary:
Table AVII-1: Summary of EMG activity in MS-4
Right

Left

Soleus

Muscle weakness in the beginning of the
stance and delayed muscle activity in the late
stance phase. Significant small similarity
appears in mid-stance phase and initial swing
phase.

A peak activity appears in the initial
contact, and weakened activity in the
rest of stance phase. Significant
small similarity appears in midstance phase and initial swing phase.

Tibialis
Anterior
(TA)

Spasticity appears in the loading response,
and delayed but increased muscle activity in
the swing phase. Significant small similarity
in initial swing phase.

Weakness appears in the early stance phase
and peak activity in the late stance phase.
Gastrocnemius
Significant small similarity appears in midLateralis
stance phase.
(LG)

Same as right TA.

Spasticity appears in the initial
contact and then the muscle
weakness appears in the rest of the
gait cycle which results in the
significant small similarity of this
muscle in a full gait cycle.

Higher muscle activity appears in stance
phase. Significant small similarity appears in
phase 3~6.

Even higher muscle activity then
right VL in the stance phase.
Significant small similarity appears
in terminal stance phase and preswing phase.

Rectus
Femoris
(RF)

Instable spasticity appears the entire gait
cycle. Significant small similarity appears in
pre-swing phase.

Similar to right RF, significant small
similarity appears in mid-swing
phase.

Biceps
Femoris
(BF)

Spasticity appears in the stance phase and the
muscle weakness appears in the swing phase.
Significant small similarity appears in preand mid-swing phase.

Same as right BF.

Gluteus
Medius
(Gmed)

Muscle weakness appears in the initial
contact. Spasticity appears in the mid-stance
phase which results in the significant small

Vastus
Lateralis
(VL)
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Same as right Gmed.

similarity in the phase.
Erector
Spinae
(ES)

•

Spasticity appears in early stance phase, and
up to 30% of the gait cycle which results in
significant small similarity appears in midstance phase.

Acceleration Patterns
(A)
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Same as right ES. Significant small
similarity appears in mid-stance
phase and mid-swing phase.

(B)

(C)
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(D)

Figure AVII-6: Comparison of acceleration pattern in a gait cycle between able-bodied subjects

and MS-4.

260

Figure AVII-7: Grade of similarity on right and left acceleration in MS-4.
Summary:

Table AVII-2: Characterization of acceleration in MS-4

Right

Left

Foot x

Sharp rise in the initial contact, lower
magnitude throughout the rest of the stance
phase, delayed and reduced acceleration in
swing phase. Significant small similarity
appears in the mid-swing phase.

Sharp rise in initial contact, much
lower magnitude in stance phase,
sharp rise in acceleration in swing
phase which causes significant small
similarity in mid-swing phase.

Foot y

Sharp rise in acceleration in initial contact,
lower magnitude in the rest of the stance
phase, delayed and reduced acceleration in
swing phase which results in the small
similarity in mid-swing phase.

Same as right foot y.

Foot z

Much higher magnitude appears entire gait
cycle, which causes significant small
similarity.

Same as right foot z.
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Shank x

Sharp rise in initial contact, lower
magnitude in stance phase, delayed and
reduced acceleration in swing phase.
Significant small similarity appears in the
pre-, initial, and mid-swing phases.

Sharp rise in initial contact, sharp
rise in the pre-swing phase, and
lower acceleration in swing phase.
Significant small similarity appears
in the initial and mid-swing phases.

Shank y

Sharp rise in initial contact, lower
magnitude during stance phase, instable and
reduced acceleration in swing phase.
Significant small similarity appears in the
mid- and terminal swing phases.

Same as right shank y. Significant
similarity appears in the mid-swing
phase.

Sharp rise in acceleration in initial contact,
lower magnitude appears in the stance
phase, delayed and reduced acceleration in
swing phase. Significant small similarity
appears in terminal stance phase and preswing phase.

Same as right shank z.

Sharp rise in initial contact, instable
magnitude throughout the stance phase,
sharp rise in initial swing phase

Delayed but higher acceleration in
the stance phase and much lower
magnitude appears in the swing
phase. Significant small similarity
appears almost entire gait cycle.

Sharp and delayed deceleration in early
stance phase, instable and lower magnitude
during stance phase. Significant small
similarity appears in the pre- and initial
swing phases.

Much lower magnitude in the initial
contact, increased acceleration in the
late stance phase, much lower
magnitude appears in the swing
phase. Significant small similarity
appears in the loading response and
terminal swing phase.

Sharp rise in initial contact, delayed
acceleration appears in the later phases of
the cycle.

Delayed but higher rise in early
stance phase, rise in pre-swing
phase, and lower magnitude in the

Shank z

Thigh x

Thigh y

Thigh z
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swing phase. Significant small
similarity appears in mid-swing.

Hip x

Hip y

Hip z

Sharp deceleration with immediate
acceleration in initial contact, continuing
with high magnitude in the stance, rise in
acceleration in terminal swing phase.
Significant small similarity appears in midand terminal stance.
Sharp acceleration and immediate
deceleration in initial contact, lower and
instable magnitude in stance phase, lower
and delayed acceleration in swing phase
which causes small similarity in the midswing phase.
Sharp rise in initial contact, lower
magnitude in the stance phase, sharp rise in
pre-swing phase before toe-off. Significant
small similarity appears in pre- and entire
swing phases.
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Similar pattern to left thigh x.

Similar pattern to left thigh y.

Sharp and delayed rise in initial
contact, lower magnitude in the
stance phase, higher magnitude in
the swing phase. Significant small
similarity appears in the terminal
swing phase.

Appendix VIII: Results of Multiple Sclerosis Patient 5 (MS5)

•

Description

Subject is a 45 year old male, was diagnosed with fairly mild multiple sclerosis in 2002.
He is on Copaxone for Relapsing-Remitting MS. The subject walked bare-foot on the
instrumented treadmill at speed of 0.75 m/s.
•

Temporal Stride Variability

Figure AVIII-1: Stride variability of a healthy subject and multiple sclerosis patient case 5 (MS-

5).
Summary: Although the MS5 had higher variability in all temporal stride variables compared

with healthy subject, the time during are very similar to the healthy which indicates the mild
symptoms of MS5. The increased variability appears constant throughout the three-minute
walking trial which also indicates the non- or mild symptom of functional fatigue in MS5
subject.
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•

Ground Reaction Forces

Figure AVIII-2: Right and left GRF in 3-D in MS-5.

Figure AVIII-3: Grade of similarity between right and left GRF in MS-5.
Summary: In the vertical direction, the GRF appears slightly smaller M shape of the ground

contact. There are smaller magnitudes of GRF in the anterior-posterior and mediolateral
directions in MS5 subject.
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•

EMG Muscle Activity Patterns

Figure AVIII-4: Comparison of EMG pattern in a gait cycle between able-bodied subjects and

MS-5.

Figure AVIII-5: Grade of similarity on right and left EMG in MS-5.
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Summary:
Table AVIII-1: Summary of EMG activity in MS-5
Right
Similar EMG pattern as the healthy
Soleus
subjects with higher similarity levels in
all gait phases.
Small spasticity appears in the loading
Tibialis
response and mid-swing phase. Small
Anterior
similarity appears in the terminal stance
(TA)
phase.
Spasticity appears in the early stance
Gastrocnemius phase.
Lateralis
(LG)

Vastus
Lateralis
(VL)
Rectus
Femoris
(RF)
Biceps
Femoris
(BF)
Gluteus
Medius
(Gmed)

Erector
Spinae
(ES)

Higher muscle activity appears in the
stance phase and terminal swing phase.
Significant small similarity appears in
pre- and initial swing phases.
Weakness appears in the initial contact,
spasticity appears late stance phase.
Significant small similarity appears preswing phase.
Spasticity appears in the stance phase.
Significant small similarity appears in the
terminal stance and pre-swing phases.
Muscle weakness appears in the initial
contact. Spasticity appears in the midstance and initial swing phases.
Significant small similarity appears in the
initial and mid-swing phases.
Higher muscle activity appear in the
transition event from stance to swing
phase, and late swing phase which
indicates some levels of adaptation for
instability gait.
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Left
Same as right soleus.

Similar to right TA, small
similarity appears in the preswing phase.
Spasticity appears in the initial
contact and terminal swing
phase. Significant small
similarity appears in mid- and
terminal swing phases.
Same as right VL.

Same as right RF with muscle
weakness in the terminal swing
phase. Significant small
similarity also appears in the
terminal swing.
Same as right BF.
Muscle weakness appears in the
initial contact. Spasticity appears
in the mid-stance phase.
Significant small similarity
appears in the initial and midswing phases.
Same as right ES, significant
small similarity appears in the
mid- and terminal swing phases.

•

Acceleration Patterns
(A)

(B)
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(C)

(D)

Figure AVIII-6: Comparison of acceleration pattern in a gait cycle between able-bodied

subjects and MS-5.
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Figure AVIII-7: Grade of similarity on right and left acceleration in MS-5.
Summary:
Table AVIII-2: Characterization of acceleration in MS-5
Right

Left

Foot x

There was an increased acceleration in swing
phase. Relatively small similarity appears in
initial swing phase.

There were general increased
magnitudes during the full gait
cycle. Relatively smaller similarity
appears in initial swing phase.

Foot y

The pattern of Fy was very similar to the
healthy subjects with high similarity through
the walking cycle.

Similar to right foot y except that
there was a little delayed
deceleration in terminal swing
phase which cause relatively small
similarity in that phase.

A sharp early rise occurs in the initial contact,
early and sharp rise also appears in the swing
phase. Smaller similarity appears in the midswing phase.

Similar to the right foot z. In
addition, there was a constant high
magnitude in the stance phase than
the right foot z and healthy

Foot z
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subjects.

Shank x

Shank y

Shank z

A lower acceleration appears in the initial
contact, following with a constant higher
magnitude in the rest of the stance phase, and
then the higher acceleration occurs in the swing
phase. Relatively small similarity appears in
mid-stance and initial swing phases.

Similar pattern to shank x, except
that there was a sharp rise in the
initial contact. The smallest
similarity appears in the midstance phase.

Sharp rise in initial contact, following with
lower magnitude during stance phase and the
most of the swing phase. Significant small
similarity appears in the mid-swing phase.

Similar pattern to shank y, except
there was a normal magnitude in
the mid-swing phase same as
healthy subjects compared with
right side, but much lower
magnitude in the terminal swing
phase.

Perfect matched pattern with healthy subjects,
there was only a little increased acceleration in
the initial contact.

Same as right shank z.

There was a sharp and delayed rise in initial
contact, instable magnitude throughout the
stance phase, following with an increased but
delayed acceleration in swing phase. Significant
small similarity appears in the terminal stance
phase.

There was a very early sharp rise
in the initial contact, following
with much lower magnitudes in
mid- and terminal stance phases,
and swing phase. Significant small
similarity appears in the terminal
stance phase.

Thigh y

Sharp deceleration in initial contact, early
increased acceleration in the pre-swing and an
early sharp deceleration in initial swing phase, a
slightly higher magnitude in swing phase.
Significant small similarity appears in initial
swing phase.

There was a sharp increased
acceleration in early stance phase,
following with inconstant and
relatively low magnitudes in the
rest of the cycle.

Thigh z

Sharp rise in initial contact, lower and instable
magnitude in the following gait cycle.
Significant small similarity appears in the
terminal swing phase.

Sharp rise in the early stance
phase, following with a instable
and slightly higher magnitude.

Hip x

There was instable and lower magnitude in the

There was a sharp deceleration in

Thigh x
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Hip y

Hip z

stance phase, following with early increased
acceleration in early swing phase, and then
lower magnitude in the terminal swing phase.
Significant small similarity appears in the midstance phase.

the early stance phase, lower
magnitude in the pre-swing phase,
and higher magnitude in the late
swing phase. Significant small
similarity appears in the pre-swing
phase.

Sharp deceleration in initial contact, following
the lower and instable magnitude in stance
phase. Relatively small similarity appears in the
initial swing phase.

There were relatively higher
magnitudes in the stance phase,
and a sharp rise in the initial swing
phase. There were modulate to
high similarity compared with
right hip y.

Sharp rise in initial contact, following with
instable lower magnitudes in the rest of the
cycle. Significant small similarity appears in the
terminal swing phase.

There was a sharp rise in the initial
contact following with a slightly
higher magnitude in the rest of the
stance phase.
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Appendix IX: Results of Multiple Sclerosis Patient 6 (MS6)

•

Description

Subject is a 29 year old male, a basketball player, was diagnosed with multiple sclerosis
in September 2009. He could walk without any assistive devices. By talking to this MS subject,
he complained that he was always feeling tired and having right leg tremor. Medication for
RRMS was Naltrexon, 4.5mg/day. Subject was tested with bare-foot walking on the
instrumented treadmill without any assistants continuing for three-minutes, at self-selective
speed of 0.5 m/s.
•

Temporal Stride Variability

Figure AIX-1: Stride variability of a healthy subject and multiple sclerosis patient case 6 (MS-

6).
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•

Ground Reaction Forces

Figure AIX-2: Right and left GRF in 3-D in MS-6.

Figure AIX-3: Grade of similarity on right and left GRF in MS-6.
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•

EMG Muscle Activity Patterns

Figure AIX-4: Comparison of EMG pattern in a gait cycle between able-bodied subjects and

MS-6.

Figure AIX-5: Grade of similarity on right and left EMG in MS-6.
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•

Acceleration Patterns
(A)

(B)
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(C)

(D)

Figure AIX-6: Comparison of acceleration pattern in a gait cycle between able-bodied subjects

and MS-6.
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Table AIX-1: Characterization of acceleration in MS-6
Right

Left

Foot x

There was a sharp rise in the initial contact,
delayed and reduced acceleration in swing
phase. Similarity was relatively high.

Foot y

Slightly increased acceleration in the initial
contact, delayed acceleration in the swing
phase. Similarity was relatively high.

Delayed acceleration after toe-off.
Similarity was relatively high.

Delayed acceleration in initial swing phase,
and smaller acceleration in terminal swing
phase. Similarity was relatively high.

Delayed and sharp rise in
acceleration in initial contact, and
sharp rise in acceleration in
terminal swing phase. Similarity
was relatively high.

Foot z

Same as right foot x.

Shank x

Sharp rise in initial contact, delayed and
reduced magnitude in the rest of the cycle.
Relatively small similarity appears almost
every phases.

Shank y

Sharp rise in initial contact, instable
acceleration during the stance phase.
Relatively small similarity appears in the
terminal swing phase.

Shank z

Sharp and increased acceleration in initial
contact, continue high level of acceleration
during stance phase, delayed deceleration on
toe-off and higher acceleration in terminal
swing. Relatively small similarity appears in
the mid-swing phase.

Thigh x

Sharp rise in initial contact, slightly lower
acceleration throughout the stance phase,
higher acceleration in swing phase. Relatively
small similarity appears in the mid-stance
phase.

Thigh y

Sharp and delayed deceleration in early stance
phase, lower acceleration during rest of the
stance phase, sharp increased acceleration in
Same as right thigh y.
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Same as right shank x.

Same as right shank y.

Same as right shank z.

Same as right thigh x.

terminal swing. Significant small similarity
appears in the pre-swing phase.

Thigh z

Sharp and delayed rise in initial contact,
lower acceleration in the rest of the stance
phase, sharp deceleration on toe-off, and
sharp increased in mid-swing phase.
Significant small similarity appears in the
initial swing phase.

Sharp and delayed rise in the
initial contact, sharp deceleration
after toe-off, and a sharp rise
acceleration in the swing phase.
Significant small similarity
appears in the terminal swing.

Hip x

Sharp and delayed rise in early stance phase,
dramatically decreased throughout the stance
phase, early lower acceleration in swing
phase, increased acceleration in terminal
swing. Significant small similarity appears in
the pre-swing phase.

Hip y

Sharp deceleration appears in early stance
phase, following with the lower magnitude in
the rest of the stance phase, delayed rise in
swing phase. Significant small similarity
appears in the initial swing phase.

Same as right hip y. Significant
small similarity appears in the
mid-stance phase.

Hip z

Sharp rise in initial contact, sharp reduction in
early single support, higher acceleration in
rest of the stance phase, much sharp
acceleration and deceleration in swing phase.
Significant small similarity appears in the
initial swing phase.

Sharp rise in the initial contact,
sharp deceleration in after toe-off.
Significant small similarity
appears in the initial swing phase.
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Same as right hip x.

Figure AIX-7: Grade of similarity on right and left acceleration in MS-6.
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Appendix X: Results of Cerebral Palsy Patient 1 (CP1)

•

Description

Subject is a 26 year old female with diplegic (both lower extremity) cerebral palsy,
community ambulatory. From the observation, she could walk without any assistant devices with
slower speed. Her gait is typically characterized by toe walking, a crouched gait with flexed
knees. She was tested during bare-foot walking on the instrumented treadmill for continuing
three minutes, at speed of 0.5 m/s.
•

Temporal Stride Variability

Figure AX-1: Stride variability of a healthy subject and female cerebral palsy patient case 1

(CP-1).
Analysis: CP-1 subject had increased variability in all temporal stride variables compared with

healthy subject. The increased variability appears constant throughout the three-minute walking
trial which also indicates the mild symptom of this patient. In addition, duration of her stance
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phase and swing phase were similar to healthy subject, only slightly increased stride time and
double stance phase in her gait.
•

Ground Reaction Forces

Figure AX-2: Right and left GRF in 3-D in CP-1.

Figure AX-3: Grade of similarity on right and left GRF in CP-1.
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Summary:

In vertical direction, CP-1 had slightly longer stance phase (left foot was slightly longer than the
right foot) than healthy subjects. She had only one shortened peak at the time around 30% of the
gait cycle which was about half time of the stance phase. In anterior-posterior direction, CP-1
shows lower GRF than healthy subjects. In the mediolateral direction, CP-1 had delayed rise of
GRF on right foot, but early sharp rise of GRF on left foot during the loading response.
•

EMG Muscle Activity Patterns

Figure AX-4: Comparison of EMG pattern in a gait cycle between able-bodied subjects and CP-

1.
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Figure AX-5: Grade of similarity on right and left EMG in CP-1.
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Summary:
Table AX-1: Summary of EMG activity in CP-1
Right

Soleus

Tibialis
Anterior
(TA)

Gastrocnemius
Lateralis (LG)

Spasticity appears in the initial contact until the
end of loading response. Muscle weakness starts
from the single support until the end of stance
phase. Spasticity occurs on toe-off time until the
cycle ends. This shows a completely opposite
EMG pattern of healthy subjects. Significant
small similarity occurs almost in every phase in
the cycle.
Muscle weakness appears in the initial contact to
the end of loading response. Spasticity appears
immediately when the single limb support starts,
until toe-off. Muscle weakness appears in the
entire swing phase. Again, this pattern shows
completely opposite EMG activity in healthy
patient. In addition, TA and Soleus are clear
agonist-antagonist muscle pair which can be seen
in this CP-1 patient’s EMG pattern, however, they
activated at wrong time compared with the
healthy subject, which can be explained why CP
patients has no heel contact, but toe-walk instead.
This complete wrong activities result in very low
similarity in CP-1.

Left

Same as right Soleus.

Same as right TA.

There were similar pattern showing in Soleus.

Same as right LG.

Vastus
Lateralis
(VL)

Weakness appears in the initial contact and
terminal swing, spasticity appears in the preswing phase until the end of mid-swing phase.
Significant small similarity appears in phase 4, 5,
and 6.

Same as right VL with
much smaller similarity
in all gait phases.

Rectus
Femoris

Weakness appears in the loading response,
spasticity appears after single support and

Same as right RF.
Significant small
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(RF)

Biceps
Femoris
(BF)

Gluteus
Medius
(Gmed)

Elector
Spinae
(ES)

continue until the end of mid-swing phase.
Weakness appears in the terminal swing phase.
Significant small similarity appears pre-and midswing phases.

similarity appears in
loading response and
terminal stance.

Muscle weakness appears in the initial contact,
following with spasticity in the mid-stance phase.
Weakness appears again in the terminal swing
phase. Significant small similarity appears in the
mid-stance and terminal swing phases.

Weakness appears in
the initial contact, and
terminal swing phase
which causes smaller
similarity in those
phases. Spasticity
appears in the initial
swing phase.

Muscle weakness appears in the loading response
until end of mid-stance phase. Spasticity appears
in terminal stance and entire swing phase.
Significant small similarity appears in initial and
mid-swing phases.

Same as right Gmed.
Significant small
similarity appears in
pre- and initial swing
phases.

Spasticity appears in the stance phase. Significant
small similarity appears in mid-stance and
terminal stance phases.
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Spasticity appears in
the stance phase, and
much higher activity in
initial swing phase.
Significant small
similarity appears in
the initial swing phase.

•

Acceleration Patterns
(A)

(B)
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(C)

(D)

Figure AX-6: Comparison of acceleration pattern in a gait cycle between able-bodied subjects

and CP-1.
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Figure AX-7: Grade of similarity on right and left acceleration in CP-1.

Summary:
Table AX-2: Characterization of acceleration in CP-1
Right

Left

Foot x

Sharp rise in the initial contact, following
with the lower magnitude throughout the
rest of the cycle. Significant small
similarity appears in the initial swing
phase.

Sharp rise in the initial contact, lower
acceleration in the terminal swing
phase. Significant small similarity
appears in terminal swing phase.

Foot y

Sharp rise in initial contact, continuing
with the high acceleration until toe-off.
Lower magnitude in the swing phase.
Significant small similarity appears in
terminal swing.

Foot z

Sharp rise in the initial contact, following
with the high acceleration before toe-off.
Lower and delayed acceleration in the
swing phase. Significant small similarity
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Same as right foot y.

Same as right foot z, significant small
similarity appears in the mid-swing
phase.

appears in the terminal stance phase.
Sharp rise in initial contact, early
deceleration appears in the end of the
stance phase, lower acceleration in the
swing phase. Small similarity appears in
the mid-swing phase.

Sharp rise in initial contact, following
with the high magnitude in the stance
phase, there was a small acceleration
at toe-off, lower acceleration appears
in the swing phase. Significant small
similarity appears in the mid-swing
phase.

Shank y

Sharp rise in initial contact, following
with high magnitude in the stance phase,
early deceleration in the pre-swing phase
which results in the small similarity at
that time.

High acceleration appears most of the
time in the full gait cycle. Small
similarity appears in the mid-stance
and mid-swing phases.

Shank z

Sharp rise in acceleration in initial
contact, following with the lower
magnitude throughout the rest of the
cycle. Significant small similarity appears
in the terminal swing phase.

Thigh x

Sharp rise in initial contact, continuing
with higher magnitude in the rest of
stance phase, a sharp rise in the initial
swing phase following with lower
magnitude in the late swing phase.
Significant small similarity appears in the
terminal stance and pre-swing phases.

Thigh y

Unstable but higher magnitudes
throughout the entire cycle. Significant
small similarity appears in the pre-swing
phase.

Thigh z

Sharp rise in initial contact, high
acceleration in stance phase, early
acceleration before toe-off. Significant
small similarity appears in the terminal
swing phase.

Shank x

Lower acceleration in the initial contact,
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Same as right shank z.

Sharp rise in the initial contact,
continuing with high magnitude in the
mid-stance phase. There were lower
magnitudes from the terminal swing
until the end of the cycle. Significant
small similarity appears in initial
swing and mid-swing phases.
Same as right thigh y.

Sharp and early rise in the initial
contact, higher acceleration in the
stance phase and terminal swing
phase. Significant small similarity
appears in the terminal swing phase.

Hip x

Hip y

Hip z

following with slightly higher
acceleration in the stance phase, lower
magnitude in the swing phase. Significant
small similarity appears in the loading
response.

Same as right hip x.

Sharp deceleration in the initial contact,
following with the lower magnitude in the
rest of stance phase and entire swing
phase. Small similarity appears in loading
response.

Lower magnitude in the initial contact,
following with high acceleration in the
single limb support, and then
decelerates in the terminal stance
phase, lower magnitude in the late
swing phase. Significant small
similarity appears in the pre- and
initial swing phases.

Sharp rise in initial contact, unstable
acceleration through the rest of the cycle.
Significant small similarity appears in the
terminal swing phase.

Same as right hip z. Significant small
similarity appears in the pre-swing
phase. This unstable pattern might be
the result from the hip deformity
(flexion contracture).
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Appendix XI: Results of Cerebral Palsy Patient 3 (CP3)

•

Description

Subject is 18 year old male with diplegic cerebral palsy (lower extremity). He had
bilateral knee flexion contracture (30 degrees on the right and 25 degrees on the left). Medication
was Botox (muscle relaxant) injection every six months. Subject walked bare-footed on the
instrumented treadmill with harness support, at speed of 0.3 m/s.
•

Temporal Stride Variability

Figure AXI-1: Stride variability of a healthy subject and a male cerebral palsy case 3 (CP-3).
Summary: Due to the slower walking speed of this CP-3 subject, there were only 80 strides

found within three-minute walking trial. The stride variability was increased slightly compared
with the healthy subject, this might be the effect of the harness support. The stance phase and
double-stance phase of this patient were much longer than the healthy, and his swing phase was
much shorter than the healthy.
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•

Ground Reaction Forces

Figure AXI-2: Right and left GRF in 3-D in CP-3.

Figure AXI-3: Grade of similarity between right and left GRF in CP-3.
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Summary:

In the vertical direction, the stance phase of CP-3 on both feet were much longer (80% of
the gait cycle) than healthy subjects. There was a typical shortened one peak in the stance phase
which was also shown in other CP patients. In anterior-posterior direction, there was much lower
GRF than healthy subjects, and same as in the mediolateral direction. Significant small similarity
appears in the mid-swing phase in vertical direction, and the entire cycle in the anterior-posterior
direction.

•

EMG Muscle Activity Patterns

Figure AXI-4: Comparison of EMG pattern in a gait cycle between able-bodied subjects and

CP-3.
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Figure AXI-5: Grade of similarity on right and left EMG in CP-3.
Summary:
Table AXI-1: Summary of EMG activity in CP-3
Right

Soleus

Tibialis
Anterior
(TA)

Left

Spasticity appears in the initial contact, and
continuing until end of the stance phase.
Significant small similarity appears in the initial
swing phase.

Muscle weakness appears in the entire stance
phase, spasticity occurs in the early swing phase. Same as right TA.
Significant small similarity appears in the loading
response and initial swing phase.

Spasticity appears in the initial contact, and
Gastrocnemius
continuing in the rest of the stance phase.
Lateralis
Significant small similarity in initial and mid(LG)
swing phases.
Vastus
Lateralis

Same as right Soleus,
significant small similarity
appears in the mid-swing
phase.

Weakness appears in the initial contact and
terminal swing, spasticity appears after single
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Same as right LG.

(VL)

support in the stance phase and early swing
phase. Significant small similarity appears in
phase 3~6.

Same as right VL.

Weakness appears in the initial contact, spasticity
appears after single support and continue until
the terminal swing. Significant small similarity
appears mid-swing phases.

Same as right RF.
Significant small similarity
appears pre-and initial
swing phases.

Biceps
Femoris
(BF)

Muscle weakness appears in the initial contact,
following with the spasticity until 40% of the gait
cycle. Spasticity appears again in the initial and
mid-swing phases. Significant small similarity
appears in the phase 2~6.

Muscle weakness appears
in the initial contact,
following with the
spasticity until 65% of the
gait cycle.

Gluteus
Medius
(Gmed)

Muscle weakness appears in the early stance
phase. Spasticity appears in the late swing phase.
This entire opposite pattern of healthy subjects
causes the significant small similarity appearing
in all phases in the gait cycle.

Elector
Spinae
(ES)

Spasticity appears in loading response.
Significant small similarity appears in pre- and
mid-swing phases.

Rectus
Femoris
(RF)
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Same as right Gmed.

Muscle weakness appears
in the initial contact.

•

Acceleration Patterns
(A)

(B)
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(C)

(D)

Figure AXI-6: Comparison of acceleration pattern in a gait cycle between able-bodied subjects

and CP-3.
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Figure AXI-7: Grade of similarity on right and left acceleration in CP-3.

Summary:
Table AXI-2: Characterization of acceleration in CP-3
Right

Foot x

Foot y

Foot z

Left

Sharp rise in the initial contact, following
with lower acceleration in the rest of the
cycle. Small similarity appears in the
terminal swing phase.
Sharp rise in initial contact, delayed
acceleration after toe-off. Small similarity
appears in the terminal swing phase.
Sharp rise in the initial contact, following
with the higher acceleration in the stance
phase. Significant small similarity appears
in the loading response.
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Sharp and delayed rise in the initial
contact, following with the higher
acceleration in the stance phase, and
lower acceleration in the swing
phase.
Same as right foot y.
Much delayed rise in the initial
contact following with high
acceleration in the stance phase.
Sharp rise in the terminal swing
phase.

Shank x

Sharp rise in initial contact, unstable
acceleration in the rest of the cycle, might
due to the bilateral knee flexion
contracture. Small similarity appears in the
mid-stance phase.

Delayed and sharp rise in initial
contact, following with unstable
acceleration in the rest of the cycle.
Small similarity appears in the midstance phase.

Shank y

Sharp rise in initial contact, unstable
acceleration in the rest of the cycle.

Same as right shank y.

Shank z

Sharp rise in acceleration in initial contact,
following with lower acceleration in the
rest of the cycle. Significant small
similarity appears in the mid- and terminal
swing phases.

Same as right shank z.

Sharp rise in initial contact, very unstable
acceleration pattern in the gait cycle.
Significant small similarity appears in the
pre- and initial swing phases.

Sharp rise in the initial contact,
following with lower acceleration in
the rest of the cycle. Significant small
similarity appears in the pre- and
initial swing phases.

Thigh y

Sharp and unstable acceleration in the
loading response, following with lower
magnitude in the rest of the stance phase.
Small similarity appears in pre-swing
phase.

Unstable acceleration appears in a
full gait cycle. Small similarity
appears in the pre-swing phase.

Thigh z

Sharp rise in initial contact, followed with
lower acceleration in the rest of the cycle.
Same as right thigh z.
Small similarity appears in the initial swing
phase.

Thigh x

Hip x

Hip y

Sharp deceleration in the initial contact,
followed with high acceleration in early
stance phase, and lower acceleration in the
swing phase. Significant small similarity
appears in the initial swing phase.
Lower acceleration in the initial contact,
following with unstable magnitudes in the
rest of the cycle, which indicate some
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Sharp increased acceleration in the
initial contact, followed with high
acceleration in the stance phase, and
high acceleration in the terminal
swing phase. Small similarity appears
in the mid-stance phase.
Same as right hip y.

levels of hip contractures.

Hip z

Sharp rise in initial contact, following with
unstable magnitude in the rest of the cycle.
Small similarity appears in initial swing
phase.
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Same as right hip z.

Appendix XII: Results of Cerebral Palsy Patient 4 (CP4)

•

Description

Subject is 55 year old male with right spastic hemiplegia due to cerebral palsy. He was
also diagnosed with epilepsy in 1966. Medication includes muscle relaxant Dantrolene sodium,
5mg per day. Subject was tested with bare-foot walking on the instrumented treadmill for
continuing three minutes, at speed of 0.45 m/s.
•

Temporal Stride Variability

Figure AXII-1: Stride variability of a healthy male subject and a cerebral palsy case 4 (CP-4).
Summary: Stride variability of CP-4 was increased compared with a healthy male subject. The

stance phase and double-stance phase were longer than healthy subject with much greater
fluctuations. The stride time was much longer than healthy subject, but gradually reduced which
showing some levels of fatigue.
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•

Ground Reaction Forces

Figure AXII-2: Right and left GRF in 3-D in CP-4.

Figure AXII-3: Grade of similarity on right and left GRF in CP-4.
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Summary: In vertical direction, CP-4 had slightly lower GRF with first peak higher than the

second peak pattern. The longer duration of the ground contact of CP-4 indicates the mild
symptoms of this subject compared with other three CP subjects. In anterior-posterior direction,
CP-4 had much lower GRF than healthy, but right leg showed more sever symptom than the left
leg which indicates the right leg was mostly affected. In mediolateral direction, there was a sharp
rise in GRF on the first peak on the right, whereas the lower GRF appeared in the full gait cycle
on the left.
•

EMG Muscle Activity Patterns

Figure AXII-4: Comparison of EMG pattern in a gait cycle between healthy subjects and CP-4.
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Figure AXII-5: Grade of similarity of right and left EMG in CP-4.

Summary:
Table AXII-1: Summary of EMG activity in CP-4
Right

Soleus

Tibialis
Anterior
(TA)

Left

Spasticity appears in the stance phase and
terminal swing phase. Significant small
similarity appears in loading response and
terminal swing phase.
Muscle weakness appears in the initial
contact, following with spasticity for the rest
of the cycle. Significant small similarity
appears in pre-swing phase.

Gastrocnemius Spasticity appears in the late stance phase.
Lateralis
Significant small similarity in initial swing
(LG)
phase.
Vastus

Slight spasticity appears in the terminal
stance and pre-swing phases. Significant
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Same as right Sol.
Significant small similarity
appears in initial and
terminal swing phases.
Same as right TA.

Same as right LG.
Similar to right VL, but with
much higher and elongated

Lateralis
(VL)

Rectus
Femoris
(RF)

Biceps
Femoris
(BF)

Gluteus
Medius
(Gmed)

Elector
Spinae
(ES)

small similarity appears in pre-swing and
initial swing phases.

muscle activities in stance
phase. Significant small
similarity appears in phase 3,
4, and 5.

Spasticity appears in the initial contact and
swing phase. Significant small similarity
appears mid-swing phase.

Spasticity appears all the
way of the gait cycle.
Significant small similarity
appears in pre-swing phase.

Spasticity appears in the stance phase,
following with muscle weakness in swing.
Significant small similarity appears in preand initial swing phases.

Muscle weakness appears in
the initial contact, and
spasticity appears in about
55% of the gait cycle, muscle
weakness appears in the late
swing phase.

Muscle weakness appears in the early stance
phase following with spasticity for the most
of the rest gait cycle. Significant small
similarity appears almost entire gait cycle.
Muscle weakness appears in initial contact,
spasticity appears in the terminal stance and
pre-swing phase. Significant small similarity
appears in the loading response and midstance.
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Same as right Gmed.

Spasticity appears from the
terminal stance to the end of
the gait cycle. Significant
small similarity appears in
mid-swing phase.

•

Acceleration Patterns
(A)

(B)
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(C)

(D)

Figure AXII-6: Comparison of acceleration pattern in a gait cycle between healthy subjects and

CP-4.
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Figure AXII-7: Grade of similarity of right and left acceleration in CP-4.

Summary:
Table AXII-2: Characterization of acceleration in CP-4
Right

Foot x

Foot y

Foot z

Left

Sharp rise in the initial contact, following
with high acceleration in stance phase, and
then much sharp deceleration on toe-off,
following with lower acceleration in swing
phase. Small similarity appears in the midswing phase.

Sharp rise in the initial contact,
following with slightly higher
acceleration in stance phase, and
sharp deceleration on toe-off,
following with slightly lower
acceleration in swing.

Lower acceleration in stance and toe-off,
sharp rise in early swing and sharp
deceleration in the late swing.

Sharp rise in the initial contact,
following with gradually reduced
magnitude in stance, and a sharp rise
in swing.

Lower magnitude in stance and sharp rise

A sharp rise in initial contact,
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in early swing and lower magnitude in late
swing.

following with slight higher
magnitude in the stance, a sharp rise
in early swing and lower magnitude
in late swing.

Shank x

Sharp rise in initial contact, following with
higher magnitude in stance, a sharp rise in
pre-swing. Significant small similarity
appears in initial and mid-swing.

Same as right shank x, in addition
with higher acceleration in swing
phase.

Shank y

Sharp and delayed rise in initial contact,
following with unstable high acceleration
during the stance phase.

Shank z

Sharp rise in initial contact, lower
acceleration on toe-off and terminal swing.

Same as right shank z.

Thigh x

Sharp rise in initial contact, slightly lower
and unstable acceleration throughout the
stance phase, unstable acceleration in
swing phase.

Sharp rise in initial contact, unstable
acceleration in stance phase and
swing phase.

Thigh y

Sharp rise in initial contact, following with
lower acceleration for the rest of the cycle.

Unstable with increased acceleration
in stance phase, higher acceleration in
swing phase.

Thigh z

Sharp rise in initial contact, lower
acceleration in stance and swing phase.

Sharp rise in initial contact, lower
acceleration in stance, a sharp rise in
swing.

Hip x

Sharp rise in initial contact, dramatically
decreased in early stance, an increased
acceleration in swing.

Sharp rise in initial contact, an
increased acceleration in terminal
stance and pre-swing phase, lower
magnitude in swing phase.

Hip y

Much unstable pattern appears in the gait
cycle.

Same as right hip y. Significant small
similarity appears in terminal stance.

Hip z

Sharp rise in initial contact, following with
higher acceleration in stance, and a sharp
rise in pre-swing phase, and an increased
acceleration in late swing phase.
Significant small similarity appears in

Sharp and delayed rise in initial
contact, sharp reduction in early
single support, higher acceleration
during rest of the stance phase, and a
sharp rise in mid-swing. Significant
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Same as right shank y.

initial swing phase.

small similarity appears in terminal
swing.

Note the CP-4 was diagnosed with diplegic cerebral palsy, the patterns of the acceleration shows
some levels of unsymmetrical with right leg sever affected.
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Appendix XIII: Results of Stroke Subject 1 with her 1st Visit (Stroke1_1)

•

Description

Subject is 37 year old female, was diagnosed as right hemiperatic stroke after her second
child was born. From the observation of her first visit to our lab, she was walking with right side
paralysis, including walking with left leg as base of support, wearing right ankle brace to protect
the foot-drop, dragging right foot gait, having difficulty with right hand activities such as lifting,
grasping, extending outward and lifting up the right arm. She also had speed problem. She was
tested with bare-foot walking on the instrumented treadmill with harness support at very slow
speed (0.1 m/s), continuing with three minutes trial.
•

Temporal Stride Variability

Figure AXIII-1: Stride variability of a healthy female subject and a female hemiparetic stroke

patient case 1 with her first visit.
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Summary: There were only 50 strides extracted from the Stroke-1 subject at her first visit due to

very slow speed of walking. She has slightly increased fluctuation, this might be the results of
partial body weight support by harness assistance. The stride time increased during the walking
which may indicate some fatigue. The double-stance phase was almost three-time greater than
healthy subject. The stance phase and swing phase were almost twice greater than the healthy
subject.
•

Ground Reaction Forces

Figure AXIII-2: Right and left GRF in 3-D in stroke patient 1 with her 1st visit.
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Figure AXIII-3: Grade of similarity between right and left GRF in stroke-1 with her 1st visit.

•

EMG Muscle Activity Patterns

Figure AXIII-4: Comparison of EMG activity in a gait cycle between healthy subjects and

stroke-1 with her 1st visit.
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Figure AXIII-5: Grade of similarity of right and left EMG in stroke-1 with her 1st visit.

•

Acceleration Patterns
(A)
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(B)

(C)
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(D)

Figure AXIII-6: Comparison of acceleration pattern in a gait cycle between healthy subjects and

stroke-1 subject with her 1st visit.

Figure AXIII-7: Grade of similarity of right and left acceleration in stroke-1 subject with her 1st

visit.
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Appendix XIV: Results of Stroke Subject 1 with her 2nd Visit (Stroke1_2)

•

Description

This is the same subject in appendix XI, but with her second visit after two months. By
talking to the subject, she had been through the hydro-physical therapy, three times a week, one
hour each time. She also did walking exercise overground without brace at home, 30 minutes per
day. From the observation of her overground walking, her gait has been improved dramatically.
Subject was walking bare-foot on the treadmill for continuing three-minute at speed of 0.5 m/s,
which was much faster than the first visit.
•

Temporal Stride Variability

Figure AXIV-1: Stride variability of a healthy female subject with a female stroke subject at her

second visit.
Summary: Stroke-1 subject at her second visit after two month of hydrotherapy treatment, has

showed much better gait dynamic. The walking speed was greatly increase, therefore, there were
100 strides found in her three-minute walking trial. The stride variability was slightly increased
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compared with the healthy subject. There was a sharp increased stance phase and a sharp
decreased swing phase at time around 42 strides, which the fall risk might occur at that time. The
double-stance phase was still greater than healthy subject almost twice of the length.
•

Ground Reaction Forces

Figure AXIV-2: Right and left GRF in 3-D in stroke-1 subject with her 2nd visit.

Figure AXIV-3: Grade of similarity between right and left GRF in stroke-1 subject at her 2nd

visit.
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•

EMG Muscle Activity Patterns

Figure AXIV-4: Comparison of EMG activity in a gait cycle between healthy subjects and

stroke-1 subject at her 2nd visit.

Figure AXIV-5: Grade of similarity of right and left EMG in stroke-1 with her 2nd visit.
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•

Acceleration Patterns
(A)

(B)

321

(C)

(D)

Figure AXIV-6: Comparison of acceleration pattern in a gait cycle between healthy subjects and

stroke-1 at her 2nd visit.
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Figure AXIV-7: Grade of similarity of right and left acceleration in stroke-1 at her 2nd visit.
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Appendix XV: Results of Stroke Patient 2 (Stroke2)

•

Description

Subject is a 53 year old female, was diagnosed with left-side hemiplegic stroke on
November 18, 2009. She was on physical therapy (walking over-ground and on the treadmill) at
the time point of the experiment, three times per week and one hour per time. By observation,
she had fairly mild symptom with left side hemiplegia. She did walk bare-footed on the treadmill
without any assistant devices at speed of 0.6 m/s. The ground reaction forces, EMG activities and
segment accelerations were recorded continually for three-minutes.
•

Temporal Stride Variability

Figure AXV-1: Stride variability of a healthy female and a female stroke subject case 2 (Stroke-

2).
Summary: The Stroke-2 subject showed quite consistent dynamic gait through the entire gait

cycle, with slightly increased fluctuation of stride variables. This indicates the stroke-2 had mild
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symptoms of the stroke compared with the stroke-1. There were slightly increased stance phase
and double-stance phase, and slightly decreased swing phase in stroke-2.
•

Ground Reaction Forces

Figure AXV-2: Right and left GRF in 3-D in Stroke-2.

Figure AXV-3: Grade of similarity between right and left GRF in Stroke-2.
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Summary:

In vertical direction, there was a sharp delayed first peak GRF in stroke-2, right foot was
apparent than the left. Her stance phase was slightly longer than the healthy subject, around 70 %
of the gait cycle. In anterior-posterior direction, there was lower GRF on both sides. In
mediolateral direction, there was much greater GRF on right side than the left side.

•

EMG Muscle Activity Patterns

Figure AXV-4: Comparison of EMG activity in a gait cycle between healthy subjects and

Stroke-2.
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Figure AXV-5: Grade of similarity of right and left EMG in Stroke-2.
Summary:
Table AXV-1: Summary of EMG activity in Stroke-2
Right

Soleus

Tibialis
Anterior (TA)

Gastrocnemius
Lateralis (LG)

Vastus
Lateralis (VL)

Slightly delayed activity results in the
smaller grade of similarity in initial
swing.
Higher activity appears in the initial
contact and swing phase, smaller
similarity appears in the pre-swing
phase.
Spasticity appears in the early stance
phase, but with muscle weakness in the
late stance phase. Significant small
similarity occurs in the initial contact,
terminal stance, pre- and initial swing,
and terminal swing phases.
Delayed but longer muscle activity in
the initial contact following with the
lower muscle activity along the rest of
the cycle. Significant small similarity
appears in the pre-swing phase.
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Left
Higher and unstable muscle
activity in the stance phase,
smaller similarity appears in the
initial swing.
Muscle weakness appears in the
initial contact, but higher activity
occurs in the early swing phase.

Latten muscle activity in the
stance phase. Smaller similarity
appears in the initial and
terminal swing phases.

Similar to right VL, smaller
similarity appears in the midswing phase.

Rectus
Femoris (RF)

Biceps
Femoris (BF)

Gluteus
Medius (Gmed)

Elector
Spinae (ES)

Muscle weakness occurs in the early
stance phase, spasticity appears in the
swing phase. Significant small similarity
appears in the mid-stance, terminal
stance, and mid-swing phases.
Spasticity appears in the early stance
phase. Significant small similarity
appears in the initial swing phase.
Muscle weakness occurs in the initial
contact, following with spasticity in the
mid-stance phase and late swing phase.
Smaller similarity appears in the preswing phase.
Spasticity appears in the initial contact
and initial swing phase. Smaller
similarity appears in the initial swing
phase.

Muscle spasticity appears in the
initial contact and early swing
phase.
Significant small similarity
appears in the pre- and midswing phases.
Similar to right BF, significant
small similarity appears in the
pre- and initial swing phases.
Muscle spasticity appears in the
mid-stance phase and early
swing phase.

Similar to right ES.

Note: Different muscle activities between right and left show typical hemiplegic symptoms of
the stroke.
•

Acceleration Patterns
(A)
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(B)

(C)

329

(D)

Figure AXV-6: Comparison of acceleration pattern in the gait cycle between healthy subjects

and Stroke-2.

Figure AXV-7: Grade of similarity of right and left acceleration in Stroke-2.
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Summary:
Table AXV-2: Characterization of acceleration in Stroke-2

Foot x

Foot y

Foot z

Shank x

Shank y

Shank z

Thigh x

Thigh y

Right
Peak rise in the initial contact following
with higher magnitude in the entire gait
cycle. There are modulate and high
similarity within the gait cycle.
There is a delayed foot clearance in the
pre-swing phase. High similarity appears in
the entire gait cycle.
Sharp acceleration appears in the initial
contact following with the high magnitude
in the stance phase, delayed acceleration in
the swing phase. Modulate similarities
appear in the entire gait cycle.
Sharp acceleration appears in the initial
contact following with the unstable
magnitude in the rest of the stance phase,
delayed and lower acceleration appears in
the mid-swing phase. Significant small
similarity appears in the mid-swing phase.

Higher unstable acceleration appears in the
stance phase, lower acceleration occurs in
the swing phase. Significant small
similarity appears in the mid-swing phase.
Sharp rise in acceleration appears in the
initial contact, delayed and lower
acceleration in the swing phase. Modulate
and high similarities occur in the entire gait
cycle.
Higher magnitude appears in the early
stance phase, following with lower
magnitude in the late stance phase. There
are sharp rise in acceleration in the swing
phase.
There is very unstable pattern of
acceleration in this direction results in
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Left
Lower acceleration in the early stance
phase, and there is a sharp rise in the
pre-swing phase.

Sharp acceleration appears in the
initial contact, delayed acceleration in
the initial swing phase.
Similar to foot z.

Lower acceleration appears in initial
contact and continues to the preswing phase. There is a sharp
increased acceleration in the late
swing phase. Significant small
similarity appears in the pre-swing
phase.
Similar to right shank y, but with
lower magnitude in late stance phase.

Similar to right shank z.

Similar patterns to right thigh x.

Similar to right thigh y.

significant small similarity appears in the
terminal stance and pre-swing phases.
A sharp rise in acceleration appears in the
initial contact, following with lower
acceleration in the rest of the gait cycle.
Thigh z

Hip x

Hip y

Hip z

Higher magnitude in the early stance phase
following with the lower magnitude in the
late stance, there is a sharp rise in the
acceleration in the early swing phase.
Significant small similarity appears in the
pre-swing phase.
A sharp deceleration appears in the loading
response, following with the lower
magnitude in the stance phase. There is a
delayed acceleration in the swing phase.
Smaller similarity appears in the terminal
stance phase.
A sharp rise in acceleration appears in the
initial contact, following with higher
magnitude in the rest of the stance phase,
there is a sharp rise in acceleration in the
swing phase.
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A sharp rise in acceleration appears
in the initial contact, following with
unstable accelerations in the rest of
the stance phase, there is a sharp
deceleration in the pre-swing phase
and a sharp acceleration in the midswing phase. Significant small
similarity appears in the initial swing
phase.
Similar to right hip x.

There is a very unstable pattern of
acceleration in the stance phase, and
a sharp rise in acceleration in the
swing phase.

Similar to the right hip z. Significant
small similarity appears in the swing
phase.

Appendix XVI: Results of Spinal Cord Injury (SCI)

•

Description

Subject is 48 year old male with a long history of intractable partial epilepsy. Several
years ago he fell as a result of a sudden seizure and fractured his cervical spine. With this he
sustained a so called Brown-Sequard syndrome (partial hemisection of the spinal cord). From the
observation of his gait, he was walking with right leg dragging and using the left leg as base of
the support and pushing away to the right.
•

Temporal Stride Variability

Figure AXVI-1: Stride variability of a healthy male subject and a male patient with spinal cord

injury (SCI).

Summary: There is increased stride variability in all stride variables, compared with the healthy

subject. There is a significant large fluctuation in stance phase and double-stance phase in SCI.
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•

Ground Reaction Forces

Figure AXVI-2: Right and left GRF in 3-D in Spinal Cord Injury subject.

Figure AXVI-3: Grade of similarity of right and left GRF in Spinal Cord Injury subject.
Summary: In the vertical direction, the behavior of the grand reaction force of SCI subject is

perfectly matched to averaged healthy subjects, having those smooth ‘M-shape’ pattern, which
indicates the mild symptoms of this subject. The left foot GRF has slightly longer ground
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contacting time than the right foot, which tells us the more server symptoms on the right side. In
the anterior-posterior direction, there is lower GRF on the right side. In the mediolateral
direction, there is higher GRF on the left side which indicates some levels of composition
mechanisms. The similarity analysis shows this SCI subject has very mild gait problems.

•

EMG Muscle Activity Patterns

Figure AXVI-4: Comparison of EMG activity in a full gait cycle between healthy subjects and

Spinal Cord Injury subject.
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Figure AXVI-5: Grade of similarity of right and left EMG activity in Spinal Cord Injury subject.

Summary:
Table AXVI-1: Summary of EMG Activity in Spinal Cord Injury Case Study

Soleus

Right
Spasticity appears in the entire stance phase.
Significant small similarity appears in the
initial contact and terminal swing phase.

Spasticity appears in the initial contact and
early swing phase. Significant small
similarity appears in the terminal stance and
pre-swing phases.
Muscle weakness appears in the stance phase,
Gastrocnemius
spasticity occurs in the early swing phase.
Lateralis
Significant small similarity appears in the
(LG)
mid-swing phase.
Vastus
Spasticity appears in the early swing phase.
Lateralis
Significant small similarity appears in the
(VL)
initial and mid-swing phases.
Rectus
Delayed muscle activity occurs in the loading
Femoris
response, and muscle spasticity occurs in the
Tibialis
Anterior
(TA)
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Left
Similar to right soleus,
significant small similarity
appears in the initial swing
phase.

Similar to right TA. Significant
small similarity appears in the
terminal stance phase.
Muscle weakness appears in
the mid-stance phase.
Spasticity appears in the midstance phase.
Spasticity appears in the entire
stance phase and early swing

(RF)

Biceps
Femoris
(BF)
Gluteus
Medius
(Gmed)
Elector
Spinae
(ES)

•

mid-swing phase. Significant small similarity
appears in the mid-swing phase.
Spasticity appears in the loading response,
pre-swing, and terminal swing phases.
Significant small similarity appears in the
terminal stance, pre-swing and initial swing
phases.

phase. Significant small
similarity appears in the midswing phase.
Spasticity appears in the entire
stance phase. Significant small
similarity appears in the
terminal stance and pre-swing
phases.

Spasticity appears in the loading response.

Similar to right Gmed.

Muscle weakness appears in the loading
response, spasticity appears in the pre-swing
and entire swing phases.

Spasticity appears in the initial
contact, spasticity appears in
the swing phase.

Acceleration Patterns
(A)
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(B)

(C)
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(D)

Figure AXVI-6: Comparison of acceleration pattern in a full gait cycle between healthy subjects

and Spinal Cord Injury subject.

Figure AXVI-7: Grade of similarity of right and left acceleration in Spinal Cord Injury subject.
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Summary:
Table AXVI-2: Characterization of acceleration in Spinal Cord Injury Case Study

Foot x

Foot y

Foot z

Shank x

Shank y

Shank z

Right
A sharp rise in acceleration in the initial
contact, following with high magnitude in
the rest of the gait cycle. Smaller similarity
appears in the mid-swing phase.
Lower acceleration occurs in the loading
response and the rest of the stance phase.
There is no deceleration at foot clearance
which indicates the gait problems on the
right foot. Smaller similarity appears in the
terminal swing phase.
Early deceleration appears in the early
stance phase, following with lower
magnitude in the rest of the stance, a sharp
rise in acceleration in the initial swing
phase, and a lower acceleration appears in
the terminal swing phase. Smaller
similarity appears in the terminal swing
phase.
A sharp rise in acceleration appears in the
initial contact, following with the lower
magnitude in mid-stance phase, higher
acceleration appears in the swing phase.
Smaller similarity appears in the terminal
stance phase.
A sharp deceleration appears in the loading
response, following with a sharp rise in the
acceleration, and continues with higher
magnitude in the rest of the gait cycle.
Significant small similarity appears in the
mid-swing phase.
A sharp rise in acceleration in the initial
contact, following with a sharp
deceleration, lower acceleration appears in
the swing phase. Smaller similarity appears
in the mid-swing phase.
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Left

Similar to foot x.

Lower acceleration occurs in the
loading response and lower magnitude
in the stance phase, slightly delayed
acceleration appears in the initial swing
phase.
Delayed acceleration appears in the
loading response, following with the
higher magnitude in the rest of the
stance phase, a sharp rise in
acceleration in early swing phase, and
lower acceleration in the terminal
swing phase.
A sharp rise in acceleration in the
initial contact, following with a sharp
deceleration, an increased acceleration
appears in the stance phase, and a sharp
rise in acceleration appears in the
swing phase.
Same as right shank y.

Similar to right shank z.

Thigh x

Thigh y
Thigh z

Hip x

Hip y

Hip z

Lower acceleration appears in the stance
phase, a sharp rise in acceleration in initial
swing phase. Smaller similarity appears in
the pre-swing phase.

A delayed deceleration in the loading
response, following with unstable behavior
of acceleration pattern.
A sharp rise in acceleration in the loading
response and pre-swing phase.
A sharp deceleration appears in the initial
contact, following with very unstable
pattern of signal, and an increased
acceleration in the swing phase. Smaller
similarity appears in the terminal stance
phase.
A sharp deceleration in the initial contact,
and lower acceleration in the initial swing
phase. Smaller similarity appears in the
initial swing phase.
A sharp rise in acceleration appears in the
initial contact, following with a large
deceleration, and a sharp acceleration
appears in the pre-swing phase. Smaller
similarity appears in the terminal stance
phase.
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A sharp rise in acceleration in the
initial contact, following with a sharp
deceleration, and continues with lower
magnitude in the stance phase, a sharp
rise in the initial swing phase.
Significant small similarity appears in
the mid-stance phase.
Similar to right thigh y.
Similar pattern to right thigh z.

Same as right hip x.

Same as right hip y.

A sharp rise in acceleration appears in
the initial contact, following with a
large deceleration in the stance phase.
Significant small similarity appears in
the terminal swing phase.

Appendix XVII: Results of Traumatic Brain Injury (TBI)

•

Description

Subject is 35 year old male who had a car accident in December 23, 2009. He was in
coma for three weeks in the hospital. He was on physical rehabilitation eight hours everyday.
Medication includes abilify (aripiprazole) for depression and anxious. He was tested at the freewalking speed (0.75 m/s) on the instrumented treadmill without any assistant devices.
•

Temporal Stride Variability

Figure AXVII-1: Comparison of stride variability between a healthy male subject and a male

with Traumatic Brain Injury (TBI).

Summary: TBI subject has much increased stride variability in all stride variables. There is and

increase in the stride time, stance phase, and double-stance phase, and decrease in swing phase.
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•

Ground Reaction Forces

Figure AXVII-2: Right and left GRF in 3-D in Traumatic Brain Injury subject.

Figure AXVII-3: Grade of similarity between right and left GRF in TBI subject.
Summary: In the vertical direction, the TBI has slightly longer stance phase with delayed for the

first peak and lower GRF in the second peak. In the anterioposterior direction, there is lower
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GRF with TBI. In the mediolateral direction, there is unstable GRF signal in TBI. Smaller
similarity appears mostly in the pre- and mid-swing phases in the vertical and anterioposterior
directions.
•

EMG Muscle Activity Patterns

Figure AXVII-4: Comparison of EMG activity in a gait cycle between healthy subjects and TBI.

Figure AXVII-5: Grade of similarity of right and left EMG in TBI.
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Summary:
Table AXVII-1: Summary of EMG Activity in Traumatic Brain Injury Case Study
Right
Muscle activities almost follow the pattern of
Soleus
the healthy. Modulate and high grade of
similarity appear in the entire gait cycle.
Spasticity occurs in the most of the stance
Tibialis
phase and early swing phase. Significant
Anterior
small similarity appears in the mid- and
(TA)
terminal stance phases.
There are some higher muscle activities in the
Gastrocnemius
early stance phase.
Lateralis
(LG)

Vastus
Lateralis
(VL)

Rectus
Femoris
(RF)
Biceps
Femoris
(BF)
Gluteus
Medius
(Gmed)
Elector
Spinae
(ES)

Left

Same as right Soleus.
Early activity appears in the preswing phase. Significant small
similarity appears in the pre-swing
phase.
There are some higher muscle
activities in the stance phase and
mid-swing phase. Significant small
similarity appears in the mid-swing.

Spasticity occurs the entire stance phase, and
terminal swing phase. Significant small
similarity appears in the terminal stance and
pre-swing phases.
Spasticity occurs in the early stance phase up
to 40% of the gait cycle, and slightly higher
activity in the terminal swing phase. Smaller
similarity appears in the terminal stance
phase.
Spasticity occurs in the mid-stance and
terminal swing phases. Significant small
similarity appears in the terminal stance, preand initial swing phases.
Spasticity occurs in the early stance and late
swing phases. Smaller similarity appears in
the initial swing phase.

Spasticity occurs in the early stance
phase up to 30% of the gait cycle,
and spasticity occurs again in the
pre-swing phase. Smaller similarity
appears in the pre-swing phase.
Spasticity occurs in the late swing
phase. Smaller similarity appears in
the mid-swing phase.

Higher muscle activities occur after midstance phase to the end of the gait cycle.
Significant small similarity appears in the
mid-swing phase.

Spasticity occurs in the pre-swing
phase.
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Similar to right VL.

Spasticity occurs in the initial
contact and most of the swing phase.
Significant small similarity appears
in the pre- and initial swing phases.

•

Acceleration Patterns
(A)

(B)
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(C)

(D)

Figure AXVII-6: Comparison of acceleration pattern in a gait cycle between healthy subjects

and TBI subject.
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Figure AXVII-7: Grade of similarity of right and left acceleration in TBI.
Summary:
Table AXVII-2: Characterization of acceleration in Traumatic Brain Injury Case Study
Right

Foot x

Foot y
Foot z
Shank x

A sharp rise in acceleration in the initial
contact, following with higher magnitude
in the rest of the stance phase and early
swing phase.

A sharp rise in acceleration in the initial
contact, foot clearance problem in the
initial swing phase.
Unstable behavior occurs in the early
stance phase.
A sharp rise in acceleration in the initial
contact, following with lower magnitude in
the stance phase. There is a sharp turning
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Left
A sharp rise in acceleration in the
initial contact, following with a large
deceleration, and continues with lower
magnitude in the rest of the stance, a
large deceleration occurs in the initial
swing phase, following with a sharp
rise in acceleration in the mid-swing
phase. Smaller similarity appears in the
mid-swing phase.

Same as right foot y.
Same as right foot z.

Same as right shank x.

Shank y

Shank z

Thigh x

Thigh y

Thigh z

Hip x

Hip y

Hip z

pattern in the initial swing, following with
a lower acceleration in the swing phase.
Smaller similarity appears in the midswing phase.
A sharp rise in acceleration in the initial
contact, following with unstable lower
magnitude in the stance phase, a lower
acceleration occurs in the swing phase.
Significant small similarity appears in the
terminal swing phase.
There is a very much matched pattern to
healthy subjects, results in the high grade
of similarity among the full gait cycle.
A sharp rise in acceleration occurs in the
initial contact, lower magnitude in the rest
of the stance phase, unstable magnitude in
the swing phase. Smaller similarity appears
in the terminal stance and pre-swing.
Some levels of unstable pattern appear in
the entire gait cycle.
A sharp rise in acceleration in the initial
contact, lower magnitude in the stance
phase, an increased acceleration occurs in
the swing initial swing phase. Smaller
similarity appears in the terminal swing.
Higher acceleration appears in the early
stance phase, lower acceleration occurs in
the initial swing phase. Significant small
similarity appears in the initial swing.
Higher deceleration appears in the stance
phase and initial swing phase.
A sharp rise in acceleration appears in the
initial contact, following with unstable
magnitude in the stance phase, a sharp rise
in the initial swing phase. Significant small
similarity appears in the terminal swing
phase.
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Same as right shank y.

Same as right shank z.
Very unstable pattern in the stance
phase, a sharp rise in acceleration in
initial swing phase, following with
unstable magnitude in the rest of the
swing phase.
A sharp rise in acceleration occurs in
the loading response, following with
unstable signals in the rest of the cycle.
Similar to right thigh z.

Unstable pattern appears in the early
stance phase, a sharp rise in
acceleration occurs in the pre-swing
phase.
Similar to right hip y. Smaller
similarity appears in the pre-swing
phase.
A sharp rise in acceleration appears in
the initial contact, following with low
and unstable magnitude in the rest of
the gait cycle. Smaller similarity
appears in the initial swing phase.

Appendix XVIII: Results of Elderly Faller

•

Description

Subject is 76 year old elderly male, had a slow moderately disorganized gait related to
probable fat embolism after a fall from a roof several years ago with hip/femur fractures. He also
had very strong diabetes. Subject was tested with bare-foot walking on the treadmill with harness
support at speed of 0.3 m/s.
•

Temporal Stride Variability

Figure AXVIII-1: Stride variability of a healthy male subject and an elderly faller subject.

Summary: Due to the slower treadmill walking speed, there were only 80 strides extracted from

this elderly faller subject. The subject has increased both in magnitude and variability, in stride
time, stance phase, and double-stance phase; and decreased magnitude in swing phase.
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•

Ground Reaction Forces

Figure AXVIII-2: Right and left GRF in 3-D in an elderly faller patient.

Figure AXVIII-3: Grade of similarity between right and left GRF in elderly faller patient.
Summary: In the vertical direction, there is a longer stance phase on both side (right foot is

longer than left foot, suggest that the affected side was left); there is also shortened peak time
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duration in the elderly faller subject. In the anterioposterior direction, there is much lower GRF
compared with healthy subject. In the mediolateral direction, there is delayed and lower gradient
in the early stance phase, especially showing on left foot. The grade similarity analysis showing
the most gait problems in GRF appear in the anteioposterior direction.

•

EMG Muscle Activity Patterns

Figure AXVIII-4: Comparison of EMG activity in a gait cycle between healthy subjects and an

elderly faller.
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Figure AXVIII-5: Grade of similarity of right and left EMG in an elderly faller subject.

Summary:
Table AXVIII-1: Summary of EMG Activity in Elderly Faller Case Study

Soleus
Tibialis
Anterior
(TA)

Right
Spasticity occurs in the mid-stance phase and
terminal swing phase. Smaller similarity
occurs in the terminal swing phase.
Muscle weakness appears in the initial
contact, and spasticity appears in swing
phase. Significant small similarity appears in
the initial swing phase.

Left
Higher and latency muscle activity in
the stance phase, and spasticity
occurs in the terminal swing phase.
Similar to right TA. Smaller
similarity appears in the pre-swing
phase.

Spasticity appears in the stance
Spasticity occurs in the early stance,
phase up to 30% of the gait cycle.
Gastrocnemius following with muscle weakness in the late
Muscle weakness occurs in the rest
Lateralis
stance, spasticity occurs in the pre-swing
of the stance phase. Spasticity occurs
(LG)
phase. Significant small similarity occurs in
in the terminal swing phase.
the initial swing phase.
Significant small similarity appears
in the terminal swing phase.
There is very unstable muscle activity pattern Spasticity occurs from mid-stance
Vastus
throughout the gait cycle. Significant small
phase to the end of the stance which
Lateralis
similarity appears in the pre- and initial swing results in the significant small
(VL)
phases.
similarity in the pre- and initial
swing phases.
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Rectus
Femoris
(RF)
Biceps
Femoris
(BF)

Unstable muscle activity pattern throughout
the entire gait cycle. Spasticity occurs in the
late stance and swing phases. Significant
small similarity appears in the initial and
mid-swing phases.

Spasticity occurs from mid-stance to
the end of the stance phase.
Spasticity occurs in the mid-swing
phase. Significant small similarity
appears in the mid-stance and midswing phases.

Spasticity occurs in the entire stance phase.
Significant small similarity appears in the
terminal stance, pre- and initial swing phases.

Same as right BF.

Gluteus
Medius
(Gmed)

Spasticity occurs in the stance phase.
Significant small similarity appears in the
pre-swing phase.

Delayed muscle activity in the initial
contact, following with spasticity in
the stance phase. Significant small
similarity appears in the pre-swing
phase.

Elector
Spinae
(ES)

Spasticity appears in the entire gait cycle.
Significant small similarity appears in the
mid- and terminal stance phases, and midswing phase.

•

Acceleration Patterns
(A)
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Same as right ES.

(B)

(C)
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(D)

Figure AXVIII-6: Comparison of acceleration pattern in a gait cycle between healthy subjects

and an elderly faller subject.

Figure AXVIII-7: Grade of similarity of right and left acceleration in elderly faller subject.
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Summary:
Table AXVIII-2: Characterization of acceleration in Elderly Faller Case Study

Foot x

Foot y

Foot z

Shank x

Shank y

Shank z

Thigh x

Right
A sharp rise in acceleration in the initial
contact, lower magnitude in the stance
phase, lower acceleration in the swing
phase.
Lower acceleration occurs in the initial
contact following with lower magnitude in
the rest of the stance phase, a delayed rise
in acceleration in the swing phase.
A sharp rise in acceleration in the loading
response following with higher magnitude
in the rest of the stance phase, delayed
acceleration occurs in the initial swing
phase.
A sharp rise in acceleration in initial
contact, following with lower magnitude in
the rest of the stance phase, lower
acceleration occurs in the swing phase.
Significant small similarity appears almost
the entire gait cycle.
A sharp rise in acceleration in initial
contact, following with unstable magnitude
in the rest of the stance phase, a delayed
and sharp deceleration occurs in the swing
phase
A sharp rise in acceleration in the initial
contact following with higher magnitude in
the stance phase, delayed deceleration and
acceleration in the swing phase. Significant
small similarity appears in the mid-swing
phase.
A sharp rise in acceleration in initial
contact, following with unstable magnitude
in the rest of stance phase. Unstable signals
appear in swing phase. Significant small
similarity appears in terminal stance phase.
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Left
Same as right foot x. Significant small
similarity appears in the mid-swing
phase.

A sharp rise in acceleration occurs in
the initial contact, delayed acceleration
in the swing phase.
A sharp deceleration in the initial
swing phase following with a sharp rise
in acceleration in the mid-swing phase.

Same as right shank x.

Same as right shank y.

Similar to right shank z.

Same as right thigh x.

Thigh y

Thigh z

Hip x

Hip y

Hip z

A sharp deceleration occurs in the loading
response, following with very unstable
magnitude in the rest of the gait cycle.
Smaller similarity appears in the initial
swing phase.
A sharp rise in acceleration occurs in initial
contact, lower magnitude in the rest of the
gait cycle.
A delayed deceleration occurs in the
loading response, following with lower
magnitude in the stance phase, a sharp rise
in acceleration in the swing phase.
Significant small similarity appears in
terminal stance phase.
A sharp deceleration occurs in the initial
contact, following with lower magnitude in
the rest of the stance phase. A delayed
acceleration in the initial swing phase.
Significant small similarity appears in the
pre-swing phase.
A sharp rise in acceleration occurs in the
initial contact, following with higher
magnitude in the rest of the stance phase,
lower acceleration occurs in the swing
phase.
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Similar to right thigh y.

A sharp rise in acceleration occurs in
initial contact, following with unstable
magnitude in the stance phase, lower
acceleration in initial swing phase.
Similar to right hip x.

Similar to right hip y, with unstable
magnitude in the stance phase.

Similar to right hip z, with more
unstable magnitude in the stance phase.
Smaller similarity appears in the
terminal swing phase.

Appendix XIX: Results of Idiopathic Neurological Disorder (IND)

•

Description

Subject is 58 year old female with idiopathic neurologic disorder for almost twenty years.
Since then she sits in a wheelchair. She was tested by walking bare-footed on the instrumented
treadmill with harness support at speed of 0.1 m/s, continuing three minutes.
•

Temporal Stride Variability

Figure AXIX-1: Stride variability of a healthy female subject and a female patient with
idiopathic neurologic disorder (IND).
Summary: Due to very slow walking speed of this IND subject, there were only 40 strides

extracted from three-minute walking trial. The subject has greater variability at the time of 20
strides, which indicates there might be some fall risk at that time. The stride time, stance phase,
and double-stance phase are much longer than healthy subject, whereas the swing phase is much
shorter.
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•

Ground Reaction Forces

Figure AXIX-2: Right and left GRF in 3-D in female patient with idiopathic neurologic disorder

(IND).

Figure AXIX-3: Grade of similarity between right and left GRF in idiopathic neurologic

disorder case study.
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Summary: In the vertical direction, the subject has much longer stance phase (more than 90% of

the full gait cycle) on both sides, compared with the healthy subject. The magnitudes of the GRF
in this direction are also quite low with shorten peak contact. In the anterioposteior and
mediolateral directions, the GRF was very low. The behavior of her GRF in three dimensions
shows the sever gait problems which results in the low to very low grade of similarity.

•

EMG Muscle Activity Patterns

Figure AXIX-4: Comparison of EMG activity in a gait cycle between healthy subjects and IND.
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Figure AXIX-5: Grade of similarity of right and left EMG in IND subject.
Summary:
Table AXIX-1: Summary of EMG Activity in Idiopathic Neurologic Disorder Case Study
Right
Spasticity occurs in the loading response,
following with very unstable muscle
activities in the rest of the gait cycle.
Soleus
Significant small similarity appears in the
initial contact, mid- and terminal swing
phases.
Muscle weakness occurs in the early stance
Tibialis
phase and early swing phase, there is
Anterior
spasticity in the terminal swing phase.
(TA)
Significant small similarity appears in the
initial and mid-swing phases.
Spasticity occurs in the loading response,
following with very unstable muscle
Gastrocnemius
activities in the rest of the gait cycle. There is
Lateralis
spasticity in the late swing phase. Significant
(LG)
small similarity appears in the terminal stance
and terminal swing phases.
Spasticity occurs in the late stance phase,
Vastus
muscle weakness occurs in the terminal
Lateralis
swing phase. Significant small similarity
(VL)
appears from mid-stance to the end of the gait
cycle.
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Left

Same as right Soleus.

Same as right TA.

Spasticity occurs in the loading
response, following with muscle
weakness in the rest of the stance
phase.

Same as right VL.

Rectus
Femoris
(RF)

Biceps
Femoris
(BF)

Gluteus
Medius
(Gmed)
Elector
Spinae
(ES)

•

Spasticity occurs in the stance phase, muscle
weakness occurs in the terminal swing phase.
Significant small similarity appears in the
terminal stance and pre-swing phases.
Spasticity occurs from loading response to
mid-swing phases. Muscle weakness appears
in the terminal swing phase, which in fact
was the entire swing phase in this subject.
Significant small similarity appears in the
initial swing phase.
Muscle weakness occurs in the early stance
phase, spasticity occurs in the terminal stance
phase with very unstable muscle activities.
Significant small similarity appears in the
pre-swing phase.
Spasticity occurs in the early stance phase
and late swing phase. The very unstable
muscle activities occur in the entire gait
cycle.

Acceleration Patterns
(A)
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Same as right RF.

Same as right BF.

Same as right Gmed.

Same as right ES.

(B)

(C)
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(D)

Figure AXIX-6: Comparison of acceleration pattern in a gait cycle between healthy subjects and

idiopathic neurologic disorder patient (IND).

Figure AXIX-7: Grade of similarity of right and left acceleration in idiopathic neurologic

disorder (IND).
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Summary:
Table AXIX-2: Characterization of acceleration in Idiopathic Neurologic Disorder Patient

Foot x

Foot y

Foot z

Shank x

Shank y

Shank z

Thigh x

Thigh y

Right
A sharp rise in acceleration occurs in the
initial contact, following with a very low
magnitude in the rest of the gait cycle.
Lower acceleration occurs in the initial
contact following with the lower
magnitude in the rest of the stance phase,
there is a sharp rise in acceleration in the
swing phase.
There are low to very low acceleration in
the entire gait cycle. Significant small
similarity appear sin the initial swing
phase.
A sharp rise in acceleration in the initial
contact following with lower magnitude in
the rest of stance and swing phases.
Significant small similarity appears in the
mid-swing phase.
A sharp rise in acceleration in the initial
contact, following with very high
magnitude in the stance phase, there is a
much delayed deceleration in the swing
phase. Significant small similarity appears
in the mid-swing phase.
A sharp rise in acceleration occurs in the
initial contact, a much delayed deceleration
occurs in the swing phase. Significant
small similarity appears in the mid-swing
phase.
A sharp rise in acceleration occurs in the
initial contact, following with very
unstable magnitude in the rest of the gait
cycle.
A sharp rise in acceleration occurs in the
initial contact, following with low and
unstable magnitude in the stance phase. A

366

Left

Same as right foot x.

Same as right foot y.

A sharp rise in acceleration in the
initial contact, a much delayed and
sharp rise in acceleration in the swing
phase.
Same as right shank x.

Same as right shank y.

Same as right shank z.

Same as right thigh x, significant small
similarity appears in the initial and
mid-swing phases.

Same as right thigh y.

Thigh z

Hip x

Hip y

Hip z

sharp rise in acceleration in swing phase.
Significant small similarity appears in the
pre-, initial, and mid-swing phases.
A sharp rise in acceleration occurs in the
initial contact, following with lower and
unstable magnitude in the rest of the gait
cycle. A much delayed and lower
acceleration occurs in the swing phase.
A sharp deceleration occurs in the initial
contact following with unstable magnitude
in the stance phase, a much delayed and
higher acceleration occurs in the swing
phase. Significant small similarity appears
in the mid-swing phase.
A sharp deceleration occurs in the initial
contact, following with unstable magnitude
in the rest of the stance phase. A much
delayed acceleration occurs in the swing
phase. Significant small similarity appears
in the initial swing phase.
A sharp rise in acceleration occurs in the
initial contact, following with unstable
magnitude in the rest of the gait cycle.
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Same as right thigh z.

Similar to right hip x, with more
unstable magnitude in the entire gait
cycle.

Same as right hip y.

Similar to right hip z.
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